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ABSTRACT 
 
The transition period in dairy cows is the most crucial time for both cow health and dairy 
management. Three experiments were conducted on transition dairy cows to evaluate the effects 
of prepartum overfeeding and lipid supplementation around parturition on hepatic mRNA 
expression using qPCR and microarray techniques.  
In the first experiment, we examined the expression of 44 genes associated with PPARα 
target genes including fatty acid oxidation, TAG metabolism and storage, potential related 
nuclear receptors (NRs) and FGF21 modulating GH/IGF signaling in cows (n = 6/diet) assigned 
to a control (CON; NEL = 1.34 Mcal/kg DM) or moderate-energy (OVE; NEL = 1.62 Mcal/kg 
DM) diet during the entire dry period. All cows were fed a common lactation diet (NEL = 1.69 
Mcal/kg DM) postcalving. Percutaneous liver biopsies were collected at -14, 7, 14, and 30 days 
relative to parturition (DIM) for transcript profiling via quantitative PCR. Estimated prepartal 
energy balance (EBAL) was greater (~159% vs. 102%, P<0.05) in OVE vs. CON, but during the 
first wk postpartum cows fed OVE prepartum were in more negative EBAL. Prior to calving, 
CON cows had greater (P < 0.05) serum FGF21, which corresponded with greater (P < 0.05) 
liver FGF21 expression. Concentration of FGF21 decreased (P < 0.05) gradually postpartum 
regardless of diet. Along with more severe negative EBAL, cows fed OVE vs. CON prepartum 
had greater (P < 0.05) postpartal concentrations of NEFA, BHBA, and GH in serum and liver 
triglyceride. Those data agreed with greater expression of ACOX1, CPT1A, ACADVL, HMGCS2, 
FGF21, and ANGPTL4 in OVE vs. CON at 7-14 DIM. Despite the gradual increase in serum GH 
after calving, at 7-14 DIM liver from cows fed OVE prepartum had greater (P < 0.05) IGFALS 
potentially to counteract the temporal decrease in hepatic GHR, STAT5ab, and IGF-1. Our 
results revealed transcriptional adaptations in liv
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energy overfeeding and postpartal negative EBAL leading to greater serum NEFA. . 
Transcriptional changes encompassed not only LCFA oxidation and GH signaling but also 
hepatokine production. 
In the second experiment, we examined blood metabolites and expression of 58 genes 
related to inflammation and ER stress in the same cows assigned (n = 6/diet) to CON or OVE 
diets during the entire dry period. All cows were fed a common lactation diet (NEL = 1.69 
Mcal/kg) postpartum. Blood was collected on d (± 3) -14, -5, -2, -1, 0, 1, 2, 5, 7, 10, 14 and 21 
relative to parturition. Percutaneous liver tissue biopsies were harvested at -14, 7, 14, and 30 d 
relative to parturition for transcript profiling via quantitative PCR. Estimated prepartal energy 
balance (EBAL) was greater (P < 0.05) for OVE and averaged 159% of requirements compared 
with 102% in CON. However, EBAL during the first week postpartum was lower in OVE (83% 
vs. 89% of requirements). After parturition the concentrations of ceruloplasmin, creatinine, 
bilirubin and reactive oxygen metabolites (ROM) were greater (Diet × Time; P < 0.05) in 
OVE.  Around calving the expression of ER and oxidative stress indicator genes XBP1, PERK, 
GRP94 and HSP40 was lower in OVE than CON but TRB3, HSPA1A, HSPA1B and CREB3L3 
had greater (Diet × Time; P < 0.05) expression in OVE. Expression postpartum of the 
inflammatory genes NFKB1, RELA, CHUK, MYD88, TNF, SAA3, and PTX3 increased (Diet × 
Time; P < 0.05) in OVE. Genes associated with cell growth (mTOR, RPTOR, AKT3, TP53) also 
had greater (Diet × Time; P < 0.05) expression in OVE after parturition. Overall, results 
indicated that postpartal negative EBAL induced by prepartal OVE was associated with hepatic 
pro-inflammatory and pro-stress upregulation.  
In the third experiment, we used a microarray platform to determine  expression of the 
hepatic transcriptome in dairy cows (n = 6/diet) fed no supplemental lipid (control) or fed 
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supplemental lipid from either Energy Booster 100 (a mixture of primarily saturated free fatty 
acids, mainly 16:0 and 18:0) or fish oil. Treatment diets were fed from -21 d until 10 d relative to 
parturition. The doses of lipid used were 250 g/d prepartum and 1% of the previous day’s feed 
intake postpartum. Percutaneous liver biopsies were harvested at -14, 1, and 14 d relative to 
parturition. A 13,257 bovine oligonucleotide (70-mers) array was used for transcript profiling. 
Pre- and postpartum feed intake, milk production, and body condition score were not affected by 
lipid supplementation. Blood NEFA (P = 0.06) and BHBA (P < 0.05) were lower postpartum in 
cows fed either lipid source but postpartal liver triacylglycerol did not differ in these cows (ca. 
4% wet weight) relative to controls (4.5%). Liver transcriptome analysis by microarray revealed 
a list of differentially expressed genes (DEGs) within diet and time comparisons. The number of 
DEG was greater at day 1 and day 14, and the contrast of EB100 vs. FO at d 14 had the highest 
number of DEGs within diet comparisons. Within time comparisons, feeding fish oil resulted in a 
greater number of DEGs and the effect was strongest at day -14. Further computational and 
bioinformatics analysis by KEGG pathways using DIA indicated highly impacted metabolic 
pathways in both diet and time comparisons. Carbohydrate and lipid metabolism were the 
pathways most impacted by feeding fish oil and EB100. Also, cell communication, immune 
system, endocrine system and nervous system of KEGG pathways were impacted among all 
comparisons. Gene ontology functional analysis of DAVID by DIA also uncovered the most 
impacted pathways of growth and cellular component organization in the biological processes 
(BP) category, biological adhesion and multicellular organismal process in the molecular 
functions (MF) category, and membrane–enclosed lumen and organelle part in the cellular 
components (CC) category. Results from this experiment showed that feeding saturated (EB100) 
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or unsaturated (fish oil) sources of fatty acids in transition cows induce strong changes in gene 
expression to control metabolism and other biological processes.   
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CHAPTER 1 
LITERATURE REVIEW 
Transition period 
The phase of transition from non-lactation to the start of lactation in dairy cows is called 
transition period or peripartal period (Drackley, 1999). Three weeks before to three weeks after 
parturition are considered as the transition period (Mulligan and Doherty, 2008). The better 
management of this period guarantees improved lactation yield, however, nearly 50 percent of 
transition dairy cows experience at least one health complication or problem during the transition 
period (Drackley et al., 2005) .  
The nutrient demands increases to promote fetal growth and onset of milk synthesis 
(Grummer et al., 1995). Usually, dry matter intake (DMI) fluctuates from lower at 1 wk 
prepartum to progressively increased at 3 wks postpartum (Bertics et al., 1992). Extensive 
metabolic and hormonal alterations are marked to regulate physiological processes of parturition 
and lactogenesis. Metabolism, esp. lipid metabolism, is affected by increased requirements of 
nutrients, strong variations in endocrine mechanism and the decline in DMI during late dry 
period (Grummer et al., 1995). Vital body organs i.e. liver, mammary gland, gut and adipose 
tissues experience sever changes to manage the essential energy balance required for the onset of 
lactation just after parturition (Drackley, 1999). Feeding strategy for dairy cows during the 
transition period makes a most crucial concern, associated with the this period such as mastitis, 
metritis and ketosis etc., of the dairy industry, optimized management practices would be 
expected to decrease the incidence of diseases.
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Feeding strategies for dairy cows 
The feeding strategies for transition dairy cows by the National Research Council (NRC 
2001) recommend a diet with 1.25 Mcal/kg of NEL for the first six wks of the dry period (far-
off), and a diet with 1.54 to 1.62 Mcal/kg of NEL for the last three weeks (close-up) prepartum. 
Two-group feeding strategy during the dry period prevents far-off overfeeding and promotes 
metabolic benefits during the close-up period (Overton and Waldron, 2004). Conversely, 
Friggens at al., (2004) reported that feeding high starch diet in the far-off part of the dry period 
did not decrease fat mobilization after calving or support DMI. Also, feeding lipid supplements 
in dairy cows management have been an important practice to minimize transition problems 
(Drackley, 1999). 
Pre-partum dietary energy 
Pre-partum dietary energy can be very crucial and help in better management of the 
transition period in dairy cows (Drackley, 1999). To feed dairy cows, the already set feeding 
strategy includes higher proportion of forage with more fiber as compared to the lactation diet 
and it benefits the rumen papillae in size and absorptive capacity along with the change in 
bacterial population (Goff and Horst, 1997). However, the above mentioned feeding strategy is 
very common and low in dietary energy but few research group reported the indication of higher 
energy consumption by dairy cows around parturition (Dann et al., 2006, Douglas et al., 2006, 
Janovick and Drackley, 2010). Furthermore, research on dairy cattle has been demonstrating 
whether dry period energy consumption may help in a successful transition of dairy cows 
(Douglas et al., 2006, Janovick and Drackley, 2010). Diet with low- energy higher fiber 
proportion can help to increase DMI, prevents; severe adipose tissue lipolysis (Douglas et al., 
2006), occurrence of displaced abomasum, reproductive stress, foot diseases and enhance the 
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body condition (Janovick and Drackley, 2010). In the result of high fiber diet, the greater rumen 
fill can help in reducing the occurrence of displaced abomasum and modulate feed intake.   
Progressive research, at the University of Illinois, has found that far-off dry period 
feeding strategy may be more vital than during the close-up period. Severe negative impacts 
were observed in the result of overfeeding during the far-off period as compared to close-up 
period on the metabolism during the transition period in dairy cows. On contrary, positive 
impacts were observed in postpartum DMI, higher milk yield and overall cow’s health feeding 
controlled energy during the far-off dry period (Dann et al., 2006). When Janovick and Drackley 
(2010) performed an experiment feeding high-fiber (low energy) diet to one group and a 
moderate-energy diet to second group during the entire dry period, they observed positive 
impacts of high fiber diet on prepartum DMI and lipid accumulation with serum BHBA 
concentrations postpartum in dairy (Janovick et al., 2011) 
Feeding diet with high grains (high energy) or overfed energy before calving results in a 
decline in DMI and excessive metabolic burden on liver and adipose tissues (Drackley et al., 
2005). Contrariwise, Douglas et al. (2006) reported a positive impact of feeding low or restricted 
energy prepartum on DMI and NEL around calving and up to 3 wks postpartum. Another study 
by Agenäs et al., (2003) showed similar results where overfed cows for 2 months prepartum has 
reduced DMI during early prepartum but lower energy fed cows improved DMI and had positive 
energy balance after parturition. A lower rate of hepatic β-oxidation but greater fatty acid 
esterification was observed in dairy cows overfed prepartum as compared with energy-resticted 
cows (Litherland et al., 2011). On the other hand, few research studies have reported the positive 
impacts of overfeeding energy prepartum. For instance, Vandehaar et al. (1999) observed 
positive NEL, enhanced body condition and body weight, and lower rate of metabolic disorders 
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postpartum in overfed dairy cows during dry period. Similarly Curtis et al. (1985) also reported 
fewer transition period disorders in the result of feeding higher energy than recommendations 
prepaprtum. In short, further advanced is important to evaluate the effects of high energy 
(overfed) or low energy (restricted fed or high fiber) diet fed during the entire dry period to early 
lactation or the conventional 2 group approach of feeding energy. 
In addition to change in feeding energy, DMI is also affected by social behavior in dairy 
cows at the level of dairy farm (Overton and Waldron, 2004). Hence, a systematic control and 
examination of herds may help in promoting positive effects at farms. Also, the nature and type 
of fiber is also important in regulating energy feeding requirements. This is obvious that higher 
dietary fiber supports rumen fill to regulate voluntary DMI (Dado and Allen, 1995) and can 
reduce digestibility in rumen to sustain its fill, function, and health (Allen et al., 2009). In case of 
fiber type, the concentration of neutral detergent fiber (NDF) is very important because it 
requires physical activity to chew before digestion (Mertens, 1997). Under all these available 
research data, we may suggest using controlled energy or lower energy (high fiber) balanced 
with optimum concentrations of minerals, vitamins, and metabolizable proteins.  
Effects of dietary fats  
Feeding supplemental fats and oils has been practiced in dairy cow management 
(Drackley, 1999). Research has characterized the effects of supplemental lipids on milk 
production and composition, intake and digestion of fats. The major focus of research with 
supplemental fats during the peripartal period was to investigate the effect of dietary fat on 
incidence of fatty liver or other metabolic disorders. In rodents and humans, dietary fats 
modulate lipid metabolism; in particular, n-3 unsaturated FAs decrease lipogenesis and increase 
FA oxidation (Jump, 2002). Similar adaptations in dairy cows could be important for the 
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utilization of dietary lipids (Drackley, 1999). Grum et al. (1996a) reported that fat supplements 
increased palmitate metabolism in liver of dairy cows. Another study by Grum et al. (1996b) 
indicated that a high-fat diet fed throughout the dry period resulted in a coordinated set of 
adaptations in lipid metabolism that resulted in less hepatic TG accumulation at parturition.  
Furthermore, many in vitro trials with calf hepatocytes have assessed the metabolism of 
saturated and unsaturated LCFA (Mashek and Grummer, 2003). It was observed that both 16:0 
and cis9-18:1 induced greater palmitate esterification into TAG, but the opposite response was 
observed with 18:2n-6 and 18:3n-3. During short-term incubations, 20:5n-3 and 22:6n-3 were 
more potent (2 to 4-fold greater) than other LCFA in inducing complete palmitate oxidation to 
CO2 (Mashek et al., 2002). Mashek et al. (2005) indicated that an intravenous emulsion of 
linseed oil or fish oil resulted in lower liver TAG accumulation, but the experiment by Kulich et 
al. (2006) reported that tallow was more beneficial than linseed oil to reduce hepatic TAG 
accumulation during feed restriction. However, in a recent study, cows fed supplemental lipid 
(saturated or unsaturated FA) had lower blood NEFA during the transition period, and greater 
blood glucose with similar dry matter intake and milk production during the first 2 weeks after 
parturition (Ballou et al., 2009). In the current project, we used a subset of liver samples from 
that study to uncover hepatic transcript expression on a large scale using a microarray platform.  
In rodents, several adaptations in enzyme activities due to a high fat supplemented diet 
are triggered by activation of specific nuclear receptors called peroxisome proliferator-activated 
receptors (PPAR) (Ferrè, 2004). In rodents, PPARα is predominantly found in liver, heart, 
kidney, and brown adipose tissue, with smaller amounts in skeletal muscle, small intestine, 
thymus, and testis; at least one of the isoforms of PPARγ is intimately involved in adipose tissue 
biogenesis. Activation of PPAR by FA, eicosanoids, or xenobiotics leads to binding of the PPAR 
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to specific response areas of target genes, leading to activation or repression of gene expression 
(Schoonjans et al., 1996). Peroxisome proliferator response elements have been identified in the 
promoter regions of a number of genes encoding proteins found in peroxisomes, mitochondria, 
microsomes, and cytosol that are involved in lipid metabolism.  
In our group at the NutriPhysioGenomics laboratory, we conducted a study to identify 
bovine PPARα targets among key genes associated with liver lipid metabolism and 
inflammation, several of which are well-established PPARα targets in non-ruminants, after 
treatment with Wy-14,643 (a potent PPARα agonist). Along with PPARα targets, the effects of 
several LCFA on PPARα activation were also determined by measuring expression of the 
bovine-specific PPARα genes (Loor, 2010). Madin-Darby Bovine Kidney cells (MDBK), which 
have been shown to be responsive to both PPARα (Wy-14,643) and PPARγ (rosiglitazone) 
agonists (Bionaz et al., 2008), were used for the study. Treatment with Wy-14,643 resulted in 
relatively fewer differentially expressed transcripts compared with previous findings in the non-
ruminant literature (Guo et al., 2007). Of all LCFA tested, results indicated that both 16:0 and 
18:0 caused the strongest effects on gene expression leading to changes in transcription of 17 
genes, 11 of which are PPARα targets in non-ruminants. The overall induction of gene 
transcription with either 16:0 or 18:0 was greater than Wy-14,643, suggesting that they are more 
potent activators of bovine PPARα. In fact, it is challenging to compare the effect of all LCFA 
across all the mentioned studies.  The responses to saturated/monounsaturated LCFA in the 
bovine are interesting because in non-ruminants PUFA are more potent activators of oxidation 
(Jump, 2008). Further molecular analysis of protein function and transcript profiling may help us 
to better understand the complexities of the effects of lipid supplements in the diet of dairy cows.   
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Energy balance in the transition cow 
The stored energy in tissues reservoirs and in feed components is used to sustain an 
energy balance in animals (Baile and Forbes, 1974). In dairy cows, the reduction in DMI marked 
the restricted dietary energy intake which can ultimately affect the energy balance during the 
entire transition period (Bertics et al., 1992). Moreover, the increasing demand of nutrients 
during pregnancy and for milk synthesis after onset of lactation is an additive factor to reduced 
DMI hence negatively affects energy balance (Grummer, 1995). At the onset of lactation, 
transition dairy cows require adequate nutrients for protein synthesis and production of lactose 
triacylglycerides (TAGs) in mammary glands (Bell et al., 1995). To fulfill the requirement of 
glucose and lactose in mammary gland, almost 66 % requirement are met by dietary glucose and 
33 % glucose requirement is supplied by the mobilization of glycerol, adipose tissue and amino 
acids of muscle and other related body protein (Bell et al., 1995).  
Combined effects of reduced DMI and gradually increased requirement of nutrients 
results in an overall negative energy balance (NEB). Adipose tissues release NEFA in the result 
of lipolysis and manage to fulfill the energy demand around this crucial time of transition period
 
(Drackley et al., 2001). Negative energy balance is considered as a natural part of lactation cycle 
but extreme NEB affects the overall health including fitness and production of dairy industry 
(Koltes and Spurlock, 2011), greater chances of metabolic disorders e.g., ketosis and fatty liver 
(Drackley, 1999). Also NEB is associated with increasing chances of digestive and locomotive 
complications around parturition (Collard et al., 2000).  
Dry matter intake 
For the maximum production in the dairy industry, DMI is the most crucial factor to 
maintain the demand and availability of nutrients (Drackley et al., 2006). The maximum milk 
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production has been observed up to 1 to 2 months postpartum but DMI was at maximum after 2 
to 5 months of lactation (Ingvartsen and Andersen, 2000). The glucose requirement in lactating 
dairy cows increases 2-3 folds than prepartum (Drackley et al., 2001, Overton et al., 1998), 
specifically, Bell (1995) claimed 3 times greater requirement for glucose,  2 times for amino 
acids (AA) and almost 5 times for FA between 9 months of pregnancy and 1 wk of early 
lactation. These extreme changings in nutrients requirements cannot be fulfilled only by DMI. 
Usually, prepartum overfed cows have lower DMI postpartum although the rate of DMI 
fluctuates around parturition. The degree of fat mobilization under NEB to meet the requirements 
of energy for milk synthesis depends on eating rate as well (Goff, 2006). Moreover, a milking 
parlor or milking herd should be established to regulate maximum DMI because of social 
behavior (Dickson, 1970).  
Extreme metabolic changes occur in liver after parturition due to overfed energy 
prepartum (Vandehaar et al., 1999) and these changes results into decrease in hepatic NEFA 
clearance (Goff and Horst, 1997). Severe metabolic changes around parturition especially in 
body condition score (BCS) are harmful for successful transition period.   
Importance of liver 
To reach the required energy for production, lipid metabolism plays the most important 
metabolic role in transition cows. The release of NEFA from adipose tissue into the bloodstream 
increases as a result of adipose lipolysis around parturition (Drackley et al., 2005). Blood NEFA 
concentrations are only modestly affected by dietary FA absorbed from gut. After absorption, 
dietary FAs are packaged into lipoproteins, which deliver dietary FA to peripheral tissues. 
Dietary FAs result in small elevations of NEFA concentration due to LPL action in peripheral 
tissues. Remnant lipoproteins and HDL are cleared by the liver, thereby delivering some FA to 
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the liver (Drackley, 1999). Blood NEFA mainly indicates energy status of the animal.  From the 
bloodstream, NEFA can be utilized as an energy source by other tissues (Drackley, 1999) but the 
liver is the most important site for removal of NEFA (Bell, 1979). In the liver, NEFA can be 
converted into acyl-CoA by the activity of acyl-CoA synthetase (ACS), then carnitine acyl 
transferase (CPT) transports acyl-CoA into the mitochondria matrix where β-oxidation occurs 
(Zammit, 1984). The end product of β-oxidation, acetyl CoA, can be oxidized for energy in citric 
acid (TCA) cycle or converted into ketone bodies. β-oxidation of long chain fatty acids (LCFA) 
also occurs in hepatic peroxisomes that may provide an oxidative pathway to utilize excess 
uptake of NEFA around parturition (Douglas et al., 2006, Drackley et al., 2001). Parallel β-
oxidation in mitochondria and peroxisome might have reduced hepatic accumulation of TG in 
cows restricted fed during the dry period (Douglas et al., 2006). In the interim, if the oxidation 
capacity of acetyl CoA declines due to reduced capacity of TCA metabolites then synthesis of 
ketone bodies (acetoacetate, β-hydroxybutyrate and acetone) may occur (Drackley, 1999). When 
glucose level is limited the ketone bodies are released into blood-stream from liver (Bell, 1979) 
and available as an alternative water-soluble fuel source by several tissues (e.g., heart and 
skeletal muscle). However, ketones accumulate and may negatively affect the health and 
productivity of the cow, if the rate of lipid mobilization surpasses the rate of ketone body 
consumption (Ingvartsen and Andersen, 2000). Ketosis results when greater than normal level of 
ketone bodies accumulate in the blood.    
Non-esterified fatty acids (NEFA) esterify and release from the liver into blood-stream as 
TAGs packaged in very low density lipoproteins (VLDL) and available for extra-hepatic tissues 
i.e., the mammary gland, where they incorporate into milk fat TAG (Smith et al., 1997). 
Metabolic disorder of fatty liver may occur if the rate of esterification surpasses the rate of TAG 
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release from liver (Drackley, 1999). Similarly, Morrow (1976) reported that if NEB increases 
then the ability of the hepatic cells to utilize NEFA and secrete triglycerides decreases in 
transition dairy cows. Therefore, TGs can build up in the liver, decreasing liver function and 
eventually causing liver lipidosis (Drackley, 1999). Severe lipid infiltration in the liver makes 
dairy cows more susceptible to other pathologies (Herdt, 1988). 
Fibroblast growth factor and growth hormone 
Fibroblast growth factor 21 (FGF21) is an unusual member of the FGF family, which 
also includes FGF19 and FGF23 (Itoh, 2010), that functions as an endocrine hormone 
(Kharitonenkov et al., 2005). In non-ruminants (mice), FGF21 is induced in liver by fasting 
which requires PPARα (Inagaki et al., 2007) and trigger the synthesis of ketone bodies which is 
an energy fuel during sustained fasting and starvation. FGF21 also sensitizes mice to the energy-
conserving state of torpor, which is characterized by decreased body temperature and physical 
activity (Inagaki et al., 2007). 
Many physiological processes, growth and metabolism are regulated by growth hormone, 
which is secreted in the anterior pituitary (Inagaki et al. 2008). Many of the anabolic actions of 
GH are mediated by insulin-like growth factor 1 (IGF-1). Growth hormone binds to GH receptor 
and activates IGF-1 transcription through a complex series of reactions on the cell surface. The 
binding of GH with GHR induces janus kinase 2 (JAK2) expression, which in turn 
phosphorylates members of the signal transducers and activators of transcription (STAT) family. 
Once phosphorylated STAT proteins translocate to the nucleus, where they bind to response 
elements in the regulatory regions of target genes including IGF-1 (Inagaki et al. 2008). Inagaki 
et al. (2008) indicated that FGF21 is very important in stimulating energy conservation during 
starvation  by preventing STAT5 signaling to blunt growth. In transition dairy cows, the NEB 
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after parturition leads to metabolic condition where liver experiences drastic changes that require 
energy conservation to maintain homeostasis.  Early lactation is a physiological state in which 
the lipid is an important source of energy and dependent on cross-talk between adipose tissue 
(AT) and liver and this relationship is reported in high-milk producing dairy cows (Vernon et al., 
2002). After calving in dairy cows, NEFA mobilize extensively from AT and remains high 
during the first four weeks of lactation, cover one-third of total energy requirement (Drackley et 
al., 2001). This metabolic shift to facilitate transition period is controlled by several hormonal 
mechanisms where AT and liver play the primary role. Antilipolytic hormone insulin level 
decreases and β-adrenergic tone increase in AT to activate NEFA mobilization (Bell et al., 
1995).   
In liver, PPARα activates β-oxidation in response to incoming NEFA in the liver. 
However, the mechanism of cross-talk between AT and liver to control the oxidative capacity is 
not well-known in dairy cows. Any drastic change in this coordinated relationship can cause 
different metabolic disease associated with extensive lipolysis and accumulation of TAG in liver. 
(Goff, 2006). The role of FGF21 is a novel which regulates the mechanism of lipolysis in AT, 
oxidation in liver (Kliewer and Mangelsdorf, 2010), maintain a significant release in blood and 
act only in Klotho or β-Klotho expressing tissues (Itoh, 2010). In non-ruminants, the elevated 
level of FGF21 was measured in response to conditions of higher lipid use e.g. during 
consumption of ketones, fasting and also β-Klotho expressing tissues. This behavior of FGF21 is 
very important because elevated TAG accumulation was observed in liver of FGF21 null mice 
with ketogenic diets and also greater rate of lipolysis upon fasting (Inagaki et al., 2007). 
Schoenberg et al. (2011) conducted an experiment in dairy cows to evaluate the 
expression of FGF21 during transition. They reported that parturition and early lactation cause a 
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dramatic increase in plasma FGF21 and liver is unique among surveyed tissues as a contributor 
to this effect. Additionally, several studies also have suggested that lactation affects β-Klotho 
and FGFR expression in liver but not in WAT and have excluded the mammary gland as an 
FGF21 target tissue.  
Endoplasmic reticulum stress and inflammation 
Highly regulated and synchronized operation of many homeostatic systems are required 
for energy and nutrient management in all organisms (Hotamisligil, 2010). Food intake with 
extra or high energy can cause pressure on cellular machinery of organs to metabolize 
ingredients, especially liver because it is the central organ for whole body metabolism. 
Endoplasmic reticulum (ER), the organelle responsible for protein folding, maturation, quality 
control, and trafficking, can be the major target. When the ER becomes stressed due to the 
accumulation of newly synthesized unfolded proteins, the unfolded protein response (UPR) is 
activated.  The UPR has three branches to control stress and intersect with a number of stress and 
inflammatory systems e.g., JNK-AP1 and NF-κB-IκB kinase (IKK) pathways along with 
molecular networks triggered by oxidative stress and impact metabolism. Inflammation and ER 
stress are connected at numerous levels: both are short-term adaptive systems essential for the 
function and survival of the organism and both are detrimental when chronically engaged 
(Hotamisligil, 2010).  
The ER is an organelle with network of membranes and the place for synthesis, post-
translational modifications of proteins. It has a prime importance for cell due to its capacity to 
manage abrupt and adverse conditions as a vital regulator of protein maturation, folding of 
proteins, quality control, trafficking, and targeting of nascent proteins. Any extra burden on ER 
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due to increased rate of protein processing or accumulation of unfolded proteins inside the lumen 
activated an adaptive response of UPR (Ron and Walter, 2007). 
During lactation in dairy cows, progressively increased milk production causes severely 
increased metabolic demands for energy resulting in extensive mobilization of body fat reserves. 
Consequently, this period of NEB can persist for many weeks, and fatty acid catabolism can 
result in the accumulation of triglycerides in the liver and increased systemic concentrations of 
lipid metabolites in the blood resulting in a period of oxidative stress (Morris et al., 2009). 
Oxidation of NEFAs in the liver result in the increased production of reactive oxygen species 
(ROS), decreased paraoxonase activity, and the onset of oxidative stress (Turk et al., 2008). This 
may be linked to depression of the immune system in early lactation, resulting in dairy cows 
becoming more vulnerable to bacterial infections at this time (Morris et al., 2009).   
In our group, Loor (2010) has identified several metabolic genes involved in stress and 
inflammation. Glutathione S-transferase mu 5 (GSTM5) encodes a protein involved in 
detoxification of electrophilic compound and is known to be markedly reduced in dairy cows 
during the transition period (Loor et al., 2005). Expression of GSTM5 decreased by 1 day after 
parturition and remained down-regulated through the first 2 weeks after parturition (Loor et al., 
2005), a period that is characterized by increased oxidative stress as well as immunosuppression 
(Loor, 2010). Yan et al. (2009) indicated a role for FABP1 in cellular antioxidant defense 
mechanisms, potentially through binding of LCFA peroxidation products. Through binding of 
polyunsaturated LCFA (PUFA), FABP1 can modulate the availability of these fatty acids to 
intracellular oxidative pathways and thus control the amount of ROS released within the cell. 
Also, genes encoding serum amyloid A1 (SAA1), tumor necrosis factor-α (TNFA) and IFN-γ-
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related proteins were found to be up-regulated after parturition compared with pre-partum or 2 
weeks post-partum in cows fed to meet prepartal energy requirements (Loor et al., 2005).  
Gene expression technology 
Gene expression technologies has recent development to improve the capacity to better 
analyze and understand the absolute and relative changes that occur at the gene expression level  
due to the effect of several  experimental treatments. The expression levels of genes can be 
instantaneously measured  to study the possible outcomes  of  different experimental conditions 
e.g., treatments, diseases, and developmental stages (Liang et al., 2002). Microarrays are 
considered as static measure of gene expression because activity, transcription and the regulation 
of enzymes cannot be investigated using this approach, although, it  provides a global assessment 
of gene expression across different comparisons.. However, this discrepancy can be improved by 
applyingother molecular technologies e.g., real time quantitative (RT) PCR, immunoblotting etc. 
and using bioinformatics approaches to uncover further relevant information on likely biological 
functions affected by the genes with altered expression. . The advancements with  new molecular 
biology procedures are helpful in understanding the basics of the models used in dairy cattle 
research and  provide promising results.  
Spotted-microarrays are tiny glass chips with series of oligonucleotides (small DNA 
fragments). These oligonucleotides are made to encode and represent specific regions of the 
genes in the genome of a specific species. Expressed sequence tags (EST) can be used to 
construct microarrays  using the species-specific information from genome sequencing projects 
which provide bulk of large sets of annotated clones and sequences of each gene (Rimm et al., 
2001). Covalent bonding using surface engineering is used to attach oligonucleotides  on a glass 
chip. Furthermore, a cDNA probe is constructed from RNA extracted form relevant samples, 
16 
 
radiolabelled, and then hybridized on chip as oligonucleotide. After running microarray 
experiment, LASER scanner or autoradiographic imaging is used for signal intensity data for 
each spot on a microarray slide then converted to digital figures before uploading into a 
commercially available database and analyzed. 
The large data sets generated by microarray experiments can be used to analyze most 
enriched biological pathways. We have utilized databases; Ingenuity Pathway Analysis (IPA), 
Kyoto Encyclopedia of Genes and Genomes (KEGG), and Database for Annotation, 
Visualization, and Integrated Discovery (DAVID) v6.7 in chapter 4 to analyze the effects of lipid 
supplements on transition dairy cows.  
Briefly, commercially available KEGG database was started in 1995 under the Human 
Genome Project of Ministry of Education Science Support and Culture in Japan. This database is 
divided into three main databases given in KEGG website: 1) pathways, 2) genes and 3) ligands. 
This database provides molecular information of major functions associated with the network of 
molecules e.g., major categories, categories and sub-categories. The information about all the 
genes of genomes has completely or partially sequenced is available on KEGG genes (Kanehisa 
and Goto, 2000). For large gene data sets or gene lists DAVID is used which is a web based 
functional annotation tool for large gene list or datasets. The very first version of DAVID started 
in 2003 and was available online, however, it has been  approved and updated with more tools in 
version 6 (Huang da W., 2007) which can help to answers questions related to  large lists of 
genes.  It helps to identify what genes and gene families are present in a given gene list or what 
annotation terms or groups are enriched for any given gene list (Huang da W., 2007). 
A  13,257-oligonucleotide bovine microarray has been developed in University of Illinois 
that is the advanced representation of previously developed 7,000 cDNA micro array 
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platform(Everts et al., 2005). The extensive details of the development and related procedure of 
the microarray platform used in chapter 4 can be found in the Supplementary Materials and 
Methods from Loor et al. (2007). Briefly, an embryonic bovine cDNA library and 38,732 high-
quality expressed sequence tag (EST) sequences based on the cattle 7,872 cDNA array (Everts et 
al., 2005) were filtered for repeats as well as sequences of viral, bacterial, or mitochondrial 
origin using Repeat Marker. Subsequently, seventy-base long (i.e., 70-mers) oligos from the 
unique cluster and singlet sequences were designed. Sequence alignments of designed oligos 
were done by BLASTN similarity searches against human RefSeq, mouse RefSeq, bovine 
RefSeq, human UniGene, mouse UniGene, bovine UniGene, bovine TIGR and the bovine 
genome using an E-value cut-off of E ≤ e-5 and scoring threshold of 40 bp (Everts et al., 2005). 
Best hits were used to annotate the cattle sequences. NCBI UniGene and Gene databases were 
used for functional annotation (e.g., gene symbol, gene name, function, OMIM number, and 
PubMed identification numbers) and Gene Ontology (GO) annotation (Everts et al., 2005). This 
microarray contains ca. 97% unique elements.   
At University of Illinois, our  group has uncovered  large-scale genomic data for bovine 
liver (Loor et al., 2005, Loor et al., 2006, Loor et al., 2007), Adipose tissue, rumen epithelium, 
polymorphonuclear cells and mammary tissues (Moyes et al., 2010, Piantoni et al., 2010). The 
microarray data from these studies has been used to explain the differences in gene expression 
observed in experimental and control groups from animal studies. Using the gene expression data 
along with blood metabolites to study hepatic tissue adaptations in function under different 
dietary conditions is a promising approach to study unexplored mechanisms in transition cows. 
In this dissertation, the use of microarray technology has been applied to study the alterations in 
gene expression in hepatic tissues from transition cows under different amounts and types of 
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lipid supplementation. The microarray data can uncover the importance of essential genes, which 
can help us in better determining appropriate dietary lipid supplementation for transition dairy 
cows. 
The mRNA expression of several important genes  including lipid metabolism, 
heptokines e.g., FGF21, growth hormones, nuclear receptors, inflammation, endoplasmic 
reticulum stress, oxidative stress and whole transcriptome adaptations in liver of transition dairy 
cows was evaluated to better understand the molecular changes due to the effect of high energy 
diet fed prepartum and lipid supplementations around parturition. The relation between gene 
expression and physiological effects can help in designing appropriate diets with the outcome of 
better cow’s health, dairy management and maximum milk production. The specific objectives 
were to measure hepatic gene expression and blood concentrations of metabolites and hormones 
related with homeorhetic adaptations, inflammation and ER stress gene networks in dairy cows 
fed two levels of dietary energy prepartum and to evaluate large-scale hepatic gene expression in 
response to two types of lipid supplements fed during the transition period in dairy cows.     
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CHAPTER 2 
 
Expression of hepatic PPARα regulated gene networks in Holstein cows is altered 
by prepartal level of dietary energy 
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INTRODUCTION 
Peripartal dairy cows are susceptible to several metabolic disorders associated with 
negative energy balance (NEB) during late pregnancy through peak lactation (Drackley, 1999). 
The NEB leads to mobilization of long-chain fatty acids (LCFA) stored in adipose tissue, 
causing a striking increase in blood NEFA and β-hydroxybutyrate (BHBA) (Drackley, 1999). An 
important player helping coordinate homeorhesis during the peripartal period is growth hormone 
(GH), which increases around calving and remains elevated for several weeks after parturition 
(Lucy, 2008). Another important function of GH is to promote the synthesis of IGF-1, which can 
then help control growth and function of cells and tissues throughout the body (Le Roith et al., 
2001).  
Although NEFA can be utilized as an energy source by other tissues the liver is the most 
important site for its removal from bloodstream (Drackley, 1999). In liver, NEFA can be 
oxidized via β-oxidation to produce ATP or be esterified to triacylglycerol (TAG), which if 
excessive can become a potential metabolic burden (Drackley, 1999). In monogatrics, several 
transcription factors (TF) and their target enzymes control lipid metabolism in liver and 
numerous studies clearly indicate that peroxisome proliferator-activated receptor α (PPARα, 
gene symbol PPARA) is one of the key TF coordinating hepatic lipid metabolism particularly 
during high-fat feeding or undernutrition leading to NEB (Mandard et al., 2004; Martinez-
Jimenez et al., 2010).  
Among the most-important functions coordinated by PPARα include LCFA uptake, 
activation and oxidation, and ketogenesis (Mandard et al., 2004).  Similar to the expression of its 
target genes involved in lipid metabolism [CPT1A, ACOX1, HMGCS2, ACADVL (Loor, 2010)], 
the expression of (PPARA) in bovine liver increases from late pregnancy to early lactation (Loor 
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et al., 2005). However, some studies have also reported up-regulation after calving of PPARA 
target genes without any change in PPARA expression (Carriquiry et al., 2009; van Dorland et 
al., 2009).  
A novel role of PPARα uncovered in recent years is the induction of fibroblast growth 
factor 21 (FGF21) (Rakhshandehroo et al., 2010), which appears to be essential for activation of 
hepatic ketogenesis. This “hepatokine” along with angiopoietin-like 4 (ANGPTL4) (Loor et al., 
2007) are secreted from liver as a result of PPARα activation during fasting (Potthoff et al., 
2012) and high-fat feeding (Carriquiry et al., 2009). In β-klotho-expressing tissues such as liver 
and white adipose tissue (Schoenberg et al., 2011), the signaling response to FGF21 requires a 
functional β-klotho as a co-receptor to augment its binding to FGF receptors (FGFR). An 
additional function of FGF21 in liver is to block GH signaling in liver, thus, decreasing IGF-1 
(Kliewer and Mangelsdorf, 2010) and compromising cellular growth (Inagaki et al., 2008). 
Specifically, FGF21 decreases the phosphorylation of STAT5 and the expression of IGF1 
(Kliewer and Mangelsdorf, 2010).  
  Although few data on the functional importance of PPAR activation in ruminants are 
available, a recent review underscored the importance that the PPARα signaling network might 
have in helping coordinate metabolic adaptations in peripartal bovine liver (Bionaz et al., 2013).  
A better understanding of the relevance of molecular adaptations in the control of hepatic cellular 
adaptations to prepartal energy level and the onset of lactation could be obtained by not only 
focusing on expression of PPARA but also its target genes. Our general hypothesis was that 
prepartal dietary energy and the onset of lactation affects the hepatic gene expression of PPARA 
and its target genes. The specific objectives were to measure gene expression and blood 
concentrations of metabolites and hormones related with homeorhetic adaptations.     
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MATERIALS AND METHODS 
Animals and diets  
All procedures were performed under protocols approved by the University of Illinois 
Institutional Animal Care and Use Committee (protocol # 06145). Details of the experimental 
design have been published previously (Graugnard et al., 2012; Graugnard et al., 2013). Briefly, 
twelve out of forty Holstein cows in their second or greater lactation were selected for this study. 
One group of cows was assigned to a control (CON) high wheat-straw diet, i.e. ~41.9% of total 
ingredients, that was fed for ad libitum intake to supply at least 100% of calculated net energy 
for lactation (NEL, 1.34 Mcal/kg DM; Supplementary Table 1). Another group of cows was fed a 
moderate-energy diet (OVE, 1.62 Mcal/kg DM) with corn silage as the major dietary component, 
i.e. ~50.3% of total, to supply >140% of calculated NEL requirements during the entire dry 
period (~45 d). Diets were fed as a total mixed ration (TMR) once daily (0600 h) using an 
individual Calan (American Calan, Northwood, NH, USA) gate feeding system during the dry 
period or in open individual managers during lactation. Calculation of energy balance, sampling 
of feed ingredients and TMR for composition analyses, and housing of cows pre and postpartum 
were as reported previously. Also, details of BW, BCS, milk weights and sampling of milk 
composition were as described previously (Graugnard et al., 2012; Graugnard et al., 2013)  
Blood metabolites 
Blood was sampled from the coccygeal vein or artery on d (± 3) -14, -5, -2, -1, 0, 1, 2, 5, 
7, 10, 14 and 21 days relative to parturition. Samples were collected at 1200 h into evacuated 
serum tubes (Becton Dickinson Vacutainer Systems, Franklin Lakes, NJ, USA) containing either 
EDTA or lithium heparin for plasma and a clot activator for serum. After blood collection, tubes 
with EDTA and lithium heparin were placed on ice while tubes with clot activator were kept at 
~37 °C until centrifugation (~30 min). Serum and plasma were obtained by centrifugation at 
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1,900 × g for 15 min. Aliquots of serum and plasma were frozen (-20°C) until further analysis. 
Measurements of NEFA, BHBA, and glucose were performed using commercial kits in an auto-
analyzer at the University of Illinois Veterinary Diagnostic Laboratory (Urbana, IL, USA). 
Triacylglycerol was measured using a commercial kit (LabAssayTM Triglyceride, Wako 
Chemicals Inc.) following the manufacturer’s protocol.  FGF21 was determined using a 
commercial ELISA kit validated for bovine (BioVendor Research and Diagnostic Products) (See 
supplementary file).  
Validation of FGF21 ELISA kit for bovine samples by Western Blotting (WB) 
Primary antibody against FGF21, protein markers and precast gels, and HRP anti-goat 
secondary antibody were purchased from BioVendor Research and Diagnostic Products, BioRad 
and GE Healthcare, respectively. SDS – PAGE was performed to detect FGF21 protein in bovine 
plasma samples (CON and OVE) diluted 20X with Laemmli sample buffer. A total of 15 uL of 
each diluted plasma sample was loaded on a 12% discontinuous polyacrylamide gel with a 4% 
stacking gel and the gel was run for 90 min. For WB analysis, proteins on gels were transferred 
to a nitrocellulose membrane then blocked with 3% BSA in Tris-buffered saline (pH 7.6) with 
0.1% Tween-20 (TBST) for 1 h at room temperature (RT) with continuous gentle agitation. After 
blocking, the membrane was washed three times (10 min each) with TBST and then incubated 
with primary antibody at a 1:1000 dilution. After incubation overnight with primary antibody, 
the membrane was washed six times (5 min each), and then incubated at RT for 1 h with HRP-
conjugated secondary antibodies at a 1:5000 dilution with 2.5 % added milk in TBST. The 
membrane was rinsed shortly with water and then horseradish peroxidase (HRP) activity was 
visualized with ECL chemiluminescence to reveal specific interactions using ImageQuant4010  
(GE HealthCare) imaging system (supplementary Figure 1). 
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Liver tissue 
Liver was sampled via puncture biopsy (Dann et al. 2006) from cows under local 
anesthesia at approximately 0700 h on d (± 3) −14 and 7, 14 and 30 relative to parturition. Liver 
was frozen immediately in liquid nitrogen and stored until further analysis for contents of total 
lipids and TAG (Dann et al., 2006) or used for RNA extraction.  
RNA extraction and quantitative PCR analysis 
RNA samples were extracted from frozen tissue using established protocols in our 
laboratory (Loor et al., 2007). Briefly, liver tissue was weighed (~0.3-0.5 g) and placed in a 15-
mL centrifuge tube (Corning Inc. ®, Corning, NY, USA) containing 5 ml of ice-cold Trizol 
reagent (Invitrogen Corp., Carlsbad, CA, USA) and 1 µL Linear Acrylamine (Ambion, Austin, 
TX, USA). The RNA extraction procedure also included acid-phenol chloroform (Ambion® ), 
which removes residual DNA. Any remaining genomic DNA was removed from RNA with 
DNase using the RNeasy Mini Kit columns (Qiagen, Hilden, Germany). The RNA concentration 
was measured using a Nano-Drop ND-1000 spectrophotometer (Nano-Drop Technologies, 
Wilmington, DE, USA). The purity of RNA (A260/A280) for all samples was above 1.81. The 
quality of RNA was evaluated using the Agilent Bioanalyzer system (Agilent 2100 Bioanalyzer, 
Agilent Technologies, Santa Clara, CA, USA). The average RNA integrity number (RIN) value 
for samples was 8.0 ± 0.4.  
qPCR Analysis: 
For qPCR, cDNA was synthesized using 100 ng RNA, 1 µg dT18 (Operon 
Biotechnologies, Huntsville, AL, USA), 1 µL 10 mmol/L dNTP mix (Invitrogen Corp., CA, 
USA), 1 µL random primer p(dN)6 (Roche®, Roche Diagnostics GmbH, Mannheim, Germany), 
and 10 µL DNase/RNase free water. The mixture was incubated at 65 °C for 5 min and kept on 
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ice for 3 min. A total of 6 µL of master mix composed of 4.5 µL 5X First-Strand Buffer, 1 µL 
0.1 M dithiothreitol, 0.25 µL (50 U) of SuperScriptTM III RT (Invitrogen Corp.CA, USA), and 
0.25 µL of RNase Inhibitor (10 U; Promega, Madison, WI, USA) was added. The reaction was 
performed in an Eppendorf Mastercycler® Gradient using the following temperature program: 25 
°C for 5 min, 50 °C for 60 min and 70 °C for 15 min.  cDNA was then diluted 1:4 (v:v) with 
DNase/RNase free water.  
Quantitative PCR (qPCR) was performed using 4 µL diluted cDNA (dilution 1:4) 
combined with 6 µL of a mixture composed of 5 µL 1 × SYBR Green master mix (Applied 
Biosystems, CA, USA), 0.4 µL each of 10 µM forward and reverse primers, and 0.2 µL 
DNase/RNase free water in a MicroAmp™ Optical 384-Well Reaction Plate (Applied 
Biosystems, CA, USA). Each sample was run in triplicate and a 6 point relative standard curve 
plus the non-template control (NTC) were used (User Bulletin #2, Applied Biosystems, CA, 
USA). The reactions were performed in an ABI Prism 7900 HT SDS instrument (Applied 
Biosystems, CA, USA) using the following conditions: 2 min at 50 °C, 10 min at 95 °C, 40 
cycles of 15 s at 95 °C (denaturation) and 1 min at 60 °C (annealing and extension). The 
presence of a single PCR product was verified by the dissociation protocol using incremental 
temperatures to 95 °C for 15 s plus 65 °C for 15 s.  Data were calculated with the 7900 HT 
Sequence Detection Systems Software (version 2.2.1, Applied Biosystems, CA, USA). The final 
data were normalized using the geometric mean (V2/3 = 0.20) of ubiquitously-expressed 
transcript (UXT), glyceraldehyde-3-phosphate dehydrogenase (GAPDH), and ribosomal protein 
S9 (RPS9).  
Primers were designed using Primer Express 2.0 or 3.0 with minimum amplicon size of 
80 bp (when possible amplicons of 100-150 bp were chosen) and limited 3’ G+C (Applied 
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Biosystems, CA). When possible, primers were designed to fall across exon–exon junctions. 
Primers were aligned against publicly available databases using BLASTN at NCBI and UCSC’s 
Cow (Bos taurus) Genome Browser Gateway (Supplementary Table 2, 3). Prior to qPCR, 
primers were tested in a 20 µL PCR reaction using the same protocol described for qPCR except 
for the final dissociation protocol. For primer testing we used a universal reference cDNA (RNA 
mixture from 5 different bovine tissues) to ensure identification of desired genes. Five µL of the 
PCR product were run in a 2% agarose gel stained with ethidium bromide (2 µL). The remaining 
15 µL were cleaned using QIAquick® PCR Purification Kit (QIAGEN) and sequenced at the 
Core DNA Sequencing Facility of the Roy J. Carver Biotechnology Center at the University of 
Illinois, Urbana-Champaign. Only those primers that did not present primer-dimer, presented a 
single band at the expected size in the gel, and had the right amplification product (verified by 
sequencing) were used for qPCR. The accuracy of a primer pair also was evaluated by the 
presence of a unique peak during the dissociation step at the end of qPCR.  
Efficiency of PCR amplification for each gene was calculated using the standard curve 
method [E = 10(-1/slope)] (Supplementary Table 4). mRNA abundance among measured genes was 
calculated as previously reported (Bionaz and Loor 2011), using the inverse of PCR efficiency 
raised to ∆Ct (gene abundance = 1/E∆Ct, where ∆Ct = Ct sample - geometric mean Ct of 3 
internal control genes; Supplementary Table 4). The % relative mRNA abundance for each 
transcript measured was calculated using the ratio of median ∆Ct of the gene/median ∆Ct of 
internal control genes (Supplementary Figure 2). Use of this technique for estimating relative 
mRNA abundance among genes was necessary because relative mRNA quantification was 
performed using a standard curve (made from a mixture of RNA), which precluded a direct 
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comparison among genes. Together, use of Ct values corrected for the efficiency of amplification 
plus internal control genes as baseline overcome this limitation.  
Genes selected for transcript profiling in this study were peroxisome proliferator-
activated receptor alpha (PPARA), peroxisome proliferator-activated receptor delta (PPARD), 
acyl-CoA dehydrogenase, very long chain (ACADVL), acyl-CoA oxidase 1(ACOX1), perilipin 2 
(PLIN2), abhydrolase domain containing 5 (ABHD5), diacylglycerol O-acyltransferase 1 
(DGAT1), diacylglycerol O-acyltransferase 2 (DGAT2), carnitine palmitoyltransferase 1A 
(liver) (CPT1A), 3-hydroxy-3-methylglutaryl-CoA synthase 2 (HMGCS2), retinoid X receptor, 
alpha (RXRA), angiopoietin-like 4 (ANGPTL4), coactivator-associated arginine 
methyltransferase 1 (CARM1), trimethylguanosine synthase 1 (TGS1), nuclear receptor 
interacting protein 1 (NRIP1), nuclear receptor coactivator 1 (NCOA1), nuclear receptor 
coactivator 3 (NCOA3), nuclear receptor corepressor 2 (NCOR2), mediator complex subunit 1 
(MED1), cytochrome b5 type A (CYB5A), RAR-related orphan receptor A (RORA), ATP-binding 
cassette, sub-family D (ALD), member 1 (ABCD1), lipin 1 (LPIN1), apolipoprotein B (APOB), 
microsomal triglyceride transfer protein (MTTP), apolipoprotein A-V (APOA5), fatty acid 
binding protein 1, liver (FABP1), stearoyl-CoA desaturase (delta-9-desaturase) (SCD), carnitine 
O-octanoyltransferase (CROT), glycosylphosphatidylinositol anchored high density lipoprotein 
binding protein (GPIHBP1), patatin-like phospholipase domain containing 3 (PNPLA3), 
fibroblast growth factor 21 (FGF21), fibroblast growth factor receptor 1 (FGFR1), ibroblast 
growth factor receptor 2 (FGFR2), ibroblast growth factor receptor 3 (FGFR3), ibroblast growth 
factor receptor 4 (FGFR4), klotho beta (KLB), insulin like growth factor 1 (IGF1), insulin like 
growth factor binding protein 1 (IGFBP1), insulin-like growth factor binding protein (IGFALS), 
growth hormone receptor (GHR), signal transducer and activator of transcription 5A (STAT5A), 
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signal transducer and activator of transcription 5B (STAT5B) and suppressor of cytokine 
signaling 2 (SOCS2) (Supplementary Table 5). The overall % relative mRNA abundance is 
shown in Supplementary Figure 2. 
Statistical analysis 
The MIXED procedure of SAS (SAS Institute, Inc., Cary, NC, USA) was used for 
statistical analysis. The fixed effects included diet (CON or OVE), time (-14 and 7, 14, 30 d 
relative to parturition), and interaction of diet × time.  The covariate structure used was AR(1). 
Data were normalized by logarithmic transformation prior to statistical analysis. All means were 
compared using the PDIFF statement of SAS (SAS Institute, Inc., Cary, NC, USA). The raw P-
values obtained for the gene expression analysis were adjusted using false discovery rate (FDR) 
to minimize the likelihood of type 2 errors due to the large number of genes studied. Significant 
difference was declared at P < 0.05 and tendency at P < 0.1, and for gene expression at an FDR-
adjusted P ≤ 0.05 (raw P ≤ 0.02). 
RESULTS 
Dry matter intake, milk production and energy balance 
Results for DMI, milk production and energy balance are shown in Figure 1. We 
observed a gradual decrease (Time P < 0.05) in DMI during the last week prepartum then a 
consistent increase after the first week of calving in both groups (OVE and CON). Cows in OVE 
exceeded calculated energy requirements during the prepartal period (-4 to -1 wk relative to 
parturition). During this period the OVE group was in significantly greater (diet × time P < 0.05) 
energy balance (EBAL ~150%) compared with the CON group (~80%) (Figure 1). However, 
both groups were in NEB 1 wk after calving with a larger drop in the OVE group. The CON 
group was able to meet ~100% EBAL by around 2 wk of calving with a gradual increase in DMI 
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but the OVE group remained in NEB even after 7 wk postpartum.  Milk production was recorded 
up to 5 wk after parturition at which point both groups were producing similar amounts of milk.  
Blood metabolites and liver tissue composition 
Serum NEFA and BHBA concentrations increased (diet × time P < 0.05) in the OVE 
group around parturition and remained higher up to 2 wk postpartum (Figure 2). Compared with 
the OVE group, no change was observed in NEFA and BHBA concentration in the CON group 
during the transition period. Interestingly, the serum concentrations of TAG and FGF21 were 
greater (diet × time P < 0.05) in the CON group prepartum but decreased just after parturition 
although there was no change (P > 0.05) observed in the OVE group over time. Insulin like 
growth factor 1 (IGF1) was higher (diet × time P < 0.05) in the OVE group from 2 wk prepartum 
to the day of calving and remained lower postpartum. We observed an abrupt increase (diet × 
time P < 0.05) in GH concentration in blood for CON groups at 2 d before parturition, after 
which the CON group decreased after 2 d but GH was elevated in the OVE group by 2 wk 
postpartum (Figure 2). No significant effect of diet × time was observed for blood glucose 
concentration although glucose decreased slightly in early lactation (time P < 0.05) as expected 
in both groups. 
Figure 3 contains liver lipid and TAG percentage of wet tissue weight. For both 
parameters, greater concentrations were observed in the OVE group at d 14 (diet × time P < 
0.05), at which point concentrations were more than two fold greater compared with the CON 
group.  
PPAR and PPARα target genes 
The expression of PPARA was not significantly affected by the interaction of diet × time 
(P > 0.05), and in both groups its expression decreased around parturition and gradually 
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increased just after calving (Figure 4). We observed a greater expression (diet × time P < 0.05) 
of RXRA, the heterodimer of PPARA, before and after 2 wk of parturition in the OVE group but  
a gradual increase in expression was observed  in the CON group from d -14 to d 30 (Figure 4). 
Our results revealed a gradual decrease (diet × time P < 0.05) in NCOR2 expression in the CON 
group around parturition but there was no apparent change in the OVE group (Figure 4). 
Interestingly, the expression of PPARD was affected by the interaction of diet × time (P < 0.05) 
because of the steady decrease in expression with OVE from d -14 to d 30 postpartum and the 
concurrent increase with CON (Table 1).  
In addition to the significant interaction of diet × time (P < 0.05) for RXRA and PPARD, 
we also detected an abrupt increase in the expression after calving (diet × time P < 0.05) of 
classical PPARA target genes, i.e. CPT1A, ACADVL, ACOX1, HMGCS2 and ANGPTL4 in the 
OVE group (Figure 4). The expression of the enzyme CROT was also significantly greater (diet 
× time P < 0.05) in the OVE group from d -14 to d 7 (Table 1).  
TAG metabolism, storage and other nuclear receptors (NR) 
Our results revealed that many of genes associated with TAG metabolism and storage 
were affected by the interaction of diet × time.  (P < 0.05) (Table 2). The expression of 
GPIHBP1, APOA5, CYB5A, SCD, DGAT1 and PLIN2 was increased (diet × time P < 0.05) in the 
OVE group but ABCD1 and ABHD5 had greater expression (diet × time P < 0.05) in the CON 
group postpartum. Moreover, overfeeding energy prepartum also resulted into greater expression 
(diet × time P < 0.05) of the NR co-regulators CARM1, NCOA3 and RORA around parturition to 
after parturition respectively (Table 3).   
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FGF21 and the GH/IGF signaling network 
The hepatokine FGF21 and its signaling proteins that control the GH/IGF-1 pathway 
were affected by the interaction of diet × time (P < 0.05). The similar expression pattern of 
FGF21 and SOCS2 (Figure 5) was increased continuously (diet × time P < 0.05) after parturition 
but KLB and IGFBP1 expression decreased (diet × time P < 0.05) after d 7 in the OVE group 
(Table 4). The coordinated expression pattern of IGF1 and GHR was decreased gradually (diet × 
time P < 0.05) from d -14 to d 7 and then increased (diet × time P < 0.05) after d 7 in both 
groups (Figure 5). The activator of IGF1 – STAT5B had a similar expression pattern to IGF1 
and GH in the OVE group but there was a steady decrease (diet × time P < 0.05) in the CON 
group between d 7 to d 30 (Figure 5). No interaction effect of diet × time was observed for 
IGFALS, STAT5A, FGFR1, FGFR2 and FGFR3 but FGFR4 was decreased (diet × time P < 
0.05) postpartum in the OVE group without any change in the CON group. 
DISCUSSION 
The results observed with OVE in terms of EBAL, NEFA, BHBA, liver TAG 
composition, and milk production were similar to previous studies (Dann et al., 2006; Janovick 
and Drackley, 2010) where cows were fed to meet or exceed (100% or 150% of NEL) prepartal 
energy requirements. Overfeeding energy prepartum resulted in EBAL of 160% of requirements 
at wk 3 prepartum followed by a marked decrease to less than 72% during the first wk 
postpartum (Janovick and Drackley, 2010). Studies from Dann et al, (2006) provided evidence 
that over-consumption of energy during the dry period results a compromised transition period in 
worse transitions, including lower postpartum DMI and lower milk production. Although DMI 
postpartum and milk production did not differ between groups, the marked NEB in the OVE 
group likely makes those cows more susceptible to disease. This is supported by data from Dann 
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et al. (2006) in which cows fed diets to meet ca. 80% of NEL requirements throughout the dry 
period were in more positive energy balance after parturition than cows fed to exceed ca. 150% 
of NEL requirements.  In our current study, differences in energy balance but with comparable 
milk production and similar DMI, is more likely result in higher concentrations of NEFA and 
BHBA concentrations with similar level of glucose in blood between diets (Figure 2).  
Serum NEFA is an essential indicator of energy status of an animal.  Liver is the most 
important site for removal of excess NEFA from the bloodstream where it can be oxidized by β-
oxidation to produce energy. Long chain fatty acids (LCFA) can also be oxidized by β-oxidation 
in hepatic peroxisomes that may provide an oxidative pathway to utilize excess uptake of NEFA 
around parturition (Drackley et al., 2001). Both sites of β-oxidation, mitochondria and 
peroxisome, might have contributed to reduce hepatic accumulation of TG in cows restricted fed 
during the dry period. Meanwhile, ketone bodies (acetoacetate, β-hydroxybutyrate and acetone) 
may be synthesized if the oxidation capacity of acetyl CoA decreases due to reduced capacity of 
TCA metabolites (Fitzpatrick and Young, 2013).  
The activity of hepatic PPARα is important during periods of under-nutrition  in terms of 
coordinating lipid metabolism including cellular uptake, activation and oxidation of LCFA 
(Rakhshandehroo et al., 2010). It has been hypothesized that lipolysis of adipose tissue around 
calving would provide NEFA to activate PPARα and RXR signaling, hence, up-regulate the 
expression of its target genes (Bionaz et al., 2013). Despite the lack of interaction or overall time 
effect for PPARA, the up-regulation of RXRA at 14 d postpartum along with several target genes 
was indicative of greater activity of these NR. Although there have been inconsistent reports 
regarding changes in hepatic PPARA expression around calving (Loor, 2010), other factors such 
as  the degree of inflammation could play a role in controlling PPAR expression (Mandard and 
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Patsouris, 2013). However, we recently observed that an inflammatory challenge postpartum did 
not alter hepatic PPARA but upregulated PPARD (Graugnard, 2013). Palin and Petit (2004) and 
Carriquiry et al (2009) also detected no effect of parturition on hepatic expression of PPARA 
when cows were fed more than 100% of their energy requirement prepartum and were fed 
different sources of fats respectively. 
The pattern of NEFA and BHBA concentration in the OVE group agreed with the 
expression profiles of CPT1A, ACADVL, ACOX1 and HMGCS2. This coordinated blood and 
gene expression data suggest that influx of NEFA into the liver might have activated the PPARα 
signaling pathway. For instance, the oxidation of NEFA to produce energy and also ketone 
bodies would have been enhanced by the greater expression of HMGCS2 (Schlegel et al., 2012). 
Both CPT1A and ACADVL are key enzymes regulating hepatic fatty acid β-oxidation pathways 
in mitochondria, ACOX1 regulates B-oxidation in peroxisomes, and HMGCS2 is considered the 
rate-limiting enzyme of hepatic ketogenesis (Litherland et al., 2010). Angiopoietin-like protein 4 
(ANGPTL4) is a key regulator of plasma cholesterol, TAG and NEFA concentrations and is 
highly expressed in the liver and adipose tissue of cattle. The PPAR agonist results in the 
upregulation of ANGPTL4 which leads to inhibition of LPL activity in adipose tissue reduced 
VLDL-TAG utilization and increased lipolysis (McCabe et al., 2012). The expression of 
ANGPTL4 was up-regulated in the liver of induced ketosis cows (Loor et al., 2007) and in cows 
with severe NEB (McCarthy et al., 2010) hence, it was proposed that up-regulated ANGPTL4 
helps in lipolysis and plays an important role to sustained release of NEFA and TAG 
accumulation in the liver. In our study, the greater expression level of ANGPTL4 postpartum 
shows evidence of a more indistinct transition period in the result of NEB in OVE group similar 
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compared to the study by McCabe et al. (2012) where up-regulation of ANGPTL4 was detected 
in dairy cows with severe NEB. 
We also measured several NRs to determine their potential role in controlling gene 
expression of enzymes and other protein necessary for lipid metabolism.  In rodents, recent 
research shows that CARM1 and RORA promote adipocyte differentiation by co-activating 
PPARG  (Viswakarma et al., 2010). Coactivator-associated arginine methyltransferase (CARM1) 
is a binding partner of glucocorticoid receptor-interacting protein 1 and stimulates transcriptional 
activation by NRs in combination with the p160 coactivator family. CARM1 activates protein-
protein interaction by methylation of CBP/p300 in the activated NR complex and helps in 
transcription of target genes (Viswakarma et al., 2010). RAR-related orphan receptor A (RORA) 
is a member of NR1 family of nulear hormone receptors, which can bind as monomer or as a 
homodimer to hormone response elements on promotor region of genes to enhance gene 
expression (Wiesenberg, 1998). Our study appears to be the first to measure these nuclear 
receptors in liver of lactating dairy cows and the higher expression of these nuclear receptors in 
the OVE group indicated a potential role in lipid metabolism, which merits further research.    
We also detected a higher level of lipid contents including TAG in OVE group after 
parturition, which was coordinated with greater expression of TAG storage genes, i.e., SCD, 
DGAT1 and APOA5. If the rate of esterification exceeds the rate of TG export from liver then 
fatty liver can occur (Drackley et al., 2006). A classical study by (Morrow, 1976) reported that if 
NEB increases then the ability of the hepatic cells to utilize NEFA and secrete triglycerides 
decreases in transition dairy cows. Therefore, TAGs can build up in the liver, decreasing liver 
function and eventually causing liver lipidosis. The severe lipid infiltration in the liver of dairy 
cows makes them susceptible to  pathologies such as fatty liver, which may even contribute to 
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cows becoming downers  (Kalaitzakis et al., 2010). Our group has observed an increased 
expression of genes in TAG synthesis and storage in a previous study where dairy cows were 
overfed relative to their energy requirement (Loor et al., 2006). The higher expression pattern of 
important lipogenic proteins DGAT1, APOA5, SCD, GPIHBP1 and PLIN1 in OVE suggest the 
accumulation of TAG in liver, which was confirmed by greater liver lipid and TAG contents. 
The enzymes DGAT1 and SCD, very important for TAG accumulation, catalyze the last step in 
TAG synthesis and desaturation of several fatty acids respectively (Conte et al., 2010). Perilipin 
(PLIN1) is identified as a lipid droplet protein (Greenberg et al., 2011), whereas APOA5 and 
GPIHBP1 are reported as modulators of LPL function (Surendran et al., 2012). The simultaneous 
expression of genes of fatty acid oxidation and TAG accumulation and storage suggests a greater 
metabolic burden in hepatic cells of OVE group.  
Peroxisome proliferator-activated receptor α (PPARA) controls FGF21 expression in 
liver of mice by fasting and FGF21 induces the synthesis of ketone bodies, the source of energy 
during extended fasting and starvation (Domouzoglou and Maratos-Flier, 2011). Many 
physiological processes, growth and metabolism are regulated by growth hormone, which is 
secreted in the anterior pituitary (Inagaki et al., 2008). Many of the anabolic actions of GH are 
mediated by insulin-like growth factor 1 (IGF-1). Growth hormone binds to GH receptor and 
activates IGF-1 transcription through a complex series of reactions on the cell surface. The 
binding of GH with GHR induces janus kinase 2 (JAK2) expression, which in turn 
phosphorylates members of the signal transducers and activators of transcription (STAT) family. 
Once phosphorylated STAT proteins translocate to the nucleus, where they bind to response 
elements in the regulatory regions of target genes including IGF-1 (Inagaki et al., 2008). Inagaki 
et al. (2008) indicated that FGF21 is very important in stimulating energy conservation during 
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starvation  by preventing STAT5 signaling to blunt growth. In transition dairy cows, the NEB 
after parturition leads to metabolic condition where liver experiences drastic changes that require 
energy conservation to maintain homeostasis.   
Schoenberg et al. (2011) conducted an experiment in dairy cows to measure the 
expression of FGF21 during transition period. They reported that the peri-partum period results 
in a dramatic increase in plasma FGF21 and liver plays the most important role in this effect. 
Additionally, other studies with rodents also have showed that lactation affects β-Klotho and 
FGFR expression in liver but not in WAT and excluded the mammary gland as an FGF21 target 
tissue. FGF21 activates FGFR signaling only in the presence of the co-receptor β-Klotho 
(Schoenberg et al., 2011). In our data, we observed an increase in FGF21 expression in cows fed 
the OVE diet, which was associated with higher NEFA concentration in these cows after 
parturition. Also, a similar gene expression of FGF21 and GH/IGF1 signaling factors was 
observed as reported in mice under starvation and suggests the inhibitory role of FGF21 on 
GH/IGF signaling. Blood concentration of IGF1 and GH also agreed with the expression of this 
pathway, although the blood level of FGF21 did not support gene expression of this protein in 
liver. We speculate that this difference could be the result of delay in post-transcriptional or 
translational modification of the FGF21 gene or secreted protein respectively.  
We have proposed an interactive model for changes in hepatic gene expression under the 
effect of NEFA infiltration and activation of PPARA in the liver of dairy cows after parturition 
(Figure 6). When NEFA enters into hepatocytes, it can act as ligand to activate PPARα and its 
target genes to mediate fatty acid oxidation and ketogenesis and inhibits the growth hormone 
signaling via FGF21 and lipoprotein lipase activity via ANGPTL4. If the level of NEFA exceeds 
hepatocyte oxidation capacity then it can accumulate in the form of triacylglycerol (TAG), which 
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can cause fatty liver (Drackley et al., 2001). These changes are more abrupt and drastic in dairy 
cows overfed prepartum, which results in greater accumulation of lipid in adipose tissue before 
calving and greater release of NEFA into blood postpartum. 
CONCLUSIONS 
Our results indicated that overfeeding energy prepartum induces drastic changes in gene 
expression of lipid metabolism including PPARA target genes and that bovine FGF21 controls 
the GH/IGF1 signaling pathway in a similar fashion as described in non-ruminants. The apparent 
lack of change in PPARA gene expression and lack of relationship between FGF21 gene 
expression and FGF21 blood concentration merit further studies to reveal the connection 
between gene and protein expression.  
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Table 1. mRNA expression of PPAR, PPAR target and fatty acid oxidation genes (n = 
6/treatment) in cows fed a control diet (CON; 1.34 Mcal/kg of DM) or a moderate-energy diet 
(OVE; 1.62 Mcal/kg of DM) during the entire dry period. 
 
 
*
 Means differ due to diet x time interaction on respective diet (P<0.05). 
a-c Means within a row with different superscript differ  (P<0.05). 
1
mRNA expression was calculated relative to expression of the three internal control genes; 
GAPDH, RSP9 and UXT after normalization of data.  
2SEM = standard error of the means. 
T= time point, D= diet and D x T = diet and time interaction. 
 
 
 
 
 
 
  
 Day relative to parturition1  (P-value) 
 
Gene 
 
Diet 
 
-14 
 
7 
 
14 
 
30 
 
SEM2 
 
T 
 
D 
 
T x D 
PPARD OVE 1.00a 0.86ac 0.84ac 0.75*bc 0.24 0.25 0.44 0.04 
CON 0.97ac 0.79c 1.04a 1.16*a 
PLIN2 
 
OVE 0.81a 1.17b 1.36b 0.72a 0.28 0.01 0.58 0.01 
CON 1.02 0.80 0.97 0.77 
FABP1 OVE 0.86 0.89 0.98 0.85 0.33 0.16 0.66 0.68 
CON 0.69 0.74 1.06 0.77 
CROT OVE 0.89*ac 0.94*c 0.76c 0.55b 0.16 0.01 0.01 0.01 
CON 0.64*ab 0.53*a 0.72b 0.53a 
PNPLA3 OVE 1.14 1.08 1.82 0.86 0.69 0.01 0.77 0.07 
CON 0.72 1.42 1.17 0.84 
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Table 2. mRNA expression of genes involved in TAG metabolism (n = 6/treatment) in cows fed 
a control diet (CON; 1.34 Mcal/kg of DM) or a moderate-energy diet (OVE; 1.62 Mcal/kg of 
DM) during the entire dry period. 
 
 Day relative to parturition1  (P-value) 
 
Gene 
 
Diet 
 
-14 
 
7 
 
14 
 
30 
 
SEM2 
 
T 
 
D 
 
T x D 
GPIHBP
1 
OVE 0.79a 0.76*a 0.70a 0.51b 0.33 0.01 0.23 0.01 
CON 0.97a 0.33*c 0.46b 0.56b  
APOB OVE 1.10 0.93 0.99 0.89 0.17 0.01 0.14 0.41 
CON 0.84 0.76 0.88 0.74 
MTTP OVE 0.66 0.82 0.90 0.74 0.38 0.04 0.32 0.06 
CON 0.97a 1.45b 0.87a 0.88a 
APOA5 
 
OVE 0.79a 1.14*c 1.24*b 1.01b 0.15 0.01 0.01 0.01 
CON 0.62 0.52* 0.91* 1.02 
CYB5A OVE 0.82 0.92 0.95 0.79 0.29 0.01 0.74 0.01 
CON 1.06a 0.63b 0.92ab 0.70b 
ABCD1 OVE 1.14a 0.85b 0.88b 0.94*a
b
 
0.24 0.01 0.94 0.01 
CON 0.78a 0.75a 0.92a 1.59*b 
LPIN1 OVE 0.68 0.66 0.65 0.72 0.25 0.26 0.28 0.15 
CON 0.67 0.70 1.08 0.76 
SCD OVE 0.75a 0.52a 0.98b 1.34bc 0.67 0.01 0.75 0.01 
CON 0.32a 1.14b 0.91b 0.83b 
DGAT1 OVE 0.68a 0.87c 0.78b 0.74ab 0.28 0.01 0.59 0.01 
CON 0.47a 0.74b 0.75b 0.79b 
DGAT2 OVE 0.99 0.92 0.95 0.82 0.26 0.38 0.73 0.19 
CON 0.85 0.74 0.90 0.93 
ABHD5 OVE 1.00*a 1.14ab 1.21b 0.91*c 0.13 0.24 0.01 0.01 
CON 1.37*a 1.15b 1.26ab 1.30*a
b
 
PLIN2 OVE 0.81a 1.17b 1.36b 0.72a 0.28 0.01 0.58 0.01 
CON 1.02 0.80 0.97 0.77 
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Table 3. mRNA expression of nuclear receptors (n = 6/treatment) in cows fed a control diet 
(CON; 1.34 Mcal/kg of DM) or a moderate-energy diet (OVE; 1.62 Mcal/kg of DM) during the 
entire dry period. 
 
*
 Means differ due to diet x time interaction on respective diet (P<0.05). 
a-c Means within a row with different superscript differ  (P<0.05). 
1
mRNA expression was calculated relative to expression of the three internal control genes; 
GAPDH, RSP9 and UXT after normalization of data.  
2SEM = standard error of the means. 
T= time point, D= diet and D x T = diet and time interaction.  
 
 
   Gene 
 
 
    Diet 
Day relative to parturition1  
 
SEM2 
P-value 
 
-14 
 
7 
 
14 
 
30 
  
T 
 
D 
 
T x D 
CARM1 OVE 0.86a 0.86a 0.91a 0.99b 0.13 0.71 0.49 0.02 
CON 0.92 0.85 0.81 0.79 
TGS1 OVE 1.05 0.94 1.07 0.98 0.14 0.03 0.37 0.44 
CON 1.03 0.88 0.90 0.86 
NRIP1 
 
OVE 1.06 0.93 0.95 1.05 0.13 0.01 0.59 0.21 
CON 1.04 0.94 0.82 0.98 
NCOA1 OVE 1.04 0.95 0.95 1.02 0.10 0.01 0.87 0.07 
CON 1.08 1.02 0.90 0.93 
NCOA3 OVE 0.98 0.80 0.89 0.68 0.16 0.01 0.80 0.32 
CON 1.06 0.67 0.92 0.78 
NCOR2 OVE 0.88a 0.96b 0.84a 1.01b 0.14 0.01 0.53 0.01 
CON 1.13a 1.03a 0.92b 0.90b 
MED1 OVE 1.03 0.98 0.92 1.03 0.15 0.01 0.03 0.33 
CON 0.86 0.78 0.68 0.73 
RORA OVE 1.13*a 0.87*b 0.88b 0.69c 0.16 0.01 0.18 0.01 
CON 0.80*a 0.64*b 0.77ab 0.85a 
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Table 4. mRNA expression of FGF21 and growth hormone related genes (n = 6/treatment) in 
cows fed a control diet (CON; 1.34 Mcal/kg of DM) or a moderate-energy diet (OVE; 1.62 
Mcal/kg of DM) during the entire dry period.  
 
*
 Means differ due to diet x time interaction on respective diet (P<0.05). 
a-c Means within a row with different superscript differ  (P<0.05). 
1mRNA expression was calculated relative to expression of the three internal control genes; 
GAPDH, RSP9 and UXT after normalization of data.  
2SEM = standard error of the means. 
T= time point, D= diet and D x T = diet and time interaction. 
  
  Day relative to parturition1  
 SEM2 
P-value 
Gene Diet  -14       7           30 T D D x T 
FGFR1 OVE 1.16 0.78 0.88 0.91 0.34 0.01 
 
0.13 0.23 
 CON 0.91 0.42 0.57 0.63  
FGFR2 OVE 1.19 0.95 0.97 0.97 0.22 0.01 
 
0.11 0.08 
CON 0.91 0.64 0.66 0.94  
FGFR3 OVE 1.31 1.13 1.23 1.33 0.30 0.46 
 
0.20 0.63 
CON 1.04 0.94 0.90 0.87  
FGFR4 OVE 0.92a 0.41b 0.43b 0.43b 0.27 0.01 
 
0.18 0.01 
CON 0.49 0.50 0.36 0.32  
KLB OVE 1.08a 1.13a 1.03a
b
 
0.85b 0.20 0.29 0.73 0.01 
 
CON 0.89a 1.06ab 1.18b 1.18b  
IGFBP1 OVE 0.21a 1.40b 0.52c 1.14b 0.38 0.01 
 
0.72 0.03 
CON 0.35a 1.05b 0.60c 1.16b  
IGFALS OVE 1.47 0.67 1.10 0.97 0.36 0.01 
 
0.04 0.38 
CON 0.76 0.40 0.51 0.68  
STAT5A OVE 0.48 0.38 0.37 0.42 0.28 0.06 0.58 0.48 
CON 0.37 0.36 0.34 0.36  
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Figure 1. Daily DMI (panel A), milk production (panel B), and weekly energy balance (panel C) 
in cows (n = 6/diet) fed a control diet (CON; 1.34 Mcal/kg of DM) or a moderate energy diet 
(OVE; 1.62 Mcal/kg of DM) during the entire dry period.   *diet × time P < 0.05.  
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Figure 2. Blood concentrations of NEFA, BHBA, TAG, FGF21, GH, IGF-1, and glucose in 
cows (n = 6/diet) fed a control diet (CON; 1.34 Mcal/kg of DM) or a moderate energy diet 
(overfed, OVE; 1.62 Mcal/kg of DM) during the entire dry period. *diet × time P < 0.05. 
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Figure 3. Liver lipid and triacylglycerol (TAG) concentration in cows (n = 6/diet) fed a control 
diet (CON; 1.34 Mcal/kg of DM) or a moderate energy diet (overfed, OVE; 1.62 Mcal/kg of 
DM) during the entire period. * diet × time P < 0.05. 
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Figure 4. Hepatic mRNA expression of PPARA heterodimer and its target genes in cows (n = 
6/diet) fed a control diet (CON; 1.34 Mcal/kg of DM) or a moderate energy diet (overfed, OVE; 
1.62 Mcal/kg of DM) during entire dry period. * diet × time (P < 0.05). 
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Figure 5. Hepatic mRNA expression of genes in FGF21 and GH/IGF1 signaling in cows (n = 
6/diet) fed a control diet (CON; 1.34 Mcal/kg of DM) or a moderate energy diet (overfed, OVE; 
1.62 Mcal/kg of DM) during entire dry period. * diet × time (P < 0.05). 
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Figure 6: Proposed steps controlling the fate of non-esterified fatty acid (NEFA) after parturition 
in liver of dairy cows fed OVE (overfed) and CON (control) diet prepartum. When NEFA enters 
into hepatocytes, it can act as ligand to activate PPARα and its target genes to mediate fatty acid 
oxidation and ketogenesis and inhibits the growth hormone signaling via FGF21 and lipoprotein 
lipase activity via ANGPTL4. If the level of NEFA exceeds hepatocyte oxidation capacity then it 
can accumulate in the form of triacylglycerol (TAG), which can cause fatty liver (Drackley et al., 
2001). NEFA = non-esterified FA; PPARA = peroxisome proliferator-activated receptor 
alpha; RXRA = retinoid X receptor, alpha; NCOR2 = nuclear receptor corepressor 2; CPT1A = 
carnitine palmitoyltransferase 1A (liver); ACADVL = acyl-CoA dehydrogenase, very long chain; 
ACOX1 = acyl-CoA oxidase 1, palmitoyl; HMGCS2 = 3-hydroxy-3-methylglutaryl-CoA 
synthase 2 (mitochondrial); FGF21 = fibroblast growth factor 21; ANGPTL4 =angiopoietin-like 
4; SOCS2 = suppressor of cytokine signaling 2; GH = growth hormone; GHR = growth hormone 
receptor; JAK2 = janus kinase 2; STAT5 = signal transducer and activator of transcription 5; 
IGF1 = insulin like growth factor 1 . 
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SUPPLEMENTAL MATERIAL 
 
Supplementary Table 1. Ingredients and chemical composition of experimental diets. 
 Prepartal energy level   
  Control Overfed  Lactation 
Ingredients     
Wheat straw 41.9 - - 
Corn silage 29.3 50.3 29.9 
Alfalfa silage 10.0 18.0 14.8 
Soybean meal 9.64 3.54 2.39 
Ground shelled corn 3.59 13.9 - 
Alfalfa hay 3.35 6.06 5.55 
Magnesium sulfate 0.64 0.63 - 
Magnesium oxide 0.42 0.43 0.13 
Vitamin E 0.27 0.24 - 
Mineral and vitamin mix1 0.18 0.18 0.22 
Magnesium chloride 0.17 0.35 0.00 
Urea 0.17 - 0.13 
Salt 0.15 0.24 0.13 
Sodium phosphate 0.13 - - 
Vitamin A 0.01 0.01 - 
Vitamin D 0.01 0.01 - 
Whole cottonseed - 5.03 5.55 
Calcium carbonate - 0.9 0.56 
Corn ground - - 20.3 
Wet brewer’s grain  - - 12.9 
Soybean hulls - - 5.55 
Sodium bicarbonate - - 0.83 
Dicalcium phosphate - - 0.54 
Vitamin H - - 0.28 
Chemical composition    
DM,  % 51.9 50.0 60.5 
NEL, Mcal/kg DM 1.34 1.62 1.69 
CP, % DM 12.0 15.0 17.4 
AP, % DM 11.2 14.3 11.9 
ADICP, % DM 0.70 0.73 5.53 
NDF, % DM 53.4 36.6 34.1 
ADF, % DM 36.6 25.7 21.8 
Ca, % DM 0.67 0.73 0.80 
P, % DM 0.24 0.31 0.43 
Mg, % DM 0.50 0.57 0.33 
K, % DM 1.45 1.28 1.16 
S %DM 0.21 0.25 0.21 
Na % DM 0.07 0.09 0.29 
Fe, ppm 305 339 203 
Zn , ppm 66.6 80.0 65.8 
Cu, ppm 13.0 14.6 10.9 
Mn, ppm 72.0 70.3 67.0 
1Mineral and vitamin mix: zinc = 60 ppm, copper = 15 ppm, manganese = 60 ppm, selenium 0.3 ppm, iodine = 0.6 ppm, iron = 
50 ppm, and cobalt = 0.2 ppm. Rumensin: 360mg/day in the lactation diet. 
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Supplementary Table 2. Sequencing results of PCR products from primers of genes designed 
for this experiment. Best hits using BLASTN (http://www.ncbi.nlm.nih.gov) are shown.   
 
Gene Sequence 
KL CGTAGTGGAAGAAAGATCCCATAAAATACAACGATTACCTGGCCGTGCAAG
AAATGACCGCACATCACCTGGGAACCC 
FGFR1 ATTTCATCCTGACAGTGCCGGTTCTGTGGCAGAATCCTCGGCCAGAGCGGGA
GCTTGGGTGTAGGGGATGGTCACCACCCC 
FGFR2 CAGCCATGTAAGTAGAGAGGTGGTGTGTTCTTGGTAGCAGCTTGGTCATTGG
GCCCATAAACCTTTCACTGGGCTTCA 
FGFR3 GCAACGCCGCCGTCCGCGTAGAGTGGAAGTGGCACCGAGGCCTTGTGTTTG
GACCGCGTCTACACCCACCAAAGTGGACGGAG 
FGFR4 GCAGTGACAGTGACAGGTCGTCGTGCCGTCTCGTAGGGAGTACCTCGACCTC
CGCCTAACAAAAA 
FGF21 CGAGATCTGAAGCAAATTGAGGCAGAAATCCTTACGTGTGAGCATGACCTA
GAAGATTCCGAAACCGCGA 
KLB ACGCCGTTAACAACTCATCAGCGACAATGGCTTCCTTTCTGAGAACAGTAGT
CCTCGATGCAGCCCAAA 
IGF1 CCGGTACAGGGAATCAGCAGTCTTCCACCCAATTATTTAAGTGCTGCTTTTG
TGATTTCTTGAAGCAGGGGTGAAAA 
IGFBP1 GACAGTAATACGGGGACAGCAGAGGCAGGAGACAAACTTTACAAATTTTAT
CTGCCAAACTGCAACAAAGATT 
IGFALS GACGTCGCGTCGCCTTTCGTCGGCCGTGGCGAGCTGCGAGAGCTGGATCTGA
GCCGGAACACCCTGCGCAGCGTCAAGGCCAATGTCTTCGTCAAGCTGCCCA
AGCTCCAGAAACTCTAATA 
GHR CGATACAACAGACACTTCTCATGTGGTGACTGAGTCAACTCATCAAGCTGTC
CATACACAGCTCAGCAATCCAAAAAT 
STAT5A AGCAGTCGTGAGACACAGTGTACGTTCTCCGGTCGTGGAAGTCTCGGCCTGT
ATGCCATGTCCCAGAACACCTTCAGATCAACCAGAAA 
STAT5B GCCATCATGTAGGGTCGCCATTACTTATCCCAGGTGATTGAAGGGCCAAGCT
TGGGGACTCAATAGATCTTGATAAAAAACCCC 
SOCS2 GACATACTATCAGCACACCCGTGCAGCATCTCTGTAGACTCACCATTAACAA
GTGTACCAGCACCGTCAAA 
PPARA CGAGATCTGAAGCAAATTGAGGCAGAAATCCTTACGTGTGAGCATGACCTA
GAAGATTCCGAAACCGCGA 
PPARD GCATGGGGACGGCGTCGGGCTCACTACGGCGTTCACGCTTGTGAGGGATGC
AAGGGCTTCTTCCGTCCACAAA 
ACADVL GAAACTAACTTTGTGGCGTATCCAGGAGAAGCGTGCCCGGAAGTGCTATGC
TGCAGTATGTGACTGAGAATCCATGGCGA 
ACOX1 ATCCTCGTATCCGCGTTCAGGGTGCGTTTAAGAAGAGTGCCATCATGGTGCA
GAAGATGAGGAAATCCCC 
ABHD5 CGTCCACCTCTCGCGTATTACCGCTCTGGGACGCAGAGTAAGGGAATCTGAC
ACGAGAACCAGGCAGTTAA 
PLIN2 ACGTGCGTCGTCGTTCGTATAAAACACCTTCATGTAGGCTGTTGTATGAATT
GGGGTCCGCTCTGAGAC 
DGAT1 CTAGGCTTCCACTACCGGTGCATCCTGAATTGGTGTGTGGGTGGATGCTGAT
CCTTAAGCAACGCACGGGTTATAATA 
DGAT2 GTCGTCGGTCCTTCTTCCCGTGCGTGGTTTGACTGGAACACACCCCCAAGAA
AGGTGGGCAGGAGGTCACAGTAATA 
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Supplementary Table 2. (continued) Sequencing results of PCR products from primers of 
genes designed for this experiment. Best hits using BLASTN (http://www.ncbi.nlm.nih.gov) are 
shown.   
Gene Sequence 
CPT1A GGACTATGAAGGTAAACCAGGCCCGGGACGCCCTTCGTACAGGCCTCT
CGCTCCAGCTGGCTCATTACAAGGGACCA 
HMGCS2 CACTAGCCAGATCGAGAACAGGTGAAGCAAGCTGGCATCGAATCGGCC
TTTCACTCTCGATGAATGTGCAAAACCC 
ANGPTL4 GCCCATCAGCATCCTCAACCGTGAAGCGGCCAGTATTTCCACTCCATTT
CCAAGGGAAGA 
CARM1 GCTCAGCACACTCAGCGCGCCATCTACAGAACCACACAGACTTCAAGG
ACAAGAATGTGTTCTCGACGTTGGGCTAAAAAA 
TGS1 CTGATCGCCCGTGGGGAGACGGACTACGCCACGTCCGAGATCTTCGAC
ATCAGCACCATGATGTCTCCGTGAA 
NRIP1 GCAAGTCAGTCAGGAGGATCAGGATACCTCAAGAATTCTAAGGCTAAA
TTCGGCACCAGAAAGGTAACCCTAGAAA 
NCOA1 GCAGGGTACGAGATCGTGTCTGTGCACGAGGCACCTTCCACCTCGTGCC
TCTACTAACTCTTCAAGGTGGTTCTTGCCCAAAAA 
NCOA3 AAGGACTTGCAGAGCAACAATATTCGAATCCGTGTAACAATGAACGTC
ATGCTTTGTCTCAACCCACTTTCTTCAAA 
MED1 CCCTACAGATTCAAGGGAGTGTCCGACTATCCAGGTTTCAGACAGGCAT
TGTGGCCCAGATGTAACTGATATCAAAA 
CYB5A CGATCTTTTTATTGTGTAGAGCCAGTGTGGGGAGGTTCTGTATCACATG
GGAAAATGCCTGGCAGAGGACTCAATT 
RORA CATGACTATATCGGGGTTCATTACAGTTGAAGGCTGCAAGGGGCTTTTT
TCAGGAGAAAGTCAGCAAAAGCAATGCCACCCTACTCCTGTCCAAAA 
ABCD1 GGAGACAGGCGGGCAGGAAGCAGGGCATCGCGGCTGCTTTCCATCACC
CACCGACCCTCCCTGTGGAAGTACCACACCCATTTGCTGCAAAA 
LPIN1 GATCATCTAGTGATGAGGAGCATGCAGCCGCCAAGCCGTCCAGCACAA
GCCACCTCCCCCTGTTGTCCAGCAGTCAGCAA 
APOB GCTACTGTACTGTCTCTCAGGTCTGTGGGTGACCACTTTGGCTACACCA
AAGATGATAAACATGAGCAGGGACATGGGGTACAAA 
MTTP GCACTGCCCCCTCTATTTTTCAGTTAATCCAAAGCCCTTTAATTTTTGGT
CACTTTGTCTTGATGAGCCCTGAGGAATATCAAA 
APOA5 GGATTTCGGTCTAGGGCCATTCGGGCAGAGGGTGGAGGGTTCCTGCAC
AGGATAGCTGAGGCCAACCAAAGGGA 
FABP1 GAGGGAGGAGTGTGAGATGGAGTTCATGACTGGGAGAGAAGATCAAG
GCAGTGGA 
SCD AGACTGTGCATGGTATCTGTGGGATGAAACGTTTCAAAACAGCCTGTTT
TTTGCCACCTTATTCCGTATATAGCCAG 
CROT CATACTAGATATTATCATGTGGCCGTACAGAGACTGTGCGACCATGTAC
AGTAGAAGCAGTCAATTTGGTGAC 
GPIHBP1 CCCGTTACGTGATCAGGTCCCCAGACCACCTACTCGGGATGGTGTGCAG
ACACATGTCAAGCCCATCAGCAACCCCCTT 
PNPLA3 AGTTCTGCACAGAGAACCTACCGATGTTCCGGTCGCTGTTAATAGCGGA
TGTCAAGATGCTTGGCCTTCAGATATGTGGACGCGCTAGG 
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Supplementary Table 3. Gene ID, GenBank accession number, hybridization position, 
sequence and amplicon size of primers for Bos taurus used to analyze gene expression by qPCR.  
 
Gene 
ID 
Accession # Gene Primers Primers (5’-3’) bp 
784635 XM_001252499.1 
 
KL F.2416 
R.2517 
GCGTTGAGCCATTACACTACCA 
CCAGGTGATGTCGGTCATTTC 
102 
281768 NM_001110207.1 FGFR1 F.2842 
R.2941 
TGAGCTTTCCTGCATTGGTTT 
GACCACCCCTACACCCAACTC 
100 
404193 XM_002698546.1 FGFR2 F.3611 
R.3710 
TTAACCACCTAACTGCCCGTATG 
GAAGCCCAGTGAAAGGTTTATGG 
100 
281769 NM_174318.3 FGFR3 F.1975 
R.2079 
TGCACAACCTCGACTACTACAAAAA 
CGTCACTTTGGTGGGTGTAGAC 
105 
317696 NM_001192584.1 FGFR4 F.2350 
R.2439 
CTCTCAGAGGCCCACTTTCAA 
GTTAGGCGGAGGTCGAGGTACT 
90 
785576 XM_002695200.1 FGF21 F.223 
R.328 
CAGAGCCCCGAAAGTCTCTTG 
AAAGTGCAGCGATCCGTACAG 
106 
514925 XR_027346.2 KLB F.2833 
R.2932 
TTCACACCCGATTTCAAAGCTA 
GGCTGCATCGAGGACTACTGT 
100 
281239 NM_001077828.1 
 
IGF1 F.166 
R.268 
CCAATTCATTTCCAGACTTTGCA 
CACCTGCTTCAAGAAATCACAAAA 
103 
282259 NM_174554.2 IGFBP1 F.645 
R.744 
CCTGCCAGCGAGAACTCTACA 
TTGTTGCAGTTTGGCAGATAAAA 
100 
532494 NM_001075963.1 
 
IGFALS F.609 
R.758 
GCTGGTCCTGGCAGGTAACA 
TAGAGTTTCTGGAGCTTGGGCA 
150 
280805 NM_176608.1 
 
GHR F.1350 
R.1459 
CTAGCCAGCAGCCCAGTGTTA 
TGGATTGCTGAGCTGTGTATGG 
110 
282375 NM_001012673.1 STAT5A F.395 
R.506 
TCGCCACATTCTGTACAATGAAC 
CTGGTTGATCTGAAGGTGTTTCTG 
112 
282376 NM_174617.3 
 
STAT5B F.130 
R.134 
TCATCAGATGCAAGCGCTGTA 
TTATCAAGATCTATTGAGTCCCAAGCT 
105 
338437 NM_177523.2 
 
SOCS2 F.995 
R.1094 
CGGCACTGTTCACCTTTATCTG 
GACGGTGCTGGTACACTTGTTAAT 
110 
281992 NM_001034036.1 PPARA F.729 
R.830 
CATAACGCGATTCGTTTTGGA 
CGCGGTTTCGGAATCTTCT 
102 
353106 NM_001083636.1 PPARD F.460 
R.559 
TGTGGCAGCCTCAATATGGA 
GACGGAAGAAGCCCTTGCA 
100 
282130 NM_174494.2 ACADVL F.1140 
R.1245 
TGCTGCTAACCGTACCCAGTTT 
CGCCATGGACTCAGTCACAT 
106 
513996 NM_001035289.2 
 
ACOX1 F.180 
R.279 
ACCCAGACTTCCAGCATGAGA 
TTCCTCATCTTCTGCACCATGA 
100 
280981 NM_173980.2 PLIN2 F.1607 
R.1706 
TTTATGGCCTCATGCTTTTGC 
CTCAGAGCAGACCCCAATTCA 
100 
535588 NM_001076063.1 ABHD5 F.1141 
R.1240 
CTGCAGATGATGTGGGAAAGC 
GACTGCCTGGTTCTCGTGTCA 
100 
282609 NM_174693.2 
 
DGAT1 F.210 
R.314 
ACCGCCTGCAGGATTCC 
ATAACCGTGCGTTGCTTAAGATC 
105 
404129 NM_205793.2 DGAT2 F.389 
R.492 
CATGTACACATTCTGCACCGATT 
ACTGTGACCTCCTGCCACCTT 
104 
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Supplementary Table 3. (continued) Gene ID, GenBank accession number, hybridization 
position, sequence and amplicon size of primers for Bos taurus used to analyze gene expression 
by qPCR.  
Gene 
ID 
Accession # Gene Primers Primers (5’-3’) bp 
506812 FJ415874.1 CPT1A F.141 
R.240 
TCGCGATGGACTTGCTGTATA 
CGGTCCAGTTTGCGTCTGTA 
100 
503684 NM_001045883.1 HMGCS2 F.837 
R.936 
TTACGGGCCCTGGACAAAT 
GCACATCATCGAGAGTGAAAGG 
100 
509963 NM_001046043.2 ANGPTL4 F.28 
R.136 
AGGAAGAGGCTGCCCAAGAT 
CCCTCTCTCCCTCTTCAAACAG 
109 
515433 XM_002696114.1 GCGR F.1116 
R.1217 
TGGCCATCCTGATCAACTTCT 
GCCGGAATTTGTAGTCAGTATAACG 
102 
784795 XM_002688868.1 
 
CARM1 F.384 
R.484 
GCAGAACATGATGCAGGACTATG 
AGCCAACGTCGAGAACAATCTT 
101 
511392 XM_002692651.1 
 
TGS1 F.2441 
R.2540 
TCTAGTCTAAAGGCCGATGTTGTG 
CAGGAGACATCATGGTGCTGAT 
100 
524960 XM_002684642.1 
 
NRIP1 F.1394 
R.1493 
TGCTAAACACTTGGGATCCAAA 
AGGGTTACTTTCTGGTGCGAATT 
100 
525346 XM_002691465.1 
 
NCOA1 F.2222 
R.2321 
AGTTACGGCATGCTGACATAGACA 
GGGCAAGAACCACTTGAAGAGT 
100 
523707 XM_602010.4 NCOA3 F.1006 
R.1111 
TTCTCTTTGGCTGATGGCACTAT 
GAAGAAAGTGGGTTGAGACAAAGC 
106 
520734 XM_598984.5 MED1 F.2431 
R.2530 
AACAACTTACCCGCAACCAGTAC 
GATATCAGTTACATCTGGGCCAATG 
100 
281110 NM_174033.3 CYB5A F.1969 
R.2068 
ACCACCCTCTGCCTCTTTTGT 
GAGTCCTCTGCCAGGCATTTT 
100 
535597 NM_001192861.1 RORA F.316 
R.430 
CATGCAAGATCTGTGGAGACAAAT 
CAATGCCACCTACACCTGTCC 
115 
515178 NM_001046190.1 
 
ABCD1 F.2310 
R.2425 
CGCTGTGAGCATCGATGTG 
GCAGCAAATGGGTGTGGTACTT 
116 
537224 XM_865119.4 LPIN1 F.147 
R.247 
TGGCCACCAGAATAAAGCATG 
GCTGACGCTGGACAACAGG 
101 
494004 XM_002691511.1 
 
APOB F.2232 
R.2336 
CAAGGCTTTGTACTGGGTTAACG 
ACCATGTCCTGCTCATGTTTATCA 
105 
280868 NM_001101834.1 
 
MTTP F.617 
R.716 
ACCAGGCTCATCAAGACAAAGTG 
GTGACACCCAAGACCTGATGTG 
100 
538914 NM_001083492.1 APOA5 F.1159 
R.1257 
CTGCGATCTGAGCCTCTAACAA 
CCTTTGGTTGGCCTCAGCTAT 
99 
327700 BC111622 FABP1 F.183 
R.283 
GTTCATCATCACCGCTGGCT 
CCACTGCCTTGATCTTCTCCC 
101 
280924 AY241933 SCD F.665 
R.765 
TCCTGTTGTTGTGCTTCATCC 
GGCATAACGGAATAAGGTGGC 
101 
281092 NM_177494.2 CROT F.1635 
R.1735 
GGACGTCCTGGTTGCTGCTA 
CACCAATTGACTGCTTCTACTGTACA 
101 
512826 XM_590408.4 GPIHBP1 F.306 
R.405 
CCCCGGGACATGCAAAG 
GCTGATGGCTTGACATGTGTCT 
100 
786474 XM_001253780.3 PNPLA3 F.663 
R.749 
GTTCACCAAGCTCAACATGCA 
AAGGCACAGCTCTCCAAGCA 
86 
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Supplementary Table 4.  qPCR performance among the genes measured in liver tissue. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1 The median is calculated considering all time points and all cows. 
2
 The median of ∆Ct is calculated as [Ct gene – geometrical mean of Ct internal 
controls]   for each time point and each steer. 
3 Slope of the standard curve. 
4
 R2 stands for the coefficient of determination of the standard curve. 
5
 Efficiency is calculated as [10(-1 / Slope)]. 
 
 
 
 
 
 
 
 
 
 
Gene Median 
Ct1 
Median 
∆Ct2 
Slope3 (R2)4 Efficiency5 
KL 28.83 6.03 -3.35 0.99 1.99 
FGFR1 29.72 7.09 -2.33 0.99 2.26 
FGFR2 23.54 0.95 -3.13 0.99 2.08 
FGFR3 23.09 0.49 -3.19 0.98 2.10 
FGFR4 23.93 1.3 -3.46 0.92 1.94 
FGF21 26.46 5.05 -2.94 0.96 2.19 
KLB 23.63 0.88 -3.13 0.97 2.08 
IGF1 22.49 -0.12 -3.24 0.99 2.03 
IGFBP1 19.41 -3.17 -3.19 0.99 2.05 
IGFALS 22.90 0.28 -3.22 0.99 2.04 
GHR 20.57 -2.02 -3.12 0.99 2.09 
STAT5A 25.01 2.39 -3.43 0.97 1.96 
STAT5B 21.10 -1.52 -2.69 0.98 2.35 
SOCS2 21.93 -0.68 -3.41 0.91 1.96 
PPARA 22.63 0.28 -3.17 0.99 2.07 
PPARD 26.98 4.14 -3.23 0.99 2.04 
ACADVL 20.38 -0.27 -3.15 0.99 2.08 
ACOX1 21.88 -0.88 -3.32 0.99 2.00 
PLIN2 27.88 5.09 -3.58 0.97 1.90 
ABHD5 28.07 5.27 -2.91 0.99 2.21 
DGAT1 25.39 2.57 -3.01 0.99 2.15 
DGAT2 24.71 1.89 -2.88 0.99 2.22 
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Supplementary Table 4. (continued)  qPCR performance among the genes measured in liver 
tissue. 
 
 
 
 
 
 
 
 
1 The median is calculated considering all time points and all cows. 
2
 The median of ∆Ct is calculated as [Ct gene – geometrical mean of Ct internal 
controls]   for each time point and each steer. 
3 Slope of the standard curve. 
4
 R2 stands for the coefficient of determination of the standard curve. 
5
 Efficiency is calculated as [10(-1 / Slope)]. 
 
 
 
 
 
 
 
Gene Median 
Ct1 
Median 
∆Ct2 
Slope3 (R2)4 Efficiency5 
CPT1A 22.88 0.51 -3.11 0.99 2.09 
HMGCS2 20.43 -2.37 -2.98 0.99 2.17 
RXRA 24.47 1.67 -3.25 0.99 2.03 
ANGPTL4 25.72 3.36 -3.14 0.93 2.08 
CARM1 24.09 3.45 -3.18 0.99 2.06 
TGS1 26.29 5.63 -3.02 0.99 2.14 
NRIP1 23.58 2.98 -3.08 0.99 2.11 
NCOA1 23.60 2.97 -3.22 0.99 2.04 
NCOA3 23.79 1.19 -3.33 0.99 1.99 
NCOR2 25.79 5.13 -3.16 0.99 2.07 
MED1 25.24 4.58 -3.07 0.99 2.12 
CYB5A 21.08 -1.26 -3.01 0.99 2.15 
RORA  24.47 1.67 -3.26 0.99 2.03 
ABCD1 25.68 2.87 -3.22 0.99 2.04 
LPIN1 24.18 1.78 -3.29 0.98 2.01 
APOB 18.48 -4.04 -3.25 0.99 2.03 
MTTP 21.13 -1.48 -2.82 0.99 2.26 
APOA5 20.75 -2.07 -3.18 0.99 2.06 
FABP1 18.78 -3.57 -2.92 0.99 2.20 
SCD  23.81 1.44 -2.87 0.99 2.23 
CROT 22.17 -0.66 -3.57 0.99 1.90 
GPIHBP1 32.86 10.03 -2.40 0.94 2.61 
PNPLA3 30.84 8.11 -3.16 0.90 2.07 
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Supplementary Table 5. Genes selected for transcript profiling in bovine liver. 
 
 
Gene Name 
 
Gene 
Symbol 
 
Description  
Peroxisome proliferator-
activated receptor alpha 
 
PPARA 
PPARalpha is a member of the nuclear receptor family of ligand-
activated transcription factors that heterodimerize with the retinoic X 
receptor (RXR) to regulate gene expression.  
Peroxisome proliferator-
activated receptor delta 
 
PPARD 
Peroxisome proliferator-activated receptor delta (PPARdelta), also 
known as PPARbeta, is a member of the nuclear receptor family of 
ligand-activated transcription factors that heterodimerize with the 
retinoic X receptor (RXR) to regulate gene expression.  
Retinoid X receptor, alpha  
RXRA 
Retinoid X receptors (RXR) are members of the NR2B family of 
nuclear receptors and are common binding partners to many other 
nuclear receptors, including PPARs, liver X receptors (LXRs) and 
vitamin D receptors (VDR).  
Acyl-CoA dehydrogenase, 
very long chain 
ACADVL Active toward esters of long-chain and very long chain fatty acids 
such as palmitoyl-CoA, mysritoyl-CoA and stearoyl-CoA.  
Acyl-CoA oxidase 1, 
palmitoyl 
ACOX1 Catalyzes the desaturation of very long chain acyl-CoAs to 2-trans-
enoyl-CoAs. 
Carnitine 
palmitoyltransferase 1A 
 
CPT1A 
CPT I is the key enzyme in the carnitine-dependent transport across 
the mitochondrial inner membrane and its deficiency results in a 
decreased rate of fatty acid beta-oxidation. 
3-hydroxy-3-methylglutaryl-
Coenzyme A synthase 2 
 
HMGCS2 
A mitochondrial enzyme that catalyzes the first reaction of 
ketogenesis, a metabolic pathway that provides lipid-derived energy 
for various organs during times of carbohydrate deprivation, such as 
fasting. 
Angiopoietin-like 4  
ANGPTL4 
May act as a regulator of angiogenesis and modulate tumorgenesis. 
Inhibits proliferation, migration, and tubule formation of endothelial 
cells and reduces vascular leakage.  
Fatty acid binding protein 1 FABP1 FABP1 encodes the fatty acid binding protein found in liver. FABPs 
roles include fatty acid uptake, transport, and metabolism. 
Carnitine O-
octanoyltransferase 
CROT Beta-oxidation of fatty acids. The highest activity concerns the C6 to 
C10 chain length substrate. Converts the end product of pristanic acid 
beta oxidation, 4,8-dimethylnonanoyl-CoA, to its corresponding 
carnitine ester. 
Patatin-like phospholipase 
domain containing 3 
PNPLA3 Multifunctional enzyme which has both triacylglycerol lipase and 
acylglycerol O-acyltransferase activities. 
Cytochrome b5 type A 
(microsomal) 
CYB5A Cytochrome b5 is a membrane bound hemoprotein which function as 
an electron carrier for several membrane bound oxygenases. 
ATP-binding cassette, sub-
family D (ALD), member 1 
ABCD1 ABC proteins transport various molecules across extra- and intra-
cellular membranes. The nucleotide-binding fold acts as an ATP-
binding subunit with ATPase activity. 
Lipin 1 LPIN1 Involved in adipocyte differentiation. 
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Supplementary Table 5. (continued) Genes selected for transcript profiling in bovine liver. 
 
 
Gene Name 
 
Gene 
Symbol 
 
Description  
Apolipoprotein B APOB This gene product is the main apolipoprotein of chylomicrons and low 
density lipoproteins. It occurs in plasma as two main isoforms, apoB-
48 and apoB-100: the former is synthesized exclusively in the gut and 
the latter in the liver. The intestinal and the hepatic forms of apoB are 
encoded by a single gene from a single, very long mRNA.  
Microsomal triglyceride 
transfer protein 
MTTP Catalyzes the transport of triglyceride, cholesteryl ester, and 
phospholipid between phospholipid surfaces. Required for the 
secretion of plasma lipoproteins that contain apolipoprotein B. 
 
Apolipoprotein A-V 
 
APOA5 
Minor apolipoprotein mainly associated with HDL and to a lesser 
extent with VLDL. May also be associated with chylomicrons. 
Important determinant of plasma triglyceride (TG) levels by both 
being a potent stimulator of apo-CII lipoprotein lipase (LPL) TG 
hydrolysis and a inhibitor of the hepatic VLDL-TG production rate. 
Stearoyl-CoA desaturase SCD Catalysis of the reaction: stearoyl-CoA + 2 ferrocytochrome b5 + O2 
+ 2 H+ = oleoyl-CoA + 2 ferricytochrome b5 + H2O involved in 
lipogenesis. 
Glycosylphosphatidylinositol 
anchored high density 
lipoprotein binding protein 1 
GPIHBP1 Plays a key role in the lipolytic processing of chylomicrons 
Perilipin 2 PLIN2 Adipocyte differentiation-related protein is associated with the 
globule surface membrane material. This protein is a major 
constituent of the globule surface. Increase in mRNA levels is one of 
the earliest indications of adipocyte differentiation. 
Abhydrolase domain 
containing 5 
ABHD5 An alpha/beta hydrolase fold, and contains three sequence motifs that 
correspond to a catalytic triad found in the esterase/lipase/thioesterase 
subfamily.  
Diacylglycerol O-
acyltransferase homolog 1 
 
DGAT1 
Catalyzes the terminal and only committed step in triacylglycerol 
synthesis by using diacylglycerol and fatty acyl CoA as substrates. In 
contrast to DGAT2 it is not essential for survival. May be involved in 
VLDL (very low density lipoprotein) assembly. 
Diacylglycerol O-
acyltransferase homolog 2 
 
DGAT2 
Essential acyltransferase that catalyzes the terminal and only 
committed step in triacylglycerol synthesis by using diacylglycerol 
and fatty acyl CoA as substrates. Required for synthesis and storage 
of intracellular triglycerides. 
Coactivator-associated 
arginine methyltransferase 1 
CARM1 Methylates (mono- and asymmetric dimethylation) the guanidino 
nitrogens of arginyl residues in several proteins involved in DNA 
packaging, transcription regulation, and mRNA stability.  
Trimethylguanosine synthase 1 
 
TGS1 Catalyzes the 2 serial methylation steps for the conversion of the 7-
monomethylguanosine (m(7)G) caps of snRNAs and snoRNAs to a 
2,2,7-trimethylguanosine (m(2,2,7)G) cap structure. The enzyme is 
specific for guanine, and N7 methylation must precede N2 
methylation.  
RAR-related orphan receptor 
A 
RORA Orphan nuclear receptor. Binds DNA as a monomer to hormone 
response elements (HRE) containing a single core motif half-site 
proceeded by a short A-T-rich sequence.  
Nuclear receptor coactivator 1 
 
NCOA1 Nuclear receptor coactivator that directly binds nuclear receptors and 
stimulates the transcriptional activities in a hormone-dependent 
fashion. Involved in the coactivation of different nuclear receptors, 
such as for steroids (PGR, GR and ER), retinoids (RXRs), thyroid 
hormone (TRs) and prostanoids (PPARs).  
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Supplementary Table 5. (continued) Genes selected for transcript profiling in bovine liver. 
 
 
Gene Name 
 
Gene 
Symbol 
 
Description  
Nuclear receptor 
coactivator 3 
NCOA3 Nuclear receptor coactivator that directly binds nuclear receptors and 
stimulates the transcriptional activities in a hormone-dependent 
fashion. Plays a central role in creating a multisubunit coactivator 
complex, which probably acts via remodeling of chromatin. 
Nuclear receptor 
corepressor 2 
NCOR2 Mediates the transcriptional repression activity of some nuclear 
receptors by promoting chromatin condensation, thus preventing 
access of the basal transcription. Isoform 1 and isoform 5 have 
different affinities for different nuclear receptors. 
Mediator complex 
subunit 1 
 
MED1 Component of the Mediator complex, a coactivator involved in the 
regulated transcription of nearly all RNA polymerase II-dependent 
genes. Mediator functions as a bridge to convey information from 
gene-specific regulatory proteins to the basal RNA polymerase II 
transcription machinery. Mediator is recruited to promoters by direct 
interactions with regulatory proteins and serves as a scaffold for the 
assembly of a functional preinitiation complex with RNA polymerase 
II and the general transcription factors. 
Fibroblast growth 
factor 21 
FGF21 Stimulates glucose uptake in differentiated adipocytes via the 
induction of glucose transporter SLC2A1/GLUT1 expression. 
 
Klotho beta 
 
KLB 
Contributes to the transcriptional repression of cholesterol 7-alpha-
hydroxylase (CYP7A1), the rate-limiting enzyme in bile acid 
synthesis. Probably inactive as a glycosidase. Increases the ability of 
FGFR1 and FGFR4 to bind FGF21. 
Insulin-like growth 
factor 1 (somatomedin 
C) 
IGF1 The protein encoded by this gene is similar to insulin in function and 
structure and is a member of a family of proteins involved in 
mediating growth and development.  
Insulin-like growth 
factor binding protein 
1 
IGFBP1 This gene is a member of the insulin-like growth factor binding 
protein (IGFBP) family and encodes a protein with an IGFBP domain 
and a thyroglobulin type-I domain. The protein binds both insulin-like 
growth factors (IGFs) I and II and circulates in the plasma. Binding of 
this protein prolongs the half-life of the IGFs and alters their 
interaction with cell surface receptors. 
Insulin-like growth 
factor binding protein, 
acid labile subunit 
IGFALS The protein encoded by this gene is a serum protein that binds insulin-
like growth factors, increasing their half-life and their vascular 
localization. Production of the encoded protein, which contains 
twenty leucine-rich repeats, is stimulated by growth hormone.  
Growth hormone 
receptor 
GHR This gene encodes a protein that is a transmembrane receptor for 
growth hormone. Binding of growth hormone to the receptor leads to 
receptor dimerization and the activation of an intra- and intercellular 
signal transduction pathway leading to growth. 
 
 
 
 
 
 
 
 
72 
 
Supplementary Table 5. (continued) Genes selected for transcript profiling in bovine liver. 
 
 
Gene Name 
 
Gene 
Symbol 
 
Description  
Signal transducer and activator of 
transcription 5A 
STAT5A The protein encoded by this gene is a member of the STAT 
family of transcription factors. In response to cytokines and 
growth factors, STAT family members are phosphorylated by 
the receptor associated kinases, and then form homo- or 
heterodimers that translocate to the cell nucleus where they act 
as transcription activators. 
Signal transducer and activator of 
transcription 5B 
STAT5B The protein encoded by this gene is a member of the STAT 
family of transcription factors. In response to cytokines and 
growth factors, STAT family members are phosphorylated by 
the receptor associated kinases, and then form homo- or 
heterodimers that translocate to the cell nucleus where they act 
as transcription activators. 
Suppressor of cytokine signaling 2 SOCS2 This gene encodes a member of the STAT-induced STAT 
inhibitor (SSI), also known as suppressor of cytokine signaling 
(SOCS), family. SSI family members are cytokine-inducible 
negative regulators of cytokine signaling.  
Fibroblast growth factor receptor 1 FGFR1 Receptor for basic fibroblast growth factor. Receptor for 
FGF23 in the presence of KL (By similarity). A shorter form of 
the receptor could be a receptor for FGF1 (aFGF). 
Fibroblast growth factor receptor 2 FGFR2 Receptor for acidic and basic fibroblast growth factors. 
Fibroblast growth factor receptor 3 FGFR3 Receptor for acidic and basic fibroblast growth factors. 
Preferentially binds FGF1. 
Fibroblast growth factor receptor 4 FGFR4 Receptor for acidic fibroblast growth factor. Does not bind to 
basic fibroblast growth factor. Binds FGF19. 
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Supplementary Figure 1: Western blot of FGF21 (23 kD) protein from plasma samples of cows 
(n = 6/diet) fed a control diet (CON; 1.34 Mcal/kg of DM) or moderate energy diet (overfed, 
OVE; 1.62 Mcal/kg of DM) during the entire dry period. 
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Supplementary Figure 2. Relative mRNA abundance in percent (%) of genes measured in A) 
PPPARs and PPARA target genes, B) Nuclear receptors, C) TAG metabolism and storage, D) 
FG21 modulating GH/IGF signaling and E) Fibroblast growth receptors. 
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CHAPTER 3 
 
Inflammation and endoplasmic reticulum stress gene network expression in liver of transition 
cows fed two levels of dietary energy prepartum 
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INTRODUCTION 
The transition period in dairy cows is associated with abrupt changes in metabolic and 
immune functions (Contreras and Sordillo, 2011). Many of these alterations are related to high 
energy requirements for fetal growth and lactogenesis (Kelton et al., 1998). Furthermore, a 
marked decrease in dry matter intake (DMI) due to metabolic and hormonal changes aggravates 
the susceptibility to several diseases such as milk fever, metritis, and clinical mastitis (Contreras 
and Sordillo, 2011). As the result of high energy demand and reduced DMI, dairy cows 
experience a negative energy balance (NEB) that is depicted by weight loss in milking cows 
(Leroy et al., 2008). Dairy cows mobilize lipid from adipose depots to adapt to NEB and release 
non-esterified fatty acids (NEFAs) into blood-stream, which are used as energy fuel by skeletal 
muscles, helps glucose usage by fetal growth and lactose synthesis (Contreras and Sordillo, 
2011). Greater prepartum stores in adipose tissue lipid from overfeeding during the dry period  
may cause higher release of NEFA after parturition and can increase metabolic burden in liver 
(Dann et al., 2005), hence making management of the transition period more difficult.   
 Alterations in inflammatory response and modifications in immune functions are 
observed due to abrupt metabolic changes especially in lipid mobilization (Contreras and 
Sordillo, 2011). Specifically, cytokines activates adipose tissue lipolysis and enhanced 
infiltration of NEFA into liver is associated with fatty liver and ketosis in dairy cows (Ingvartsen, 
2006, Kushibiki et al., 2001). Moreover, tumor necrosis factor-alpha (TNFα) decreases glucose 
production and also stimulates the accumulation of TAG in liver (Bradford et al., 2009). In 
addition to inflammatory stress, increased hepatic oxidation of NEFA results in greater 
production of reactive oxygen species (ROS), lower paraoxonase activity, and increased 
oxidative stress (Turk et al., 2008). This metabolic and associated oxidative stress is linked to 
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depression of immune system function postpartum, which makes dairy cows more prone to 
bacterial infection during the transition period (Morris et al., 2009).   
The endoplasmic reticulum (ER) has an important role in cellular metabolism (Invernizzi 
et al., 2012). The ER is the primary intracellular organelle responsible for protein folding, 
maturation, and trafficking (Ron and Walter, 2007). The ER consists of a network of folded 
membranes in which secretory and most membrane proteins are synthesized to maintain 
structural and metabolic functions including lipid and steroid hormone synthesis, carbohydrate 
metabolism, and drug detoxification (Zhang et al., 2011). Numerous physiological conditions 
such as energy or nutrient deficiency and variation in the redox status can affect the capacity of 
ER in protein folding and results in the accumulation of unfolded or mis-folded proteins in the 
ER lumen, called ER stress (Ozcan and Tabas, 2012). Cells trigger an adaptive response 
mechanism to remove lethal proteins, which consists of a number of intracellular signaling 
pathways collectively known as the unfolded protein response (UPR) (Jing et al., 2012). The 
UPR can trigger different inflammatory and stress signaling pathways including the NF-κB-IκB 
kinase (IKK) and JNK-AP1 pathways along with oxidative stress pathways; hence, the UPR can 
influence metabolism (Hotamisligil, 2010).  
Major metabolic changes in dairy cows during transition from a non-lactating to a 
lactating state and the stress of parturition may result in a failure to adapt to metabolic and 
management changes; therefore cows become susceptible to certain infectious pathologies and 
metabolic disorders. Dairy cows need to sustain body fat reserves to supply the demands of milk 
production and maintain health status (LeBlanc et al., 2006). Over-feeding high energy diets 
prepartum can increase lipid stores in adipose tissue and aggravate severe health problems upon 
transition under the effect of stress hormones such as catecholamines (Contreras and Sordillo, 
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2011) and the effects of inflammation and ER stress. Our general hypothesis was that 
overfeeding dietary energy during the entire dry period would result in increased inflammation 
including oxidative and ER stress in dairy cows postpartum.  The main objective of this study 
was to determine the effects of controlled-energy or overfeeding energy during the entire dry 
period on inflammation and ER stress gene networks in liver of transition dairy cows. 
MATERIALS AND METHODS 
Animals and diets  
All procedures were performed under protocols approved by the University of Illinois 
Institutional Animal Care and Use Committee (protocol # 06145). Details of the experimental 
design have been published previously (Graugnard et al., 2012, Graugnard et al., 2013). Briefly, 
twelve out of forty Holstein cows in their second or greater lactation were selected for this study. 
One group of cows was assigned to a control (CON) high wheat-straw diet, i.e. ~41.9% of total 
ingredients, that was fed for ad libitum intake to supply at least 100% of calculated net energy 
for lactation (NEL, 1.34 Mcal/kg DM; Supplementary Table 6). Another group of cows was fed a 
moderate-energy diet (OVE, 1.62 Mcal/kg DM) with corn silage as the major dietary component, 
i.e. ~50.3% of total, to supply >140% of calculated NEL requirements during the entire dry 
period (~45 d). Diets were fed as a total mixed ration (TMR) once daily (0600 h) using an 
individual Calan (American Calan, Northwood, NH, USA) gate feeding system during the dry 
period or in open individual managers during lactation. Calculation of energy balance, sampling 
of feed ingredients and TMR for composition analyses, and housing of cows pre and postpartum 
were as reported previously. Also, details of BW, BCS, milk weights and sampling of milk 
composition were as described previously (Graugnard et al., 2012, Graugnard et al., 2013).  
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Blood metabolites 
Blood was sampled from the coccygeal vein or artery on d (± 3) -14, -5, -2, -1, 0, 1, 2, 5, 
7, 10, 14 and 21 days relative to parturition. Samples were collected at 1200 h into evacuated 
serum tubes (Becton Dickinson Vacutainer Systems, Franklin Lakes, NJ, USA) containing either 
EDTA or lithium heparin for plasma and a clot activator for serum. After blood collection, tubes 
with EDTA and lithium heparin were placed on ice while tubes with clot activator were kept at 
~37 °C until centrifugation (~30 min). Serum and plasma were obtained by centrifugation at 
1,900 × g for 15 min. Aliquots of serum and plasma were frozen (-20°C) until further analysis. 
Albumin, β-carotene, cholesterol, bilirubin, creatinine, urea, and glutamic-oxalacetic 
transaminase (GOT) were determined using kits purchased from Instrumentation Laboratory (IL 
Test) following the procedures previously described by Bionaz et al. (2007) in a clinical auto-
analyzer (ILAB 600, Instrumentation Laboratory, Lexington, MA, USA). Haptoglobin and 
ceruloplasmin were analyzed using methods described by Bertoni et al. (2008) adapted to the 
ILAB 600 conditions. Plasma vitamin A, vitamin E and β-carotene were extracted with hexane 
and analyzed by reverse-phase HPLC using Allsphere ODS-2 3µm in a 150 × 4.6 mm column 
(Grace Davison Discovery Science, Deerfield, IL, USA); a UV detector set at 325 nm (for 
vitamin A) or 290 nm (for vitamin E) or 460 nm (for β-carotene); and 80:20 
methanol:tetrahydrofurane as the mobile phase. Total plasma reactive oxygen metabolites 
(ROM) were measured using the analytical method patented by Diacron International s.r.l. 
(Grosseto, Italy). 
Liver tissue 
Liver was sampled via puncture biopsy (Dann et al., 2006) from cows under local 
anesthesia at approximately 0700 h on d (± 3) −14 and 7, 14 and 30 relative to parturition. Liver 
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was frozen immediately in liquid nitrogen and stored until further analysis for contents of total 
lipids, TAG (Dann et al., 2006) and used for RNA extraction.  
RNA extraction and quantitative PCR analysis 
RNA samples were extracted from frozen tissue using established protocols in our 
laboratory (Bionaz and Loor, 2007). Briefly, liver tissue was weighed (~0.3-0.5 g) and 
straightway placed in a 15 mL centrifuge tube (Corning Inc. ®, Cat. No. 430052, Corning, NY, 
USA) containing 5 ml of ice-cold Trizol reagent (Invitrogen Corp., Carlsbad, CA, USA) and 1 
µL Linear Acrylamine (Ambion® Cat. No. 9520, Austin, TX, USA). The RNA extraction 
procedure also included acid-phenol chloroform (Ambion® Cat. No. 9720, Austin, TX, USA), 
which removes residual DNA. Any remaining genomic DNA was removed from RNA with 
DNase using the RNeasy Mini Kit columns (Qiagen, Hilden, Germany). The RNA concentration 
was measured using a Nano-Drop ND-1000 spectrophotometer (Nano-Drop Technologies, 
Wilmington, DE, USA). The purity of RNA (A260/A280) for all samples was above 1.81. The 
quality of RNA was evaluated using the Agilent Bioanalyzer system (Agilent 2100 Bioanalyzer, 
Agilent Technologies, Santa Clara, CA, USA). The average RNA integrity number (RIN) value 
for samples was 8.0 ± 0.4.  
qPCR Analysis 
For qPCR, cDNA was synthesized using 100 ng RNA, 1 µg dT18 (Operon 
Biotechnologies, Huntsville, AL, USA), 1 µL 10 mmol/L dNTP mix (Invitrogen Corp., CA, 
USA), 1 µL random primer p(dN)6 (Roche® Cat. No. 11 034 731 001, Roche Diagnostics 
GmbH, Mannheim, Germany), and 10 µL DNase/RNase free water. The mixture was incubated 
at 65 °C for 5 min and kept on ice for 3 min. A total of 6 µL of master mix composed of 4.5 µL 
5X First-Strand Buffer, 1 µL 0.1 M dithiothreitol, 0.25 µL (50 U) of SuperScriptTM III RT 
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(Invitrogen Corp.CA, USA), and 0.25 µL of RNase Inhibitor (10 U; Promega, Madison, WI, 
USA) was added. The reaction was performed in an Eppendorf Mastercycler® Gradient using the 
following temperature program: 25 °C for 5 min, 50 °C for 60 min and 70 °C for 15 min.  cDNA 
was then diluted 1:4 (v:v) with DNase/RNase free water.  
Quantitative PCR (qPCR) was performed using 4 µL diluted cDNA (dilution 1:4) 
combined with 6 µL of a mixture composed of 5 µL 1 × SYBR Green master mix (Applied 
Biosystems, CA, USA), 0.4 µL each of 10 µM forward and reverse primers, and 0.2 µL 
DNase/RNase free water in a MicroAmp™ Optical 384-Well Reaction Plate (Applied 
Biosystems, CA, USA). Each sample was run in triplicate and a 6 point relative standard curve 
plus the non-template control (NTC) were used (User Bulletin #2, Applied Biosystems, CA, 
USA). The reactions were performed in an ABI Prism 7900 HT SDS instrument (Applied 
Biosystems, CA, USA) using the following conditions: 2 min at 50 °C, 10 min at 95 °C, 40 
cycles of 15 s at 95 °C (denaturation) and 1 min at 60 °C (annealing and extension). The 
presence of a single PCR product was verified by the dissociation protocol using incremental 
temperatures to 95 °C for 15 s plus 65 °C for 15 s.  Data were calculated with the 7900 HT 
Sequence Detection Systems Software (version 2.2.1, Applied Biosystems, CA, USA). The final 
data were normalized using the geometric mean (V2/3 = 0.20) of ubiquitously-expressed 
transcript (UXT), glyceraldehyde-3-phosphate dehydrogenase (GAPDH), and ribosomal protein 
S9 (RPS9).  
Primers were designed using Primer Express 2.0 or 3.0 with minimum amplicon size of 
80 bp (when possible amplicons of 100-150 bp were chosen) and limited 3’ G+C (Applied 
Biosystems, CA). When possible, primers were designed to fall across exon–exon junctions. 
Primers were aligned against publicly available databases using BLASTN at NCBI and UCSC’s 
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Cow (Bos taurus) Genome Browser Gateway (Supplementary Table 7, 8). Prior to qPCR, 
primers were tested in a 20 µL PCR reaction using the same protocol described for qPCR except 
for the final dissociation protocol. For primer testing we used a universal reference cDNA (RNA 
mixture from 5 different bovine tissues) to ensure identification of desired genes. Five µL of the 
PCR product were run in a 2% agarose gel stained with ethidium bromide (2 µL). The remaining 
15 µL were cleaned using QIAquick® PCR Purification Kit (QIAGEN) and sequenced at the 
Core DNA Sequencing Facility of the Roy J. Carver Biotechnology Center at the University of 
Illinois, Urbana-Champaign. Only those primers that did not present primer-dimer, a single band 
at the expected size in the gel, and had the right amplification product (verified by sequencing) 
were used for qPCR. The accuracy of a primer pair also was evaluated by the presence of a 
unique peak during the dissociation step at the end of qPCR.  
Efficiency of PCR amplification for each gene was calculated using the standard curve 
method [E = 10(-1/slope)] (Supplementary Table 9). mRNA abundance among measured genes was 
calculated as previously reported (Bionaz and Loor 2011), using the inverse of PCR efficiency 
raised to ∆Ct (gene abundance = 1/E∆Ct, where ∆Ct = Ct sample - geometric mean Ct of 3 
internal control genes; Supplementary Table 9). The % relative mRNA abundance for each 
transcript measured was calculated using the ratio of median ∆Ct of the gene/median ∆Ct of 
internal control genes (Supplementary Figure 3). Use of this technique for estimating relative 
mRNA abundance among genes was necessary because relative mRNA quantification was 
performed using a standard curve (made from a mixture of RNA) which precluded a direct 
comparison among genes. Together, use of Ct values corrected for the efficiency of amplification 
plus internal control genes as baseline overcome this limitation.  
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Genes selected for transcript profiling in this study were CCAAT/enhancer binding 
protein (C/EBP) homologous protein (CHOP/GADD153), RNA-activated protein kinase (PKR)-
like ER kinase (PERK), telomerase repeat binding factor 3 (TRB3), heat shock protein 40 
(HSP40), membrane-bound transcription factor peptidase, site 1 (MBTPS1), glucose-regulated 
protein (GRP94), activating transcription factor 3 (ATF3), activating transcription factor 4 
(ATF4), activating transcription factor 6 (ATF6), X box binding protein-1 (XBP1), heat shock 
70kDa protein 1A (HSPA1A), heat shock 70kDa protein 1B (HSPA1B), cAMP responsive 
element binding protein 3-like 3 (CREB3L3), nuclear factor of kappa light polypeptide gene 
enhancer in B-cells 1 (NFKB1), signal transducer and activator of transcription 3 (STAT3), toll-
like receptor 4 (TLR4), v-rel reticuloendotheliosis viral oncogene homolog A (RELA), inhibitor 
of kappa light polypeptide gene enhancer in B-cells, kinase beta (IKBKB), inhibitor of kappa 
light polypeptide gene enhancer in B-cells, kinase gamma (IKBKG), conserved helix-loop-helix 
ubiquitous kinase (CHUK), alpha-1 acid glycoprotein (ORM1), umor necrosis factor-α (TNFA), 
serum amyloid A 3 (SAA3), haptoglobin (HP), myeloid differentiation primary response gene 
(88) (MYD88), interleukin-1 receptor-associated kinase 1 (IRAK1), suppressor of cytokine 
signaling 1 (SOCS1), interleukin 1, beta (IL1B), caveolin 1 (CAV1), mitogen-activated protein 
kinase 14 (MAPK14), pentraxin 3 (PTX3), nuclear receptor subfamily 3, group C, member 1 
(glucocorticoid receptor) (NR3C1), solute carrier family 25 (mitochondrial carrier; adenine 
nucleotide translocator), member 6 (SLC25A6), prostaglandin-endoperoxide synthase 2 
(PTGS2/COX2), catalase (CAT), superoxide dismutase 2 (SOD2), glutathione peroxidase 1 
(GPX1), thioredoxin reductase 1 (TXNRD1), paraoxonase 1 (PON1), 3-hydroxy-3-
methylglutaryl-CoA reductase  (HMGCR), sterol regulatory element binding transcription factor 
2 (SREBF2), acetoacetyl-CoA synthetase (AACS), cytochrome P450, family 4, subfamily A, 
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polypeptide 11 (CYP4A11), phospholipase D2 (PLD2), CDP-diacylglycerol--inositol 3-
phosphatidyltransferase 1 (CDIPT1), mechanistic target of rapamycin (MTOR), regulatory 
associated protein of MTOR, complex 1 (RPTOR), RPTOR independent companion of MTOR, 
complex 2 (RICTOR), V-akt murine thymoma viral oncogene homolog 1 (AKT1), V-akt murine 
thymoma viral oncogene homolog 2 (AKT2), V-akt murine thymoma viral oncogene homolog 3 
(AKT3), eukaryotic translation initiation factor 4E binding protein 1 (EIF4EBP1), Kruppel-like 
factor 10 (KLF10), tumor protein p53 (TP53), cytokeratin 18 (KRT18), serpin peptidase 
inhibitor, clade F (alpha-2 antiplasmin, pigment epithelium derived factor), member 1 
(SERPINF1), forkhead box A2 (FOXA2) and hypoxia-inducible factor 1-alpha (HIF1A) 
(Supplementary Table 10). The overall % relative mRNA abundance is shown in Supplementary 
Figure 3. 
Statistical analysis 
The MIXED procedure of SAS (SAS Institute, Inc., Cary, NC, USA) was used for 
statistical analysis. The fixed effects included diet (CON or OVE), time (-14 and 7, 14, 30 d 
relative to parturition), and interaction of diet × time.  The covariate structure used was AR(1). 
Data were normalized by logarithmic transformation prior to statistical analysis. All means were 
compared using the PDIFF statement of SAS (SAS Institute, Inc., Cary, NC, USA). The raw P-
values obtained for the gene expression analysis were adjusted using false discovery rate (FDR) 
to minimize the likelihood of type 2 errors due to the large number of genes studied. Significant 
difference was declared at P < 0.05 and tendency at P < 0.1, and for gene expression at an FDR-
adjusted P ≤ 0.05 (raw P ≤ 0.02). 
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RESULTS 
Blood metabolites 
Results of blood metabolites are shown in Figures 7 and 8. Blood concentrations of 
ceruloplasmin, reactive oxygen metabolites (ROM) and bilirubin concentration increased (diet × 
time P < 0.05) in the OVE group around calving where ceruloplasmin and ROM remained higher 
up to 3 wk and bilirubin up to 1 wk postpartum (Figure 7). Bilirubin concentration was higher 
(diet × time P < 0.05) in the CON group before parturition but gradually decreased postpartum. 
Interestingly, the blood concentration of creatine increased at the time of calving (diet × time P < 
0.05) and then gradually decreased in both groups up to 3 wk after parturition (Figure 7). The 
cholesterol concentration was similar in both groups before calving (diet × time P < 0.05) and 
increased postpartum.  No significant effect of diet × time was observed for blood urea, 
haptoglobin, glutamic oxalacetic transaminase (GOT) and albumin concentration although 
haptoglobin and GOT concentration peaked around parturition in both group (time P < 0.05) and 
albumin decreased in the CON group after onset of lactation (time P < 0.05) (Figure 7). Vitamin 
E and β-carotene concentrations were almost 2-fold higher (diet × time P < 0.05) in OVE group 
2 wks prepartum, decreased around parturition and gradually increased up to 3 wk postpartum 
(Figure 8). Moreover, no significant effect of diet × time was observed for blood calcium, zinc 
and vitamin A concentration (Figure 8) although concentration level was decreased (time P < 
0.05) around parturition in both groups. 
ER stress genes 
 The expression of key ER stress genes was significantly affected by the interaction of diet 
× time (P < 0.05). We observed a greater expression of PERK, XBP1, HSPA1A and HSP1B in 
the CON group before calving (Figure 9); the expression of PERK gradually decreased up to 1 
wk and then increased to a similar level as in OVE 4 wk after parturition. Expression of XBP1 
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remained same after 1 wk of calving and then gradually ecreased. The expression of HSPA1A 
and HSP1B gradually decreased following similar pattern of expression (Figure 9). We also 
observed higher expression (diet × time P < 0.05) of HSP40 and GPR94 in CON group at 1 wk 
and 4 wk postpartum respectively but the expression of CREB3L3 was greater (diet × time P < 
0.05) in OVE group after parturition (Table 5). No interaction effect of diet × time was observed 
for CHOP, MBTPS1, ATF3, ATF4 and ATF6 (Table 5).  
Inflammation genes 
Our results revealed that many of genes related to inflammation were affected by the 
interaction of diet × time (P < 0.05) (Figure 10). We observed a higher and approximately 
similar expression pattern (diet × time P < 0.05) of NFKB1, TLR4, RELA and IKBKG in OVE 
group that decreased gradually around parturition (Figure 10). We also observed the higher 
expression (diet × time P < 0.05) of HP and SOCS1 at 2 wk prepartum and IKBKB at 4 wk 
postpartum in the CON group (Figure 8).  The expression of STAT3 (Figure 10) and PTX3 (Table 
6) was greater (diet × time P < 0.05) after 1 wk and gradually decreased 4 wk postpartum in 
OVE group. Interestingly, the expression of TNFA, SAA3, MYD88, CHUK and ORM1 was 
higher (diet × time P < 0.05) in OVE group after parturition (Figure 10, Table 6) but PTGS2 
expression remained higher (diet × time P < 0.05) in CON compared to OVE at all-time points 
measured (Table 6). We did not observe any interaction effect of diet × time (P > 0.05) on IL1B, 
CAV1, MAPK14 and SLC25A6 (Table 6). 
Oxidative stress and lipid metabolism genes 
We observed a gradually increased expression (diet × time P < 0.05) of SOD2 and GPX1 
in the CON group 2 wk after parturition (Figure 11).  Expression of PON1 was greater (diet × 
time P < 0.05) prepartum and expression of SREBF2, AACS and CYP4A11 postpartum in the 
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OVE group compared with the CON group (Table 7). Also, we observed higher expression (diet 
× time P < 0.05) of PLD2 and CDIPT1 in the CON group after parturition (Table 7). There was 
no interaction effect of diet × time (P > 0.05) on CAT or TXNRD1 however HMGCR had tended 
to have  greater expression (diet × time P = 0.06) in the OVE group (Table 7).  
Cell cycle and cell growth genes 
 We also measured the expression of several cell cycle and cell growth genes. The 
expression of mTOR, RPTOR, KLF10, AKT3 and FOXA2 was greater (diet × time P < 0.05) in 
OVE group postpartum at 1 wk and then gradually decreased to 4 wk (Figure 12, Table 8). We 
observed higher expression (diet × time P < 0.05) of AKT1 and TP53 in CON group prepartum, 
which gradually decreased up to 1 wk postpartum following increased AKT1 expression at 2 wk 
postpartum (Figure 12). There was no interaction effect of diet × time (P > 0.05) observed on 
AKT2, RICTOR, EIF4EBP1, KRT18 and HIF1A but SERPINF1 expression was greater (diet × 
time P < 0.05) at 2 wk prepartum in the OVE group and higher at 4 wk postpartum in the CON 
group (Table 8).    
DISCUSSION 
 
In ruminants, urea is a vital source of protein synthesis for the rumen microbes through 
the urea cycle (Herdt, 2000) and it is synthesized from nitrogen from deamination of endogenous 
amino acids or ammonia absorbed from the rumen (Quiroz-Rocha et al., 2009). Although 
overfed cows received a diet with higher crude protein content (Supplemental Table 6) and also 
ate more before calving, there was no difference observed in urea concentration between groups. 
Plasma urea concentration therefore does not indicate differences in hepatic function between 
groups in this experiment. Creatinine is an index of muscle mass (Baxmann et al., 2008) and 
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higher blood creatinine postpartum shows potentially higher muscle mass in overfed cows before 
calving. 
The bilirubin concentration in blood is used as an index of liver function (Bionaz and 
Loor, 2007). In non-ruminants, the elevated concentration of bilirubin is considered as 
inflammation that could be the result of pro-inflammatory cytokines such as IL-1β, which 
inhibits NFKB that controls the mRNA expression of major enzymes responsible for bilirubin 
clearance in the liver (Assenat et al., 2004). The increased demand for NEFA oxidation in the 
liver may produce ROM especially when peroxisomal β-oxidation occurs. Some ROM are 
always produced in the liver but early lactation may result in enhanced production of these 
metabolites (Grum et al., 1996). Although higher peroxisomal oxidation increases the total 
capacity for β-oxidation of FA in the cell, hydrogen peroxide is produced in the first step rather 
than NADH, so it promotes increased production of ROM compared with mitochondrial 
oxidation (Drackley, 1999). Plasma albumin concentrations is known to decrease in transition 
dairy cows especially during the first weeks of early lactation and also due to the onset of 
inflammation (Contreras and Sordillo, 2011). The NEFA and BHBA concentration (data not 
shown) was significantly increased around parturition in the OVE vs. CON group. The results for 
ROM, bilirubin, ceruloplasmin, albumin and cholesterol along with NEFA and BHBA suggests 
that overfed cows were at high risk for inflammation and oxidative stress around and after 
parturition. Similarly, Trevisi et al. (2009) suggested that moderate energy-fed cows experienced 
a sustained inflammatory state during early lactation and the concentrations of cholesterol, 
haptoglobin and ceruloplasmin can be used as indicators of inflammation and liver function. We 
speculate that excessive lipid deposition in adipose tissue during the dry period and then abrupt 
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release of NEFA at the time of calving induced a mild but chronic inflammatory state in OVE 
dairy cows.  
Vitamin A (diet × time P = 0.07), β-carotene and vitamin E were higher prepartm in OVE 
vs. CON group. The higher concentrations of these vitamins in OVE cows could be a result of 
greater DMI; resulting storage of these vitamins and did not experience significant impairment of 
liver functions prepartum. Vitamin E is an antioxidant that can neutralize ROM and helps to 
decrease the chances of inflammation. Weiss et al. (1990) reported that the blood concentration 
of α-tocopherol (vitamin E) decreases during the transition period in dairy cows, and transition 
disorders are associated with low antioxidant status (LeBlanc et al., 2004).  Antioxidant status 
was improved when vitamin E was supplemented prepartum (Weiss et al., 1990) and incidence 
of clinical mastitis was also reduced. Furthermore, the precursor of vitamin A, β-carotene, can 
also function as an antioxidant (Spears and Weiss, 2008). LeBlanc et al. (2004) showed that 
concentrations of both vitamin A and β-carotene decreased around calving. Similarly, we 
observed a gradually decreased level of these vitamins from prepartum to calving and then 
gradually increased to 3 wk postpartum in OVE group, although vitamin E concentration was 
higher in CON group at the time of calving. We also observed a decline (day P < 0.05) in blood 
calcium concentration of OVE group around calving that could be  the potential indication of 
inflammatory risk in OVE group (Bertoni et al., 2008).   
Intense lipid mobilization at the time of parturition results in accumulation of lipids in the 
cytoplasm of non-adipose cells and causes steatosis (Contreras and Sordillo, 2011).  Fatty liver is 
the most common form of steatosis that is related to severe lipid mobilization (Bobe et al., 2004). 
The concentration of NEFA was greater around the time of calving in the OVE group vs. CON 
group, which indicates greater lipolysis in adipose tissue and release of NEFA into the blood-
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stream. Excessive NEFA accumulation can induce ER stress, which can lead to inflammation or 
apoptosis. In rodents, the major NEFA, palmitate (C16:0) and oleate (C18:1), induced apoptosis 
by ER stress (Kharroubi et al., 2004). The UPR is activated when the ER becomes stressed 
because of unfolded protein accumulation and induced inflammatory pathways. Both ER stress 
and inflammation are short term adaptive systems, important for the survival and function of the 
organism (Hotamisligil, 2010). We observed significant changes in mRNA expression of 
proteins of UPR signaling pathway (e.g., PERK, XBP1, and TRB3.).  
In non-ruminants, the UPR signaling cascade pathway is mediated by the ER 
transmembrane transcription factors activating transcription factor 6 (ATF6) and RNA-
dependent protein kinase (PKR)-like ER kinase (PERK) (Brewer and Diehl, 2000). The PERK 
activates ATF4 and inhibits cellular proliferation pathways directly or indirectly inducing 
apoptosis. A third player; ER to nucleus signaling 1 (IRE-1), in UPR activates XBP1, which 
trigger the cascade signaling to inflammation.  The nuclear translocation of ATF4 and ATF6 
promotes the expression of DNA damage-inducible transcript 3 protein (CCAAT/enhancer-
binding protein homologous protein (CHOP) and TRB3, which leads to apoptosis (Ohoka et al., 
2005). Also, heat shock proteins HSP70 (HSP1A and HSP1B) are considered to be the sensors of 
ER stress (Gupta et al., 2010). The expression of CHOP, ATF4 and ATF6 was not significant 
numerically but lower expression of PERK, XBP1 and HSP40 and higher identical expression 
pattern of TRB3, CREB3L3 (CREBH), HSPA1A and HSPA1B along with blood NEFA 
concentration and liver TAG accumulation suggests a mild but sustained level of ER stress in 
OVE cows. The CREBH protein is the sensor of inflammation by lipopolysaccharide and 
cytokines in the liver and activates UPR with acute phase response (Zhang et al., 2006b).  
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We are aware of no data for ER stress gene expression in ruminant liver but our group 
has shown a significant increase in expression of ER stress genes in mammary glands of early 
milking dairy cows (Invernizzi et al., 2012). Bobrovnikova-Marjon et al. (2008) reported another 
role of UPR via MBTPS1 in maintaining lipid homeostasis in mammary epithelial cells of mouse 
through SREBF and its target proteins. We speculate that the role of SREBF and MBTPS1 
induced ER stress is not a significant cause of ER stress in transition dairy cows as bovine liver 
is not a lipogenic organ (Drackley, 1999). Higher concentration of NEFA can induce 
inflammation in the hepatic cells directly, by activating the inhibitor of kB kinase (IKKB) 
(Contreras and Sordillo, 2011), or indirectly, by activating UPR to NFKB (Hotamisligil, 2010). 
The toll-like receptor 4 (TLR4) pathway can be induced directly by palmitate (C16:0) and 
stearate (C18:0) and activate NFKB-mediated inflammation response (Maloney et al., 2009). The 
upregulation of classical inflammatory genes NFKB1, TLR4, RELA, IKBKG, TNF, SAA3, 
MYD88, CHUK, ORM1, IRAK1 and NR3C1 in OVE cows is concomitant to NEFA and 
ceruloplasmin concentrations in blood and TAG accumulation in bovine liver. These data 
suggest the activation of inflammation irrespective of the level of ER stress because NEFA can 
also activate cascade mechanism of inflammatory pathways directly (Contreras and Sordillo, 
2011). Interestingly, the expression of lipid mediator (COX2) was upregulated at 2 wk prepartum 
and gradually decreased around calving, which may suggest the role of lipid mediator 
independent to classical inflammation gene expression. The function of each gene is briefly 
described in supplementary table 10. 
Several types of NEFA can enhance ROM production during β-oxidation, which 
increases in early lactation, and certain lipid peroxides promote inflammatory cascade hence 
alter nutrient metabolism (Bernabucci et al., 2005, Pessayre et al., 2004). These ROM can down-
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regulate immune response against infection and can be very harmful to immune cells (Spears and 
Weiss, 2008). Also, ER stress can result in the accumulation of ROM and promotes a state of 
oxidative stress (Hotamisligil, 2010). The downregulation in mRNA expression of antioxidant 
enzymes, SOD2 and GPX1, in OVE group after parturition suggest a consistent risk of 
inflammation. In addition, the UPR pathways have also been reported to regulate cellular 
lipogenesis and ER is an important organelle in both fatty acid synthesis and cholesterol 
metabolism in non-ruminants. The SREBFs are resident in ER and are very critical mediators in 
the regulation of lipid metabolism (Gregor and Hotamisligil, 2007). The higher expression of 
SREBF2, AACS and CYP4A11 suggest a possible connection of ER stress with lipids and 
cholesterol metabolism in bovine liver. But a better understanding of the link between ER stress 
and regulation of lipogenesis merits further investigation using appropriate animal models 
(Hotamisligil, 2010). 
The mRNA expression of major proteins of cell growth and apoptosis, especially the 
mTOR complex proteins, was significantly affected by OVE. Hotamisligi (2010) proposed that 
ER is a nutrient-sensing organelle that may communicate with the mTOR signaling pathway. 
Nutrient-responsive mammalian target of rapamycin (mTOR) signaling pathway activation 
stimulates protein synthesis and post-translational modifications in the ER (Polak and Hall, 
2009). It forms multi-protein complexes, mTORC1 (with RAPTOR) and mTORC2 (with 
RICTOR); mTORC1 is the regulator of cell growth and metabolism whereas mTORC2 controls 
actin cytoskeleton organization and cell-spreading (Kato et al., 2012). Akt activates mTORC1, 
which inhibit the activity of Akt by negative feedback mechanism (Zhang et al., 2006a). In our 
data, the expression pattern of mTOR, RPTOR and AKT1 suggests the activation of mTORC1 
complex and inhibition of AKT postpartum in OVE group which can be the indication of cell 
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growth inhibition and low level of apoptosis under a sustained level of ER stress. Our results 
agree with non-ruminant data; Kato et al (2012) reported that mTORC1 causes apoptosis via 
suppression of Akt under ER stress conditions. We also observed a similar pattern of mRNA 
expression of cell growth inhibitors KLF10 and TP53 to mTORC1.     
CONCLUSION 
Results from blood and gene expression data of this experiment indicated that allowing 
cows to overconsume energy prepartum induces significant changes in the immune state of dairy 
cows. The changes in gene expression of ER stress, inflammation, oxidative stress and apoptosis 
are similar to those documented in non-ruminant liver. . Better understanding of the whole 
inflammation model including blood metabolites and hepatic gene expression in dairy cows 
under overfeeding strategy demand further investigation at both gene and respective protein 
expression level.   
 
.   
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Table 5.  mRNA expression of ER stress genes (n = 6/treatment) in cows fed a control diet 
(CON; 1.34Mcal/kg of DM) or a moderate-energy diet (OVE; 1.62 Mcal/kg of DM) during the 
entire dry period. 
 
 
 
*
 Means differ due to diet x time interaction on respective diet (P<0.05). 
a-d Means within a row with different superscript differ  (P<0.05). 
1SEM = standard error of the means. 
T= time point, D= diet and D x T = diet and time interaction. 
 
 
 
 
 
 
 
 
 
 
  
 Time relative to parturition (Day)  P-value 
Gene Diet     -14       7      14      30    SEM1 T D D x T 
CHOP/ 
GADD153 
OVE 1.27 0.94 0.97 1.15 0.28 0.01 0.99 0.35 
CON 1.49 0.74 1.01 1.20 
HSP40 OVE 0.84 0.79* 0.73 0.78 0.20 0.02 0.11 0.01 
CON 0.79a 1.24*b 0.99c 0.99c 
MBTPS1 OVE 1.08 0.97 0.98 1.01 0.17 0.58 0.99 0.17 
CON 0.87 0.97 1.14 1.08 
GRP94 OVE 0.66 0.60 0.63 0.68* 0.24 0.01 0.18 0.04 
CON 0.60a 0.77a 0.69a 1.17*b 
ATF3 OVE 0.74 0.76 0.90 0.75 0.25 0.56 0.62 0.64 
CON 0.82 0.89 0.86 0.87 
ATF4 OVE 0.85 0.55 0.67 0.65 0.33 0.17 0.22 0.18 
CON 0.96 0.98 0.75 0.97 
ATF6 OVE 1.12 1.04 1.02 1.21 0.17 0.14 0.41 0.22 
CON 1.36 1.01 1.26 1.12 
CREB3L3 
 
OVE 0.64 1.32* 1.20* 0.65 0.19 0.01 0.01 0.01 
CON 0.66a 0.57*a 0.61*ab 0.82b 
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Table 6. mRNA expression of inflammation genes (n = 6/treatment) in cows fed a control diet 
(CON; 1.34Mcal/kg of DM) or a moderate-energy diet (OVE; 1.62 Mcal/kg of DM) during the 
entire dry period. 
 
*
 Means differ due to diet x time interaction on respective diet (P<0.05). 
a-d Means within a row with different superscript differ  (P<0.05). 
1SEM = standard error of the means. 
T= time point, D= diet and D x T = diet and time interaction. 
  
 Time relative to parturition (Day)  P-value 
Gene Diet     -14       7      14      30    SEM1 T D D x T 
CHUK OVE 0.94a 0.93*a 0.97a 0.82b 0.14 0.17 0.22 0.05 
CON 0.87a 0.73*b 0.79a 0.82a 
ORM1 OVE 0.47a 0.96b 0.85*b 0.49a 0.31 0.01 0.14 0.01 
CON 0.28a 0.69bc 0.44*c 0.57c 
IRAK1 OVE 0.86a 0.87a 0.91a 0.73b 0.16 0.28 0.52 0.03 
CON 0.75 0.79 0.75 0.80 
SOCS1 OVE 0.59*a 0.91b 0.56a 0.56a 0.20 0.01 0.50 0.03 
CON 0.84*a 0.70a 0.60b 0.62b 
IL1B OVE 0.57 0.49 0.43 0.54 0.56 0.53 0.57 0.20 
CON 0.71 0.55 0.95 0.39 
CAV1 OVE 1.79 1.42 1.33 1.42 0.18 0.01 0.01 0.16 
CON 1.54 1.01 1.04 0.83 
MAPK14 OVE 0.98 0.96 0.88 0.96 0.13 0.01 0.72 0.18 
CON 1.11 0.94 0.85 1.03 
PTX3 OVE 0.83 0.95* 0.81 0.81* 0.19 0.01 0.92 0.01 
CON 0.92ab 0.67*a 0.69a 1.17*b 
NR3C1 OVE 1.14a 0.85b 0.94b 0.84b 0.16 0.01 0.61 0.01 
CON 0.97a 0.70b 0.94a 0.94a 
SLC25A6 
 
OVE 0.82 1.17 1.16 0.81 0.15 0.01 0.15 0.11 
CON 0.79 0.89 0.93 0.80 
PTGS2/ 
COX2 
OVE 1.22*a 0.47*b 0.81*a 0.92a 0.52 0.01 0.01 0.01 
CON 5.23*a 3.79*ab 2.33*ab 1.01b 
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Table 7. mRNA expression of oxidative stress and lipid metabolism related genes (n = 
6/treatment) in cows fed a control diet (CON; 1.34Mcal/kg of DM) or a moderate-energy diet 
(OVE; 1.62 Mcal/kg of DM) during the entire dry period. 
 
*
 Means differ due to diet x time interaction on respective diet (P<0.05). 
a-d Means within a row with different superscript differ  (P<0.05). 
1SEM = standard error of the means. 
T= time point, D= diet and D x T = diet and time interaction. 
 
 
 
 
 
 
 
 
 
  
 Time relative to parturition (Day)  P-value 
Gene Diet     -14       7      14      30     SEM1 T D D x T 
CAT OVE 0.96 0.80 1.00 1.03 0.20 0.01 0.69 0.30 
CON 0.93 0.72 1.06 0.88 
TXNRD1 OVE 1.04 1.06 1.11 1.13 0.19 0.83 0.47 0.64 
CON 1.20 1.20 1.26 1.07 
PON1 OVE 1.24a 0.80b 0.92bc 0.76b 0.18 0.01 0.89 0.01 
CON 0.99a 0.71b 1.00a 0.93a 
HMGCR OVE 0.81 0.89 1.21 1.15 0.55 0.01 0.40 0.06 
CON 0.41a 1.18b 1.17b 0.51a 
SREBF2 OVE 0.96a 0.96a 1.04ab 1.21b 0.14 0.18 0.65 0.02 
CON 0.94a 1.19b 0.91a 0.96a 
AACS 
 
OVE 1.19a 1.17a 1.21a 0.77b 0.29 0.15 0.82 0.01 
CON 1.02 0.86 1.08 1.11 
CYP4A11 
 
OVE 0.83a 1.34*b 1.25*b 0.99a 0.14 0.09 0.01 0.01 
CON 0.91a 0.60*b 0.84*a 0.98a 
PLD2 
 
OVE 1.17a 0.98b 0.81*b 0.85ab 0.34 0.05 0.08 0.04 
CON 1.65a 1.06ab 1.90*a 1.23a 
CDIPT1 
 
OVE 0.86a 0.95b 0.96b 0.78*a 0.18 0.03 0.94 0.01 
CON 0.81a 0.75a 0.89b 1.08*b 
102 
 
Table 8. mRNA expression of cell cycle and cell growth genes (n = 6/treatment) in cows fed a 
control diet (CON; 1.34Mcal/kg of DM) or a moderate-energy diet (OVE; 1.62 Mcal/kg of DM) 
during the entire dry period. 
 
*
 Means differ due to diet x time interaction on respective diet (P<0.05). 
a-d Means within a row with different superscript differ  (P<0.05). 
1SEM = standard error of the means. 
T= time point, D= diet and D x T = diet and time interaction. 
 
 
 Time relative to parturition (Day)  P-value 
Gene Diet     -14       7      14      30     SEM1 T D D x T 
RICTOR 
 
OVER 0.97a 0.93ab 0.92ab 0.83b 0.17 0.06 0.39 0.06 
CON 1.12a 0.87b 1.03a 1.07a 
AKT2 
 
OVER 1.38 1.24 0.98 1.13 0.42 0.06 0.60 0.74 
CON 1.21 0.89 0.82 1.09 
AKT3 
 
OVER 1.06 0.97* 1.13 0.90 0.19 0.01 0.47 0.03 
CON 1.13a 0.70*b 0.92a 1.00a 
EIF4EBP1 
 
OVER 1.07 0.85 1.07 1.01 0.29 0.01 0.75 0.20 
CON 1.19 0.74 0.91 0.90 
KRT18 
 
OVER 0.85 1.08 0.91 0.87 0.11 0.01 0.96 0.50 
CON 0.94 1.07 0.87 0.85 
SERPINF1 
 
OVER 1.00*a 0.87b 0.89b 0.60*c 0.11 0.01 0.62 0.01 
CON 0.76*a 0.99b 0.85a 0.85*a 
FOXA2 
 
OVER 1.07a 1.27*a 1.63b 1.26a 0.17 0.01 0.85 0.01 
CON 1.34a 0.85*b 1.74c 1.30a 
HIF1A OVER 0.85 0.95 1.02 0.94 0.19 0.60 0.72 0.19 
CON 1.04 1.01 0.98 0.89 
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Figure 7. Blood concentration of indices of liver function and inflammation in cows (n = 6/diet) 
fed a control diet (CON; 1.34 Mcal/kg of DM) or a moderate energy diet (overfed, OVE; 1.62 
Mcal/kg of DM) during the entire dry period. Creatinine, urea, haptoglobin, ceruloplasmin, 
reactive oxygen metabolites (ROM), bilirubin, glutamic oxalacetatic transaminase (GOT) and 
albumin. *diet × time P < 0.05. 
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Figure 8. Blood concentration of selected minerals and vitamins in cows (n = 6/diet) fed a 
control diet (CON; 1.34 Mcal/kg of DM) or a moderate energy diet (overfed, OVE; 1.62 Mcal/kg 
of DM) during the entire dry period. Calcium, zinc, vitamin A, vitamin E, β-carotene. *diet × 
time P < 0.05. 
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Figure 9. Hepatic mRNA expression of ER stress genes in cows (n = 6/diet) fed a control diet 
(CON; 1.34 Mcal/kg of DM) or a moderate energy diet (overfed, OVE; 1.62 Mcal/kg of DM) 
during entire dry period. * diet × time (P < 0.05). 
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Figure 10. Hepatic mRNA expression of inflammation genes in cows (n = 6/diet) fed a control 
diet (CON; 1.34 Mcal/kg of DM) or a moderate energy diet (overfed, OVE; 1.62 Mcal/kg of 
DM) during entire dry period. * diet × time (P < 0.05). 
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Figure 11. Hepatic mRNA expression of oxidative stress genes in cows (n = 6/diet) fed a control 
diet (CON; 1.34 Mcal/kg of DM) or a moderate energy diet (overfed, OVE; 1.62 Mcal/kg of 
DM) during entire dry period. * diet × time (P < 0.05). 
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Figure 12. Hepatic mRNA expression of cell cycle and cell growth genes in cows (n = 6/diet) 
fed a control diet (CON; 1.34 Mcal/kg of DM) or a moderate energy diet (overfed, OVE; 1.62 
Mcal/kg of DM) during entire dry period. * diet × time (P < 0.05). 
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SUPPLEMENTAL MATERIAL 
 
Supplementary Table 6. Ingredients and chemical composition of experimental diets. 
 Prepartal energy level   
  Control Overfed  Lactation 
Ingredients     
Wheat straw 41.9 - - 
Corn silage 29.3 50.3 29.9 
Alfalfa silage 10.0 18.0 14.8 
Soybean meal 9.64 3.54 2.39 
Ground shelled corn 3.59 13.9 - 
Alfalfa hay 3.35 6.06 5.55 
Magnesium sulfate 0.64 0.63 - 
Magnesium oxide 0.42 0.43 0.13 
Vitamin E 0.27 0.24 - 
Mineral and vitamin mix1 0.18 0.18 0.22 
Magnesium chloride 0.17 0.35 0.00 
Urea 0.17 - 0.13 
Salt 0.15 0.24 0.13 
Sodium phosphate 0.13 - - 
Vitamin A 0.01 0.01 - 
Vitamin D 0.01 0.01 - 
Whole cottonseed - 5.03 5.55 
Calcium carbonate - 0.9 0.56 
Corn ground - - 20.3 
Wet brewer’s grain  - - 12.9 
Soybean hulls - - 5.55 
Sodium bicarbonate - - 0.83 
Dicalcium phosphate - - 0.54 
Vitamin H - - 0.28 
Chemical composition    
DM,  % 51.9 50.0 60.5 
NEL, Mcal/kg DM 1.34 1.62 1.69 
CP, % DM 12.0 15.0 17.4 
AP, % DM 11.2 14.3 11.9 
ADICP, % DM 0.70 0.73 5.53 
NDF, % DM 53.4 36.6 34.1 
ADF, % DM 36.6 25.7 21.8 
Ca, % DM 0.67 0.73 0.80 
P, % DM 0.24 0.31 0.43 
Mg, % DM 0.50 0.57 0.33 
K, % DM 1.45 1.28 1.16 
S %DM 0.21 0.25 0.21 
Na % DM 0.07 0.09 0.29 
Fe, ppm 305 339 203 
Zn , ppm 66.6 80.0 65.8 
Cu, ppm 13.0 14.6 10.9 
Mn, ppm 72.0 70.3 67.0 
1Mineral and vitamin mix: zinc = 60 ppm, copper = 15 ppm, manganese = 60 ppm, selenium 0.3 ppm, iodine = 0.6 ppm, iron = 
50 ppm, and cobalt = 0.2 ppm. Rumensin: 360mg/day in the lactation diet. 
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Supplementary Table 7. Sequencing results of PCR products from primers of genes designed 
for this experiment. Best hits using BLASTN (http://www.ncbi.nlm.nih.gov) are shown.  
 
Gene Sequence 
CHOP/ 
GADD153 
GGAAAGTATCTCATACATCACCACACCTGAAGCAGAGCCTGATCCAGCCACAGAGATG
GCAGCTGAGTCACATCAATA 
PERK GATCAGCATCTCTCATAGTGACATCTTTTCTTTGGGCCTCATTCTGTTTGAATTACTATA
CCCGTTCGGCACCTCGAA 
TRB3 CGTCGTCGCATGCCCCTCCAGAAGAGCGGTTGGAGCTGGATGATGACCTAGGACACTG
AGTGTCCCAGCCCAGAAACAAGCTCGAAGTGGGCACAA 
HSP40 CATGTCTACTATTCGGGAGGACTACGTGTCTTTTTTAGCTATGGGGCAAATCAAAAGCA
GCACTTCCACG 
MBTPS1 GGTCTCAGTGATCTTTACGGCCAAGCTAGAAATTCATTTATTTCAAGCGCCCTGAAGAG
CAGTGCAATCCGACAAGG 
GRP94 GAGATGCAGGTAATTAGTGTGACAGGAGAAGAACCTGCTGCATGTCACAGACACTGGT
GTAGGAATGCAAC 
ATF3 CGTGAGtGTAGTGCGTAGCGTAGGGCGCAGATTGAGGAGCTCAAGAACGAGAAGCAGC
ATTTGATATACATGCTCACACCTGCAA 
ATF4 GCACGAGAGATTCTTCTGGGACAGATGTGATGGTGGAGAAAATGGATTTGCAAG 
ATF6 GATTACCGAATTCAACAGAAAACTCAGTATTCTTCAGGGGTGCTCTGGGAACAGGGCTC
AAATTCTCAGCTCATGGCCACATCA 
XBP1 GGGATGTAGGACACTTTTCAGCCCTCAGAGAAAGATCACCCTGAATTCACAGGTAAG 
NFKB1 CCGCGACTCTCACAATAGAGCAGCCACCATCAGCGGAAGAAGTACGTCTGTCTGCCAC
GTACGTGGAGGTAAAAA 
STAT3 GCATCCCTCTACGAGCACGGCTAGATGTGGTCGGCTACAGCCATCTTGTCTCAGTTGAC
CAGAGTTTCTAGGGATGCAA 
HSPA1A CGATCTAGGTGACAGGCTTGCATTGCCTTATATATCTGGCCTTTCATCAGCCATCAGCTA
TGCAAGGCTGGTTTGAGATGTTGAACTGTCCCTTTTAAAA 
HSPA1B TGAGCAACGGTGACTCAGCTTTGCCATTGCCCTTATATATCTGCCTTTCATCAGCCATCA
GCTATGCAAGCTGTTTCGAGATGTTGAAAA 
TLR4 GCATCCCTCACCGTTATGGTCAGGTGAATTCCTGGGATAAGGCCAGGCTTCCTCTTGTT
GGTTACTTCAGCCAGAAA 
RELA GACAGCTCGGAGGGTGTATTCACGGGACCAGGCTGGGAGGGCCCGAGGCTCTTTTTCA
CAAGCTGACGTGCAATA 
IKBKG ACGGAGTACAGCTCTTTCAGAGCTGTAGGGGTCCTTTTCAGTTCTGGTATAAATGGCCT
GCTTGGATTTTTTTATCAGAA 
CHUK GCAGCTCAGTAGGTTACCTCAGCTGCCCACTTCAGCAGAACGTGAACATCCTCTGTCAT
GCGTGGTAA 
IKBKB CTGTCACGTTCTATTATACACCTCTGGTTGGACTTAACAAACTCGAAACCCAACTGCAA
TGGAACGTTTGATGAAA 
ORM1 CCGTGTCTCCCTTCGGACTTCATGCTTGCTGCCTCCTGGAATGGCACAAAGAACGTGGG
GGTGTCCTTACAA 
CAT CGCAGCAGTAGGATAGGATCGCATACTTTCAGCTGGTTAATGCAAATGGAGAGGCAGT
TTATTGCAACCCCTTTA 
SOD2 GCATGTTTGGCCGATTATCTGAGGCCATTTTGGAATGTGATCAACTGGGAGAATGTAAC
TGCAATAC 
GPX1 GTAAATCGTCGACAGGCGGCGGGTTCGAGCCCAACTTTATGCTCTTCGCAAAAGTGCGA
GGTGAAGGAAA 
TXNRD1 CACCATGGTCCAGCGCGTGTTTGGTCAGCCTCGAGACTCTCGAAACTATGGGTGGAACG
TCGAGGAAAA 
PON1 GATAACTCATATCACGTCTGTCCACATCTGTGGGGGCCACAGTGATCTCATCTCAACAG
TGAACGCTGACCCAA 
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Supplementary Table 7. (continued) Sequencing results of PCR products from primers of 
genes designed for this experiment. Best hits using BLASTN (http://www.ncbi.nlm.nih.gov) are 
shown.  
 
Gene Sequence 
TNF CTCTGGTTTTGTGGGCCCAGGACCCCTCACACTCAGGAATCAATCTTTCCTCAAAAT
TCGAGTGAACAAGCCCT 
SAA3 GCTAGCAGTGGGTGTCTGTGGCTGTGCTTAAGGTGATTCAGTGTAATCGCCAGGAGA
GACTATTCAGGGAATTCACAGACCCTTCAGTAA 
HP CATGATCGGCTGGTCTAGTGAGCAGCCTGTCCTGTGAAGGACGAGGGGGAAAGCCT
GTCACAGGAGTTGGAGGGGACCACCGAGTGTGTA 
MYD88 CATCGAGGAGACTGCCAAAGTATATTCTAAGCAGCAGCGAGGCATCTGAGAAGCCT
TTACAGGTGGAC 
SOCS1 GGCCTGAACTCGTACCTCCTACCTCTTCATGTTTACATACTCAGTATCTTTGCACAAA
CCAGGGGTTG 
IL1B CCACCTCCTCTCACAGGAAATGAACCGAGAAGTGGTGTTCTGCATGAGCTTTGTGCA
AGGAGAGGAA 
CAV1 CGTAGTGAATAGGTCATCAGCCGGTTCTATTCCATCTACGGTCCACACCTTCTGTGA
CCCGCCCTGTTTGAAGAA 
MAPK14 CCATCTATGAGACATGAAATGTAATTGGTCTGTTGGATGTTTTCACACCTGCAAGGT
CTCTGGAGGA 
PTX3 GCTCAGTCAGCGTCACCTCCTGTGCACGCACTTGGGGATTCAAAGCAAGGGGCCAC
ATGGCCTTGTGGGTTAATATGAANTCTCNCCCCCCCC 
CREB3L3 GCCAGGATCGGGTCCACGTAAACGGATTCTCAGACAAAGGACCATTAAGGGCCACA
AAGTCTGAGAAATTCTACA 
NR3C1 CCGATCGGTGTCTGTGTCGAGAGAGGGGGAATGTGATGGACTTCTATAAAACCCTA
AGGGGGAGGAGCTACTGTGAGTGCCC 
HMGCR CGCCGAGTGATCGACTTATCTGTTGGAGTGGCGGACTCTGTGCTTGGATGGAAAGAA
TTTCAGGATTCCAATGGCAAAT 
SREBF2 GCATCACTTCAATACTTGCAGCGGTCATCATAACTGCGCCGGGAGAACATGGTGCTG
AAGCTGGCCAATCAGAAGAGCAACCAT 
AACS GCGTGCTCGTGTCGGCGGTCGGCATCCTGTGGTCAGCTCAGGCTCTGGGGAATCAAC
CAGCTTGGCAGCCCTTAAAGGTTT 
CYP4A11 GACCGTCTCGTCTTTCATTACCTTCTCTTTCATCAAGACTTTGTGTCTTACCTGGGGC
AACTCAGATCAAACAAA 
mTOR CAGCATGCTTCTCGAGGCCGCGCTAGAGACTGTGGACCGTCTGACAGAGTCTCTGGA
TTTCACGGACTATGCCTCTCGGATCATTCATCCGATTGTACGCACACAGA 
RPTOR GGCACGACGTCGCTGAGCACCGGACCATGACGGGCCTTCATTCTGGGCTGTAATCGT
CAACAGCTATAACACGGCGGGCAAT 
RICTOR CTGTGTGTTGATTGAGCGAATTTTGCACCCTATACCGATTTTCACTACAGACATAGTC
CAGATACAGCTGAAGGGACAA 
AKT1 GTGTTGGACTCAGCGTGGACCTCATGCTGGACAAGGGACGGGCACATCAAGATCAC
CGACCTTTCGGAAAA 
AKT2 GCGGGCAGGTCTCGGCGTGCTCAGCTGCCCCCGATGACAGACACTTATCTGGGTCTC
CAGGTTTGCTGCAA 
AKT3 CGACACGTTCAGGTGCAGAATTGTCTCTGCCTTGGACTATCTACATTCCGGAAAGAT
TGTGTACCGCTGATCTCAAAA 
EIF4EBP1 GGATAGTGGAACTACTGGAACAGACGCCCCCGCGGGACCTGCCCACCATTCCCGGG
GTCACTAGCCCTACAGGCGATGAAA 
KLF10 GCATCGTCAGGTAGGGACGACATTGTGACCAACACGCCCGTCGCCACCTGTGTCAG
CCAAGAAGCTACCGAACTGGGCAGAAAA 
TP53 TGTTTGTGCCTGTCCTGGGAGAGACCGCCGCACTGAGGAAGAAAATC
TTCGCAAGAAGGGGCAGTCTTGCCCCGAGCCACCC 
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Supplementary Table 7. (continued) Sequencing results of PCR products from primers of 
genes designed for this experiment. Best hits using BLASTN (http://www.ncbi.nlm.nih.gov) are 
shown.  
 
Gene Sequence 
KRT18 GGCATGAGCCAGCTGGGAGACAGCCGTGTAGGGGAAGGGTGGAGGGCCCCGATATGCC
ATGTCAGAATGGAGCAGCTTCAACTCG 
SERPINF1 CATGGCGTTACTGGTACGGCTGTGGATTCTGGATCTCAACTGGCAAGGATTCGGCCCAG
GCTGGCCCTTGGACCGGGGGAGCACAAGTATTCAAAA 
SLC25A6 TAAACAGGTCTCATTGTTACTTAAGCACTATCCTCTCTTTTGGCACAGGCCGAAATACG
CGCGATTATGTTTAA 
FOXA2 CAGAAGAAGAAAGCATTCGCATTCTTGATACGGGGAAATCCAGGTCTCAAGTCTGACT
AATTTATGGTTTCTGCGTGCATTTAA 
PLD2 CGCCGTGCTGAGGGACTCTCCACAGGGGGGTAACTCCATCCAGGCCATTCTGCACTTCA
CTTACAGGACGGA 
CDIPT1 GCATCGTCGGAGAGGAGGGTGGCATCCTCTTGTGGGGTGATATGGATGGATTTCTCCGT
AATCCTGGGGGGACCAGTTCACA 
PTGS2/COX
2 
GACTTGAGAAGTCAGAAGAGAAGGAATGGCTGCAGAGTTAGAAGCGCTCTATGGAGAC
ATAGATGCCATGGAGAC 
HIF1A 
 
CACTGATTTAGACTTGGAGATGTTAGCTCCTTATATCCCAATGGATGATGACTTCCAGTT
ACGTTCCTTCGATCAGTTGTCACCA 
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Supplementary Table 8. Gene ID, GenBank accession number, hybridization position, 
sequence and amplicon size of primers for Bos taurus used to analyze gene expression .  
 
Gene ID Accession # Gene Primers Primers (5’-3’) bp 
777788 NM_001078163.1 CHOP/ 
DDIT3 
F.83 
R.183 
GAACCTGAGGAGAGAGTGTTCCA 
AGTGACTCAGCTGCCATCTCTGT 
101 
535820 NM_001098086.1 
 
PERK/ 
EIF2AK3 
F.3160 
R.3260 
ATATGAGCCCGGAACAGATTCAT 
AGTGCCGAACGGGTATAGTAATTC 
101 
824147 NM_001076103.1 TRB3 F.86 
R.208 
GGGTCCAGATGCGAGCAA 
GCCCACTTCGAGCTTGTTTCT 
123 
528862 BC126580.1 HSP40/ 
DNAJ1 
F.314 
R.403 
TGCAGTAGATGGTGACCCTGATA 
GGAAGTGCTGCTTTTGATTTGC 
90 
511682 NM_001025330.2 MBTPS1 F.268 
R.372 
CAACGGTTGTGGAATATGAGTACATT 
TGTCGATTGCACTGCTCTTCA 
105 
282646 BC104549.1 
 
GRP94 F.461 
R.560 
GATGAAAATGCTCTTGCTGGAAAT 
TCATTCCTACACCAGTGTCTGTGA 
100 
515266 NM_001046193.1 
 
ATF3 F.537 
R.643 
CCTGCAGAAAGAGTCGGAGAA 
GCAGGTTGAGCATGTATATCAAATG 
107 
509107 BC151812.1 
 
ATF4 F.482 
R.562 
GTGGATTGGTTGGTCTCAGACA 
CTTCAAATCCATTTTCTCCACCAT 
81 
530610 NM_001075935.1 
 
ATF6 F.514 
R.613 
AGTGGAAAGGACCAAGTCAAGAAG 
GGCCATGAGCTGAGAATTTGAG 
100 
541236 XM_001255847.2 XBP1 F.618 
R.697 
GAGAGCGAAGCCAATGTGGTA 
ACTGTGAATTCAGGGTGATCTTTCT 
80 
616115 NM_001076409.1 
 
NFKB1 F.172 
R.266 
TTCAACCGGAGATGCCACTAC 
ACACACGTAACGGAAACGAAATC 
95 
508541 NM_001012671.2 
 
STAT3 F.3804 
R.3913 
GGTAGCATGTGGGATGGTCTCT 
GCATCCCTAGAAACTCTGGTCAA 
110 
282254 NM_203322.2 HSPA1A F.2105 
R.2205 
TTCCCTGGATTGCTCATGTTT 
AAAAGGGACAGTTCAACATCTCAAA 
101 
282254 NM_203322.2 HSPA1B F.2107 
R.2196 
CCCTGGATTGCTCATGTTTGT 
TCAACATCTCAAACAGCTTGCA 
90 
281536 NM_174198.6 TLR4 F.102 
R.203 
GCTGTTTGACCAGTCTGATTGC 
GGGCTGAAGTAACAACAAGAGGAA 
102 
508233 NM_001080242.2 
 
RELA F.719 
R.818 
TCTTCCTGCTGTGTGACAAGGT 
TGCACGTCAGCTTGTGAAAAA 
100 
281855 NM_174354.3 
 
IKBKG F.2111 
R.2210 
AAGGTGAGCTCCTCTCTGTTAAGAGT 
AAAAAAATCCAAGCAGGCCATT 
100 
281073 NM_174021.2 
 
CHUK F.2026 
R.2125 
GAGTTCTGCTCGGTCCCTTGT 
TACCACGCATGACAGAGGATGT 
100 
281854 NM_174353.2 
 
IKBKB F.3068 
R.3176 
AACAGACTCTCTATTTTGCAACATGAC 
CATCAAACGTTCCATTGCAGTT 
91 
497200 NM_001040502.1 
 
ORM1 F.370 
R.469 
TCGGACAGAGAACACTTTGTTGA 
AGGACACCCCCACGTTCTTT 
100 
531682 NM_001035386.1 
 
CAT F.644 
R.743 
TTCAGTGATCGAGGGATTCCA 
TGCAATAAACTGCCTCTCCATTT 
100 
281496 NM_201527.2 
 
SOD2 F.620 
R.714 
TGTGGGAGCATGCTTATTACCTT 
TGCAGTTACATTCTCCCAGTTGA 
95 
281209 NM_174076.3 
 
GPX1 F.353 
R.452 
AACGCCAAGAACGAGGAGATC 
CATTCACCTCGCACTTTTCGA 
100 
282388 NM_174625.3 
 
TXNRD1 F.393 
R.492 
GTGTGAATGTGGGTTGCATACC 
TCCTCGACGTTCCACCCATA 
100 
523798 NM_001046269.1 
 
PON1 F.1088 
R.1187 
ATCCGTACCCCTACCCTGACA 
GGGTCAGCGTTCACTGTTGA 
100 
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Supplementary Table 8. (continued) Gene ID, GenBank accession number, hybridization 
position, sequence and amplicon size of primers for Bos taurus used to analyze gene expression. 
 
  
Gene ID Accession # Gene Primers Primers (5’-3’) bp 
280943 EU276079.1 TNF F.438 
R.537 
TCTCAAGCCTCAAGTAACAAGCC 
CCATGAGGGCATTGGCATAC 
 
281474 NM_181016.3 SAA3 F.50 
R.155 
GGGCATCATTTTCTGCTTCCT 
TTGGTAAGCTCTCCACATGTCTTTAG 
106 
280692 NM_001040470.1 HP F.1210 
R.1310 
GGTTCGGAAAACCATCGCTA 
CACTCGTGTCCCCTCCACTC 
101 
444881 NM_001014382.2 MYD88 F.367 
R.471 
GGAGGACTGCCAAAAGTATATTCT 
GCCATGTCATTTATCCGAGTTATG 
105 
518795 XM_002697964.1 SOCS1 F.938 
R.1032 
ACTCGTACCTCCTACCTCTTCATGTT 
CACAGCAGAAAAATAAAGCCAGAGA 
95 
281251 NM_174093.1 IL1B F.453 
R.552 
TCCACCTCCTCTCACAGGAAA 
TACCCAAGGCCACAGGAA 
100 
281040 NM_174004.3 
 
CAV1 F.446 
R.545 
GGCAGTTGTACCATGCATTAAGAG 
CTCAAACAGCGGGTCACAGAA 
100 
534492 NM_001102174.1 
 
MAPK14 F.596 
R.715 
AAGAACCTACAGAGAACTGCGGTTA 
GTCACCAGGTACACATCATTGAATTC 
120 
541148 NM_001076259.1 
 
PTX3 F.855 
R.954 
AACAGACTGGTCGCTGATGCT 
CATTTACCCACAAGGCCATGT 
100 
513010 NM_001034432.1 CREB3L3 F.1606 
R.1705 
TGGAGATGCACAGATACACAGCTA 
AGATTTCTCAGACTTTGTGGCCTTA 
100 
281946 XM_002689269.1 NR3C1 F.395 
R.494 
AAGCACCCCCAGTAGAGAAGAA 
CACAGTAGCTCCTCCCCTTAGG 
100 
407159 NM_001105613.1 HMGCR F.1665 
R.1764 
GGAGCTTGCTGTGAGAACGTT 
TTGCCATTGGAACCTGAAATT 
100 
507102 XM_002687950.1 
 
SREBF2 F.1089 
R.1200 
GCACAAGTCTGGCGTTCTGA 
GCTCTTCTGATTGGCCAGCTT 
112 
505842 NM_001163929.1 
 
AACS F.2275 
R.2377 
ACCTGCGTGTGTGCCATTAC 
TTAAGGCTGCAAGCTGGTTGA 
103 
511890 NM_001077908.1 
 
CYP4A11 F.1769 
R.1868 
TCAAATCCAGCAGCATCTTCA 
GTTTGATCTGAGTTGCCCAGGTA 
100 
100139219 XM_001788228.1 mTOR F.3347 
R. 3487 
CCCCGATCGTGAAGTTATTTG 
GTGTGCGTACAATCGGATGAA 
141 
507056 XM_583606.4 
 
RPTOR F.1999 
R.2105 
CCACAAGTACTTCCTCTCGGTCTT 
GCCCCGTGTTATAGCTGTTGA 
107 
527459 NM_001144096.1 
 
RICTOR F.733 
R.839 
CATCCAAAGACCCGACAGTATG 
TGTCCTTCAGCTGTATCTGGACTATG 
107 
280991 NM_173986.2 AKT1 F.864 
R.963 
GGATTACCTGCACTCGGAAAAG 
TCCGAAGTCGGTGATCTTGAT 
100 
534923 XM_864913.3 
 
AKT2 F.4646 
R.4745 
GCCTCCAGCCGCTTCAC 
GCAGCAAACTGGAGACCAGAT 
100 
100137872 XM_001788690.1 
 
AKT3 F.750 
R.859 
TTGTCGAGAGAGCGGGTGTT 
TTGAGATCACGGTACACAATCTTTC 
110 
509613 NM_001077893.1 
 
EIF4EBP1 F.170 
R.280 
GATCATCTATGACCGGAAGTTCCT 
TCATCGCCTGTAGGGCTAGTG 
111 
522795 NM_001168462.1 KLF10 F.1411 
R.1515 
AGAAGTTCGCCTGTCCCATGT 
TCTGCCAGTTCGGTAGCTTCT 
105 
281542 NM_174201.2 TP53 F.939 
R.1041 
TGTTTGTGCCTGTCCTGGG 
TGCTCGCTTAGTGCTCCTAGG 
103 
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Supplementary Table 8. (continued) Gene ID, GenBank accession number, hybridization 
position, sequence and amplicon size of primers for Bos taurus used to analyze gene expression. 
 
  
Gene ID Accession # Gene Primers Primers (5’-3’) bp 
506480 NM_001192095.1 
 
KRT18 F.1021 
R.1120 
GGAGATCGACCTGGACTCCAT 
GTTGAGCTGCTCCATCTGCAT 
100 
281386 NM_174140.2 
 
SERPINF1 F.730 
R.839 
CCGTGAAAGTCCCCATGATG 
GATACTTGTGCTCCCGGTCAA 
110 
282480 NM_174660.1 
 
SLC25A6 F.1203 
R.1305 
AGGACCGACCCGTGTTTAAGT 
AAACATAATCGCGCGTATTCG 
103 
503580 XM_599153.4 FOXA2 F.1924 
R.2043 
AAAGCACGCAGAAACCATAAATTAGT 
AATAATAATGTAAGGGACTGTTGTAAATGC 
120 
522159 NM_001075827.1 PLD2 F.2105 
R.2208 
TCCGAGTCTACGTGCTTTTGC 
CGTCCTGTAAGTGAAGTGCAGAA 
104 
515135 NM_001034482.1 CDIPT1 F.1082 
R.1183 
CAGGCTCACATCTTTCCAATTG 
GAACTGGTCCCCAGGATTACG 
102 
282023 NM_174445.2 PTGS2/COX2 F. 1472 
R.1574 
CGTTTTCTCGTGAAGCCCTATG 
ACTCCATGGCATCTATGTCTCCAT 
103 
281814 NM_174339.3 
 
HIF1A F. 1959 
R.2062 
GATGTTAGCTCCTTATATCCCAATGG 
TGCTTGCACTCTGAGGACTTGTA 
104 
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Supplementary Table 9.  qPCR performance among the genes measured in liver tissue. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1 The median is calculated considering all time points and all cows. 
2
 The median of ∆Ct is calculated as [Ct gene – geometrical mean of Ct internal 
controls]   for each time point and each steer. 
3 Slope of the standard curve. 
4
 R2 stands for the coefficient of determination of the standard curve. 
5
 Efficiency is calculated as [10(-1 / Slope)]. 
Gene Median Ct1 Median ∆Ct2 Slope3 (R2)4 Efficiency5 
CHOP/GADD153 26.99 4.61 -2.69 0.98 2.35 
PERK 25.46 3.11 -3.09 0.99 2.10 
TRB3 28.68 6.29 -2.94 0.99 2.19 
HSP40 23.08 0.74 -3.13 0.99 2.09 
MBTPS1 23.64 1.29 -3.45 0.99 1.95 
GRP94 21.40 -0.83 -3.39 0.95 1.97 
ATF3 25.85 3.54 -3.31 0.99 2.00 
ATF4 22.19 -0.17 -2.20 0.96 2.85 
ATF6 23.50 1.16 -2.9 0.98 2.21 
XBP1 24.94 2.60 -2.77 0.97 2.29 
NFKB1 24.04 1.25 -3.15 0.99 2.07 
STAT3 23.08 0.30 -3.06 0.99 2.12 
HSPA1A 24.96 2.53 -4.21 0.97 1.73 
HSPA1B 25.32 2.18 -3.37 0.97 1.98 
TLR4 33.49 10.72 -2.37 0.98 2.64 
RELA 24.03 1.24 -3.00 0.99 2.15 
IKBKG 25.13 2.39 -3.64 0.99 1.88 
CHUK 24.70 1.94 -3.02 0.99 2.14 
IKBKB 25.79 3.08 -2.85 0.99 2.25 
ORM1 15.83 -6.96 -2.52 0.99 2.49 
CAT 17.81 -4.96 -3.12 0.99 2.09 
SOD2 22.43 -0.33 -3.37 0.98 1.98 
GPX1 22.86 0.06 -2.90 0.99 2.21 
TXNRD1 24.76 1.98 -3.03 0.99 2.14 
PON1 18.78 -4.04 -2.90 0.99 2.21 
TNF 28.16 5.54 -2.85 0.99 2.25 
SAA3 23.98 1.35 -2.83 0.99 2.25 
HP 19.55 -3.18 -3.12 0.98 2.06 
MYD88 23.87 1.05 -3.05 0.99 2.13 
IRAK1 24.41 1.60 -2.85 0.99 2.24 
SOCS1 27.84 5.07 -3.08 0.98 2.11 
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Supplementary Table 9.  (continued) qPCR performance among the genes measured in liver 
tissue. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1 The median is calculated considering all time points and all cows. 
2
 The median of ∆Ct is calculated as [Ct gene – geometrical mean of Ct internal 
controls]   for each time point and each steer. 
3 Slope of the standard curve. 
4
 R2 stands for the coefficient of determination of the standard curve. 
5
 Efficiency is calculated as [10(-1 / Slope)]. 
Gene Median Ct1 Median 
∆Ct2 
Slope3 (R2)4 Efficiency5 
IL1B 25.85 3.24 -2.03 0.98 3.10 
CAV1 19.12 -3.45 -3.03 0.99 2.14 
MAPK14 23.25 2.63 -3.27 0.99 2.02 
PTX3 28.37 7.69 -3.14 0.99 2.08 
CREB3L3 21.33 -1.47 -3.05 0.99 2.13 
NR3C1 22.36 -0.45 -3.07 0.99 2.12 
HMGCR 21.91 -0.62 -2.3 0.99 2.72 
SREBF2 22.11 1.44 -3.06 0.99 2.12 
AACS 30.39 7.64 -3.16 0.97 2.07 
CYP4A11 21.09 -1.70 -3.20 0.99 2.05 
mTOR 24.30 1.50 -3.00 0.99 2.15 
RPTOR 25.32 2.50 -2.86 0.99 2.24 
RICTOR 24.56 1.74 -2.44 0.94 2.57 
AKT1 23.83 1.07 -3.01 0.96 2.14 
AKT2 27.36 4.49 -2.14 0.98 2.93 
AKT3 26.05 3.30 -3.14 0.98 2.08 
EIF4EBP1 25.33 2.53 -3.32 0.98 2.00 
KLF10 23.878 1.07 -2.93 0.99 2.20 
TP53 26.56 3.81 -2.79 0.99 2.29 
KRT18 21.87 1.16 -3.15 0.99 2.09 
SERPINF1 20.22 -2.53 -2.98 0.99 2.17 
SLC25A6 22.19 -0.62 -3.16 0.99 2.07 
FOXA2 26.16 3.80 -3.38 0.96 1.98 
PLD2 28.13 5.34 -2.20 0.98 2.85 
CDIPT1 23.36 0.54 -2.91 0.99 2.21 
HIF1A 22.90 2.343332 -3.21 0.98 2.05 
PTGS2/COX2 30.01 7.24 -2.22 0.94 2.83 
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Supplementary Table 10. Genes selected for transcript profiling in bovine liver. 
 
Gene Name 
 
Gene 
Symbol 
 
Function 
CCAAT/enhancer 
binding protein 
(C/EBP) 
homologous Protein 
 
CHOP/GA
DD153 
 
Gene involved in apoptosis response to ER Stress. 
RNA-activated 
protein kinase 
(PKR)-like ER 
kinase 
 
PERK 
 
PERK plays a major role in the ability of cells to adapt to 
ER stress. 
Telomerase Repeat 
binding factor 3 
TRB3 It is associated with CHOP to suppress the CHOP-
dependent transactivation. 
Heat shock protein 
40 
HSP40 Member of heat shock protein plays important role in 
chaperon activity.  
Membrane-bound 
transcription factor 
peptidase, Site 1 
 
      
MBTPS1 
 
The encoded protein has a central role in the regulation of 
lipid metabolism in cells. It is a sterol-regulated subtilisin-
like serine protease that cleaves ER membrane-bound sterol 
regulatory element-binding proteins (SREBPs), a reaction 
that initiates the two-step proteolytic process by which 
transcriptionally active fragments of SREBPs are released 
from the membrane for translocation to the nucleus. 
Glucose-regulated 
protein 
 
GRP94 
GRP94 belongs to a class of stress proteins that localize in 
the endoplasmic reticulum (ER). It acts as a molecular 
chaperone and is involved in the maintenance of cell 
survival because it exerts a specific protection against 
stresses due to Ca2+ depletion from the ER. 
Activating 
transcription factor 3 
ATF3 ATF3 is a transcriptional repressor that is rapidly induced in 
cells exposed to wide range of Stress stimuli. 
Activating 
transcription factor 4 
ATF4 ATF4 is involved in the expression of genes essential for 
amino acid import, glutathione biosynthesis, and resistance 
to oxidative stress. 
Activating 
transcription factor 6 
ATF6 ATF is a transcription factor and the main sensor of 
unfolded or mal-folded protein accumulation in ER. 
X box binding 
protein-1 
XBP1 Transcription factor essential for hepatocyte growth, the 
differentiation of plasma cells, the immunoglobulin 
secretion, and the unfolded protein response (UPR). Acts 
during endoplasmic reticulum stress (ER) by activating 
unfolded protein response (UPR) target genes via direct 
binding to the UPR element (UPRE).  
Nuclear factor of 
kappa light 
polypeptide gene 
enhancer in B-cells 1 
NFKB1 It is involved in many biological processed such as 
inflammation, immunity, differentiation, cell growth, 
tumorigenesis and apoptosis. 
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Supplementary Table 10. (continued) Genes selected for transcript profiling in bovine liver. 
 
Gene Name 
 
Gene Symbol 
 
Function 
Signal transducer 
and activator of 
transcription 3 
STAT3 Transcription factor that binds to the interleukin-6 (IL-6)-
responsive elements identified in the promoters of various 
acute-phase protein genes. Activated by IL31 through 
IL31RA 
Heat shock 70kDa 
protein 1A 
HSPA1A Hsp70s stabilize preexistent proteins against aggregation 
and mediate the folding of newly translated polypeptides 
in the cytosol as well as within organelles. These 
chaperones participate in all these processes through their 
ability to recognize nonnative conformations of other 
proteins. 
Heat shock 70kDa 
protein 1B 
HSPA1B Hsp70s stabilize preexistent proteins against aggregation 
and mediate the folding of newly translated polypeptides 
in the cytosol as well as within organelles.  
Toll-like receptor 4 TLR4 Participates in the innate immune response to microbial 
agents. 
v-rel 
reticuloendotheliosis 
viral oncogene 
homolog A 
RELA NFKB1 (MIM 164011) or NFKB2 (MIM 164012) is 
bound to REL (MIM 164910), RELA, or RELB (MIM 
604758) to form the NFKB complex. The p50 
(NFKB1)/p65 (RELA) heterodimer is the most abundant 
form of NFKB.  
Inhibitor of kappa 
light polypeptide 
gene enhancer in B-
cells, kinase gamma 
IKBKG Regulatory subunit of the IKK core complex which 
phosphorylates inhibitors of NF-kappa-B thus leading to 
the dissociation of the inhibitor/NF-kappa-B complex and 
ultimately the degradation of the inhibitor. 
Conserved helix-
loop-helix 
ubiquitous kinase 
CHUK Acts as part of the IKK complex in the conventional 
pathway of NF-kappa-B activation and phosphorylates 
inhibitors of NF-kappa-B thus leading to the dissociation 
of the inhibitor/NF-kappa-B complex and ultimately the 
degradation of the inhibitor. 
Inhibitor of kappa 
light polypeptide 
gene enhancer in B-
cells, kinase beta 
IKBKB Acts as part of the IKK complex in the conventional 
pathway of NF-kappa-B activation and phosphorylates 
inhibitors of NF-kappa-B thus leading to the dissociation 
of the inhibitor/NF-kappa-B complex and ultimately the 
degradation of the inhibitor.  
Alpha-1 acid 
glycoprotein 
ORM1 Appears to function in modulating the activity of the 
immune system during the acute-phase reaction. 
Catalase CAT It occurs in almost all aerobically respiring organisms and 
serves to protect cells from the toxic effects of hydrogen 
peroxide. Promotes growth of cells including T-cells, B-
cells, myeloid leukemia cells, melanoma cells, 
mastocytoma cells and normal and transformed fibroblast 
cells. 
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Supplementary Table 10. (continued) Genes selected for transcript profiling in bovine liver. 
 
Gene Name 
 
Gene 
Symbol 
 
Function 
Superoxide dismutase 
2 
SOD2 It destroys radicals which are normally produced within 
the cells and which are toxic to biological systems. 
Glutathione 
peroxidase 1 
GPX1 It protects the hemoglobin in erythrocytes from 
oxidative breakdown. 
Thioredoxin 
reductase 1 
TXNRD1 Isoform 1 may possess glutaredoxin activity as well as 
thioredoxin reductase activity and induces actin and 
tubulin polymerization, leading to formation of cell 
membrane protrusions.  
Paraoxonase 1 PON1 Hydrolyzes the toxic metabolites of a variety of 
organophosphorus insecticides. Capable of hydrolyzing 
a broad spectrum of organophosphate substrates and a 
number of aromatic carboxylic acid esters. May mediate 
an enzymatic protection of low density lipoproteins 
against oxidative modification and the consequent series 
of events leading to atheroma formation 
Tumor necrosis factor TNF Cytokine that binds to TNFRSF1A/TNFR1 and 
TNFRSF1B/TNFBR. It is mainly secreted by 
macrophages and can induce cell death of certain tumor 
cell lines. It is potent pyrogen causing fever by direct 
action or by stimulation of interleukin-1 secretion and is 
implicated in the induction of cachexia, Under certain 
conditions it can stimulate cell proliferation and induce 
cell differentiation 
Serum amyloid A 3 SAA3 Serum amyloid A (SAA) proteins are a family of 
apolipoproteins associated with high-density lipoprotein 
(HDL) in plasma. Different isoforms of SAA are 
expressed constitutively (constitutive SAAs) at different 
levels or in response to inflammatory stimuli (acute 
phase SAAs). 
Haptoglobin HP Haptoglobin combines with free plasma hemoglobin, 
preventing loss of iron through the kidneys and 
protecting the kidneys from damage by hemoglobin, 
while making the hemoglobin accessible to degradative 
enzymes 
 
Myeloid 
differentiation 
primary response 
gene (88) 
MYD88 Adapter protein involved in the Toll-like receptor and 
IL-1 receptor signaling pathway in the innate immune 
response. Acts via IRAK1, IRAK2, IRF7 and TRAF6, 
leading to NF-kappa-B activation, cytokine secretion 
and the inflammatory response. 
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Supplementary Table 10. (continued) Genes selected for transcript profiling in bovine liver. 
 
Gene Name 
 
Gene 
Symbol 
 
Function 
Interleukin-1 
receptor-
associated kinase 
1 
IRAK1 Binds to the IL-1 type I receptor following IL-1 
engagement, triggering intracellular signaling cascades 
leading to transcriptional up-regulation and mRNA 
stabilization. Isoform 1 binds rapidly but is then degraded 
allowing isoform 2 to mediate a slower, more sustained 
response to the cytokine. Isoform 2 is inactive suggesting 
that the kinase activity of this enzyme is not required for IL-
1 signaling. Once phosphorylated, IRAK1 recruits the 
adapter protein PELI1. 
 
Suppressor of 
cytokine signaling 
1 
SOCS1 SOCS family proteins form part of a classical negative 
feedback system that regulates cytokine signal transduction. 
SOCS1 is involved in negative regulation of cytokines that 
signal through the JAK/STAT3 pathway. Through binding 
to JAKs, inhibits their kinase activity. In vitro, also 
suppresses Tec protein-tyrosine activity. 
 
Interleukin 1, beta IL1B Produced by activated macrophages, IL-1 stimulates 
thymocyte proliferation by inducing IL-2 release, B-cell 
maturation and proliferation, and fibroblast growth factor 
activity. IL-1 proteins are involved in the inflammatory 
response, being identified as endogenous pyrogens, and are 
reported to stimulate the release of prostaglandin and 
collagenase from synovial cells. 
 
Caveolin 1 CAV1 May act as a scaffolding protein within caveolar 
membranes. Interacts directly with G-protein alpha subunits 
and can functionally regulate their activity (By similarity). 
Involved in the costimulatory signal essential for T-cell 
receptor (TCR)-mediated T-cell activation. Its binding to 
DPP4 induces T-cell proliferation and NF-kappa-B 
activation in a T-cell receptor/CD3-dependent manner. 
 
Mitogen-activated 
protein kinase 14 
 
MAPK14 Responds to activation by environmental stress, pro-
inflammatory cytokines and lipopolysaccharide (LPS) by 
phosphorylating a number of transcription factors, such as 
ELK1 and ATF2 and several downstream kinases, such as 
MAPKAPK2 and MAPKAPK5. Plays a critical role in the 
production of some cytokines, for example IL-6. May play a 
role in stabilization of EPO mRNA during hypoxic stress. 
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Supplementary Table 10. (continued) Genes selected for transcript profiling in bovine liver. 
 
Gene Name 
 
Gene Symbol 
 
Function 
Pentraxin 3 PTX3 Plays a role in the regulation of innate resistance to 
pathogens, inflammatory reactions, possibly clearance 
of self-components and female fertility (By similarity). 
 
cAMP responsive 
element binding 
protein 3-like 3 
CREB3L3 Transcription factor that may act during endoplasmic 
reticulum stress by activating unfolded protein 
response target genes. Activated in response to cAMP 
stimulation. Seems to function synergistically with 
ATF6. In acute inflammatory response, may activate 
expression of acute phase response (APR) genes. May 
be involved in growth suppression. 
 
Nuclear receptor 
subfamily 3, group 
C, member 1 
(glucocorticoid 
receptor) 
NR3C1 Receptor for glucocorticoids (GC). Has a dual mode of 
action: as a transcription factor that binds to 
glucocorticoid response elements (GRE) and as a 
modulator of other transcription factors. Affects 
inflammatory responses, cellular proliferation and 
differentiation in target tissues.  
3-hydroxy-3-
methylglutaryl-CoA 
reductase 
HMGCR This transmembrane glycoprotein is involved in the 
control of cholesterol biosynthesis. It is the rate-
limiting enzyme of sterol biosynthesis. 
 
Sterol regulatory 
element binding 
transcription factor 2 
SREBF2 This gene encodes a ubiquitously expressed 
transcription factor that controls cholesterol 
homeostasis by stimulating transcription of sterol-
regulated genes. The encoded protein contains a basic 
helix-loop-helix-leucine zipper (bHLH-Zip) domain. 
Acetoacetyl-CoA 
synthetase 
AACS Activates acetoacetate to acetoacetyl-CoA. May be 
involved in utilizing ketone body for the fatty acid-
synthesis during adipose tissue development.  
Cytochrome P450, 
family 4, subfamily 
A, polypeptide 11 
CYP4A11 Catalyzes the omega- and (omega-1)-hydroxylation of 
various fatty acids such as laurate, myristate and  
palmitate. Has little activity toward prostaglandins A1 
and E1. Oxidizes arachidonic acid to 20-
hydroxyeicosatetraenoic acid.  
Mechanistic target of 
rapamycin 
mTOR These kinases mediate cellular responses to stresses 
such as DNA damage and nutrient deprivation. This 
protein acts as the target for the cell-cycle arrest and 
immunosuppressive effects of the FKBP12-rapamycin 
complex. 
Regulatory 
associated protein of 
MTOR, complex 1 
RPTOR Works with MTOR in the pathway. 
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Supplementary Table 10. (continued) Genes selected for transcript profiling in bovine liver. 
 
Gene Name 
 
Gene Symbol 
 
Function 
RPTOR independent 
companion of 
MTOR, complex 2 
RICTOR Subunit of mTORC2, which regulates cell growth and 
survival in response to hormonal signals. mTORC2 is 
activated by growth factors, but, in contrast to 
mTORC1, seems to be nutrient-insensitive. 
 
V-akt murine 
thymoma viral 
oncogene homolog 1 
AKT1 Akt (Protein kinase B, PKB) is a serine/threonine 
kinase that plays a key in regulating cell survival, 
insulin signaling, angiogenesis and tumor formation. 
Akt is a downstream mediator of the PI 3-K pathway, 
resulting in the recruitment of Akt to the plasma 
membrane via the PH (plexstrin homology domain) of 
Akt.  
V-akt murine 
thymoma viral 
oncogene homolog 2 
AKT2 
 
General protein kinase capable of phosphorylating 
several known proteins. 
V-akt murine 
thymoma viral 
oncogene homolog 3 
AKT3 IGF-1 leads to the activation of AKT3, which may play 
a role in regulating cell survival. Capable of 
phosphorylating several known proteins.  
Eukaryotic 
translation initiation 
factor 4E binding 
protein 1 
EIF4EBP1 Regulates eIF4E activity by preventing its assembly 
into the eIF4F complex. Mediates the regulation of 
protein translation by hormones, growth factors and 
other stimuli that signal through the MAP kinase and 
mTORC1 pathways. 
Kruppel-like factor 
10 
KLF10 Transcriptional repressor involved in the regulation of 
cell growth. Inhibits cell growth. 
Tumor protein p53 TP53 Acts as a tumor suppressor in many tumor types; 
induces growth arrest or apoptosis depending on the 
physiological circumstances and cell type.  
Cytokeratin KRT18 Involved in the uptake of thrombin-antithrombin 
complexes by hepatic cells (By similarity). When 
phosphorylated, plays a role in filament reorganization. 
Involved in the delivery of mutated CFTR to the 
plasma membrane. Together with KRT8, is involved in 
interleukin-6 (IL-6)-mediated barrier protection. 
Serpin peptidase 
inhibitor, clade F 
(alpha-2 antiplasmin, 
pigment epithelium 
derived factor), 
member 1 
SERPINF1 Neurotrophic protein; induces extensive neuronal 
differentiation in retinoblastoma cells. Potent inhibitor 
of angiogenesis.  
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Supplementary Table 10. (continued) Genes selected for transcript profiling in bovine liver. 
 
Gene Name 
 
Gene 
Symbol 
 
Function 
Solute carrier 
family 25 
(mitochondrial 
carrier; adenine 
nucleotide 
translocator), 
member 6 
SLC25A6 Catalyzes the exchange of ADP and ATP across the 
mitochondrial inner membrane. May participate in the 
formation of the permeability transition pore complex 
(PTPC) responsible for the release of mitochondrial 
products that triggers apoptosis 
 
Forkhead box A2 FOXA2 Transcription activator for a number of liver genes such as 
AFP, albumin, tyrosine aminotransferase, PEPCK, etc. 
Interacts with the cis-acting regulatory regions of these 
genes. 
Phospholipase D2 PLD2 Phosphatidylcholine (PC)-specific phospholipases D 
catalyze the hydrolysis of PC to produce phosphatidic acid 
and choline. It may have a role in signal-induced 
cytoskeletal regulation and/or endocytosis. 
CDP-
diacylglycerol--
inositol 3-
phosphatidyltransfe
rase 
CDIPT1 Catalyzes the biosynthesis of phosphatidylinositol (PtdIns) 
as well as PtdIns:inositol exchange reaction. May thus act 
to reduce an excessive cellular PtdIns content.  
 
Prostaglandin-
endoperoxide 
synthase 2 
 
PTGS2/CO
X2 
May have a role as a major mediator of inflammation 
and/or a role for prostanoid signaling in activity-dependent 
plasticity. 
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 Supplementary Figure 3. Relative mRNA abundance in percent (%) of genes measured in A) 
ER stress genes, B) Inflammation genes, C) Oxidative stress, and D) Cell cycle and cell growth 
genes.  
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CHAPTER 4 
 
Hepatic transcriptome profiles in Holstein cows are affected by lipid supplementation during the 
transition period  
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INTRODUCTION 
Supplemental fats and oils have been widely used in dairy cow management (Drackley, 
1999). Supplemental lipid is added to increase the energy density of the diet, and might improve 
the energy balance of early lactating dairy cows. However, data on the influence of supplemental 
lipid on the energy balance of early lactating cows are variable, mostly because of variation in 
DMI and milk production (Grummer and Carroll, 1991). The genetic potential of modern dairy 
cows predisposes them to dysfunctional lipid metabolism, including ketosis and hepatic lipidosis 
(Douglas et al., 2006). An area of current research interest is to investigate the effect of dietary 
fat on incidence of fatty liver or other metabolic diseases.  
Dietary nutrients influence the supply of energy to tissues and modify the metabolic 
status of animals. In addition to the energetic effects that lipids may have on metabolic status, 
they also modulate metabolism by influencing enzyme activities (Jump, 2002). From a 
teleological standpoint, it is not surprising that lipids interact with genes and proteins to alter 
lipid metabolism (Jump, 2002). In rodents and humans, fatty acids (FA) modulate lipid 
metabolism, especially omega 3 FA, which decrease lipogenesis and increase FA oxidation. 
However, a consistent association between the FA composition of cell culture medium and in 
vitro hepatocyte lipid metabolism or intravenous lipid emulsions (including fish oil) and in vivo 
hepatic lipid metabolism in dairy cows has not been demonstrated (Mashek et al., 2005, Mashek 
and Grummer, 2003). These contradictory data suggest that differences may exist between 
ruminants and other species in the role that dietary FA play on hepatic lipid metabolism.  
Ballou et al. (2009) conducted a study to determine the effects of supplemental FO during 
the peripartum period on blood metabolites, hepatic FA composition, and TAG concentration in 
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liver of multiparous Holstein cows. In this study, we have used a microarray platform to evaluate 
the transcriptional adaptation in bovine liver response to lipid supplements fed during transition 
period. The main objective of this study was to evaluate large-scale hepatic gene expression in 
response to two types of lipid supplements fed during transition period in Holstein dairy cows.  
MATERIALS AND METHODS 
Animals, diets and sampling 
 Samples (n = 6/treatment) used in this study were a subset obtained from a larger 
experiment (Ballou et al., 2009). All animal procedures were conducted approved by the Animal 
Care and Use Committee of University of California at Davis. Specific details on feeding, 
management and sample collection have been reported previously (Ballou et al., 2009). Briefly, 
multiparous Holstein cows were randomized to 1 of 3 treatment diets at 21 d before anticipated 
date of parturition. Treatments were no supplemental lipid (control) or supplemental lipid from 
either Energy Booster 100 (EB100; Milk Specialties Global, Carpentersville IL) or fish oil (FO) 
and fed from 21 d before expected date of parturition until 10 d after parturition. Treatments 
were fed as a bolus immediately before the a.m. feeding. The bolus was offered within 15 min of 
collecting the prior day's refusals. The dose of lipid during the prepartum period was 250 g/d, 
whereas the dose in the postpartum period was 1% of the previous day's as-fed intake (92% 
DM). The composition of the bolus was 150 g each of rolled barley grain, shredded beet pulp, 
and cane molasses plus 550 g of the respective TMR plus the supplemental lipid source. Control 
cows were fed the same bolus without the supplemental lipid. After the entire bolus was 
consumed, within approximately 10 min, each cow was offered ad libitum either a single 
prepartum diet before parturition or lactation diet postpartum (Table 9). Immediately after 
parturition cows were switched to the lactation diet and milked twice daily. Body weight and 
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BCS were determined at study enrollment, parturition, and d 10 and 21 d after parturition. 
Percutaneous liver biopsy was performed to obtain liver tissue at d 14 prepartum and at 1 and 14 
d after parturition. Liver tissue samples from 6 animals each in control, EB100 and FO were used 
for transcript profiling. 
RNA extraction 
RNA samples were extracted from frozen tissue using established protocols in our 
laboratory (Loor et al., 2007). Briefly, liver tissue sample was weighed (~0.3-0.5 g) and 
straightway was put inside a 15 ml centrifuge tube (Corning Inc. ®, Cat. No. 430052, Corning, 
NY, USA) with 1 µl of Linear Acrylamine (Ambion® Cat. No. 9520, Austin, TX, USA) as a co-
precipitant, and 5 ml of ice-cold Trizol reagent (Invitrogen Corp., Carlsbad, CA, USA) to 
proceed with RNA extraction. This extraction procedure also utilizes acid-phenol chloroform 
(Ambion® Cat. No. 9720, Austin, TX, USA), which removes residual DNA. Any residual 
genomic DNA was removed from RNA with DNase using RNeasy Mini Kit columns (Qiagen, 
Hilden, Germany). RNA concentration was measured using a Nano-Drop ND-1000 
spectrophotometer (Nano-Drop Technologies, Wilmington, DE, USA). The purity of RNA 
(A260/A280) for all samples was above 1.81. The quality of RNA was evaluated using the Agilent 
Bioanalyzer system (Agilent 2100 Bioanalyzer, Agilent Technologies, Santa Clara, CA, USA). 
The average RNA integrity number (RIN) value for samples was 8.0 ± 0.4.  
Microarray procedure 
An annotated bovine oligonucleotide (70-mers) microarray containing >13,000 annotated 
sequences developed at the University of Illinois (Loor et al., 2007) was used for transcript 
profiling. The cDNA was obtained by RT-PCR in a 30 µL reaction adding 10 µg RNA, 2 µL of 
random hexamer primers (3 mg/ml; Invitrogen Corp., CA) and 1 µg oligo dT18 (Operon 
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Biotechnologies, AL), and DNase-RNase-free water to a volume of 17.78 µL. The mixture was 
incubated at 65°C for 5 min and kept on ice for 3 min. To the mixture 12.2 µL solution 
composed of 6 µL 5X First-Strand Buffer, 3 µL 0.1 M DTT, 0.6 µL 100 mMdNTP mix 
(Invitrogen Corp., CA), 0.12 µL of 50 mM 5-(3-aminoallyl)-dUTP (Ambion, CA), 2 µL (100 U) 
of SuperScriptTM III RT (Invitrogen Corp., CA), and 0.5 µL of RNase Inhibitor (Promega, WI) 
was added. The reaction was performed at 23°C for 1 min and 46°C for 9 h. The cDNA obtained 
was then treated with 10 µL 1M NaOH, and incubated for 15 min at 65°C to remove residual 
RNA. The solution was neutralized by adding 10 µL 1M HCl. The unincorporated 5-(3-
aminoallyl)-dUTP and free amines were removed using a Qiagen PCR Purification Kit (Qiagen, 
Germany). Clean cDNA was dried and resuspended in 4.5 µL 0.1 M Na2CO3 buffer (pH 9.0) 
and 4.5 µL of AmershamCyDye™ fluorescent dyes diluted in 60 µL of DMSO (Cy3 or Cy5; GE 
Healthcare, USA). Binding of Cy dyes with 5-(3-aminoallyl)-dUTP incorporated into cDNA was 
obtained by incubation at room temperature for 1 h. The unbound dyes are removed using a 
Qiagen PCR Purification Kit (Qiagen, Germany) and clean labelledcDNA was measured by 
means of a NanoDrop ND-1000 spectrophotometer (www.nanodrop.com). Sample and reference 
were then vacuum-dried in the dark. 
Hybridizations 
Hybridizations were performed in a dye-swap reference design. The reference was 
prepared by pooling RNA from bovine muscle, liver, and adipose tissues already available in our 
tissue bank.  Prior to hybridization, slides were re-hydrated, placed in an UV cross-linker, 
washed with 0.2% SDS solution, thoroughly rinsed with purified water to remove un-bound 
oligonucleotide, and pre-hybridized using a solution containing 1% albumin, 5 × SCC, and 0.1% 
SDS at 42 C° for ≥ 45 min with the aim of decreasing background. After pre-hybridization, 
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slides were rinsed with abundant purified water and immersed in isopropanol for ~10s and spin-
dried. Dried slides were immediately hybridized in a dye-swap-reference design (i.e. each 
sample is labeled twice with each of the two dyes and hybridized in each slide with the reference 
labeled with the opposite dye). Labeled cDNA of the sample was re-hydrated with 80µL of 
hybridization buffer #1 (Ambion) and mixed thoroughly. This solution was used to re-suspend 
the reference sample labeled with the opposite dye and mixed thoroughly in order to obtain a 
homogenous solution of the two-labeled cDNA. Before hybridization, the labeled cDNA 
resuspension of the sample + reference was incubated at 90-95 C for ca. 3 min to allow for 
cDNA denaturation to increase the efficiency of binding of oligos onto the slide. 
Hybridizations were carried out using humidified slide chambers (Corning) with cover 
slips (LifterSlip, Thermo Scientific) at 42 C° for ca. 40 hours in the dark. After hybridization, 
slides were removed from the chamber and washed for 5 min by agitation 3 times with wash 
buffers in the following order: 1×SSC and 0.2% SDS solution preheated at 42°C, 0.1× SSC and 
0.2% SDS, solution, and 0.1× SSC solution. Lastly, slides were spin-dried and inserted into a 50 
mL tube prior to gassing with Argon to preserve dye from bleaching. Arrays were scanned with a 
ScanArray 4000 (GSI-Lumonics, Billerica, MA) dual-laser confocal scanner and images 
processed and edited using GenePix 6.0 (Axon Instruments). Array quality was assessed using an 
in-house parser written in Perl language as previously described (Loor et al., 2007). Spots on the 
slide are considered “good” if the median intensity was ≥3 standard deviation above median 
background for each channel (i.e., dye). Spots are flagged “present” when both dyes pass the 
criteria, “marginal” if only one dye passes the criteria, or “absent” when both dyes fail to pass 
the criteria. Statistical analysis was conducted on oligos that are flagged as “present” and 
“marginal”. 
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Data mining  
Data from a total of 108 microarrays were normalized for dye and microarray effects 
(i.e., Lowess normalization and microarray centering) and used for statistical analysis. Data were 
analyzed using the Proc MIXED procedure of SAS (SAS, SAS Inst. Inc., Cary, NC). Fixed 
effects were treatments (control, EB100, FO), day (-10, 1, 14) and dye (Cy3, Cy5). Random 
effects included cow and microarray. Raw P values were adjusted using Benjamini and 
Hochberg’s false discovery rate (FDR). Differences in relative expression due to diet or 
treatment were considered significant at an FDR-adjusted P < 0.028. Computational analysis was 
performed by using a recently developed approach (described below) and online databases. 
Functional Enrichment Analysis   
The entire data set of microarrays were imported into Database for Annotation, 
Visualization and Integrated Discovery (DAVID) (Huang et al., 2009) analyses tools 
(http://david.abcc.ncifcrf.gov). The whole annotated microarray was used as the reference dataset 
(i.e., background) for enrichment analysis. Furthermore, we have provided functional analysis 
using the novel proposed Dynamic Impact Approach (DIA) (Bionaz et al., 2012). The DIA is a 
functional analysis tool that allows visualization of the impact and the direction of the impact of 
DEG from several annotation databases including Gene Ontology and Kyoto Encyclopedia of 
Genes and Genomes (KEGG) pathways. The DIA is described in detail in Bionaz et al. (2012); 
briefly, the impact and the direction of the impact (flux) for KEGG pathways were calculated for 
only those terms that were represented by at least 30% in the microarray compared to the whole 
annotated bovine genome.  
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RESULTS 
In this experiment, repeated-measures of ANOVA at a cutoff FDR P < 0.04 and P < 
0.028 was used for generating the list of differentially expressed genes (DEGs) in all the 
comparisons mentioned. In order to analyze the gene expression data, we used computational 
analysis with the dynamic impact analysis (DIA) approach; pathways adequately represented in 
our bovine microarray were used in the KEGG database. Adequately represented pathways were 
represented >30% (genes in pathways of whole bovine genome in array/gene in pathways whole 
bovine genome) (Bionaz et al., 2012). By following this criterion, 229 out of a total 230 Bos 
taurus KEGG pathways were represented in our array. We analyzed all 28 categories within 
DAVID but only selected categories are represented in this chapter, including Biological Process 
(GOTERM BP_1), Molecular Function (GOTERM_ MF_1), and Cellular Component 
(GOTERM_CC_1). Details on each categories of DAVID were already reported (Bionaz et al., 
2012).  
Differentially expressed genes (DEGs) and their overall pattern 
The microarray analysis of data with above mentioned cutoff values showed a significant 
effect of diet × day interaction for the bovine liver transcriptome. A total of 18 comparisons were 
used for comprehensive analysis of data. Within diet comparisons (same day with comparison of 
two diets), we analyzed 9 comparisons including d -14 F vs. C (Fish oil vs. control), d 1 F vs. C, 
day 14 F vs. C, day -14 EB vs. C (EB100 booster vs. control), day 1 EB vs. C, day 14 EB vs. C, 
day -14 EB vs. F (EB100 booster vs. Fish oil), day 1 EB vs. F, day 14 EB vs. F. Within time 
comparisons (same diet with comparison of two time points), we analyzed 9 comparisons 
including; CON d 14 vs. d 1, CON day 14 vs. -14, CON day 1 vs. -14, EB100 d 14 vs. d 1, 
EB100 day 14 vs. -14, EB100 day 1 vs. -14, FO d 14 vs. d 1, FO day 14 vs. -14, FO day 1 vs. -14.  
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Table 10 and Table 11 show the total number of DEG in each comparison of diet and 
time respectively. From 75-80 % of the DEGs were annotated to bovine ENTREZ gene ID and 
were used for further computational gene expression analysis. We observed a greater number of 
DEG within diet comparisons at day 14 in EB100 vs. FO (total 1034; up-regulated: 406, down-
regulated 628), at day 1 in EB100 vs. CON (total 1008; up-regulated: 508, down-regulated 500) 
and at day 14 in EB100 vs. FO (total 516; up-regulated: 194, down-regulated 322) (Table 10). 
Similarly, the greater number of DEGs within time comparisons were observed in CON at d 14 
vs. d -14 (total 1166; up-regulated: 551, down-regulated 615), in EB100 at d 14 vs. d 1 (total 
1454; up-regulated: 712, down-regulated 742) and in FO at d 1 vs. d -14 (total 1925; up-
regulated: 994, down-regulated 981) (Table 11). Overall, a greater number of DEGs were 
observed within time comparisons. 
Impact of DEGs on KEGG pathways using DIA  
Within diet comparisons 
An overall summary result of all major categories from KEGG analysis using DIA within 
diet comparisons is shown in Figure 13. We observed that ‘Metabolism’ was the most impacted 
category within diet the diet × day interaction and comparison EB vs. C d 1 was the most 
impacted among all measured comparisons. The major category ‘Metabolism’ is further 
categorized into 11 metabolic pathways including lipid metabolism and amino acid metabolism 
which were impacted in all 9 comparisons. The overall effect of F vs. C was the least at day -14, 
however, lipid metabolism was very highly impacted and down-regulated and almost similar 
pattern was observed at d 1. In contrast, feeding FO induced up-regulation of lipid metabolism, 
metabolism of cofactors and vitamins and biosynthesis of other secondary metabolites at d 14. 
The effect of EB vs. C was almost negligible at d -14, but at d 1, the impact was very strong and 
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almost all major metabolic pathways were down-regulated except amino acid metabolism and 
metabolism of other amino acids. Contrary to d 1 results, an opposite expression pattern of 
KEGG metabolic pathway in EB vs. C was observed at d 14. The effect of EB vs. F was 
pronounced and almost similar at all three time points although the expression trend of 
metabolism was up-regulated to down-regulated from prepartum to postpartum respectively. At d 
-14, all metabolic pathways were up-regulated except amino acid metabolism due to the effect of 
EB vs. F, however, this trend was reversed at 2 wk after parturition. 
In addition to ‘Metabolism’, cell communication under ‘Cellular Processes’, immune 
system, endocrine system and nervous system under ‘Organismal Systems’ were highly impacted 
in all comparisons. Cell communication, immune system and endocrine system were down-
regulated due to the effect of FO over control and EB100 over control, except at d 1 where cell 
communication was strongly up-regulated due to EB100. Interestingly, EB vs. F had opposite 
impact and up-regulation of these pathways at all-time points.  
The top-most impacted metabolic pathways were sorted from all 9 comparisons within 
diet effects and are shown in Figure 14. We observed a strong down-regulation of 
glycolysis/gluconeogenesis at d 1 and up-regulation at day 14, regardless of diet. Pentose and 
glucuronate interconversions, fructose and mannose metabolism, galactose metabolism and 
steroid metabolism were among 10 most impacted pathways in all comparisons. Feeding FO up-
regulated but EB100 down-regulated carbohydrate metabolism around parturition at all measured 
time points. The comparison of EB100 vs. FO revealed highly impacted carbohydrate 
metabolism including up-regulation of fructose and mannose metabolism and galactose 
metabolism at d -14 and down-regulation at d 1 and 14. In lipid metabolism, the effect of FO at d 
14 was very strong; fatty acid biosynthesis and synthesis and degradation of ketone bodies were 
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induced but fatty acid metabolism and fatty acid elongation in mitochondria were down-
regulated. At d 1, down-regulation of steroid biosynthesis and synthesis and degradation of 
ketone bodies was observed by treatment of FO. Interestingly, pathways of lipid metabolism 
were down-regulated by EB100 treatment and this effect was profound at d 1 of parturition.    
Within time comparisons 
There was a strong effect of time within the same diet as shown in Figure 15. Similar to 
the within effects of diet on metabolism, the category ‘Metabolism’ was the most impacted 
across the time of parturition. A bigger picture of these results revealed prominent changes in 
metabolic pathways including carbohydrate metabolism, lipid metabolism, amino acid 
metabolism, metabolism of other amino acids, metabolism of cofactors and vitamins, and 
biosynthesis of other secondary metabolites. Most of these metabolic pathways except amino 
acid metabolism and metabolism of other amino acids were down-regulated prepartum to 
postpartum in control-fed cows. Feeding FO induced up-regulation of most of the metabolic 
pathways from prepartum to postpartum and this expression was greater at d 14 vs. d 1. Similar 
to the effect of FO, feeding EB100 also induced up-regulation of metabolic pathways especially 
at d 14 vs. d -14 and d 14 vs. d 1. Surprisingly, lipid metabolism was down-regulated at all-time 
points in control-fed cows but very strongly up-regulated in cows fed EB100 and FO around 
parturition.  
In ‘Cellular Processes’ and ‘Organismal System’, a huge impact of both treatments was 
observed in cell communication, immune system, endocrine system and nervous system. 
Immune system was up-regulated in cows fed control and EB100 but down-regulated to no 
change in cows fed FO around the parturition. On the other hand, endocrine system was induced 
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in cows fed EB100 and FO than controls. Interestingly, cell communication and nervous system 
had similar trend and were up-regulated at the time of parturition regardless of treatment.  
Further sorting of top-most impacted pathways among 9 comparisons within time 
revealed that lipid metabolism was strongly induced due the effect of FO and EB100 (Figure 16). 
Glycolysis/gluconeogenesis, pentose and glucuronate interconversions, galactose metabolism 
and synthesis and degradation of ketone bodies were among 10 most impacted KEGG terms 
uncovered within time comparisons. Gycolysis/gluconeogenesis, and fructose and mannose 
metabolism was down-regulated in all comparisons except EB100 d 14 vs. day 1. Fatty acid 
biosynthesis genes were highly up-regulated due to treatment of FO. Furthermore, fatty acid 
elongation in mitochondria, fatty acid metabolism, synthesis and degradation of ketone bodies 
and steroid biosynthesis were highly impacted around parturition regardless of diet.    
Impact of DEGS on gene ontology (GO) Functional Categories of DAVID  
To uncover the impact on pathways of functional categories from DAVID, DIA was also 
used on 9 comparisons with diet interaction. Pathways within the terms obtained from DAVID as 
it relates to GO Biological Process (GOTERM_BP_1), Molecular Function (GOTERM_MF_1) 
and Cellular Components (GOTERM_CC_1). A cutoff of the mean plus 1 standard deviation 
was used to obtain the overall top impacted pathways in each term (Figure 17). For 
GOTERM_BP_1, cell killing, cellular component organization, cellular component biogenesis, 
cell death, and immune system processes were up-regulated, whereas rhythmic process and 
pigmentation were down-regulated. Most of top impacted pathways had no change in flux and 
showed approximately similar number of up-regulated and down-regulated DEGs in each 
pathway. For GOTERM_MF_1, we observed very strong down-regulation of biological 
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adhesion, multicellular organismal process, cellular component organization and cellular process 
and mild up-regulation of cell killing, metabolic process and immune system processes. The 
GOTERM_CC_1 had a trend for up-regulation of various pathways including membrane 
enclosed lumen, organelle part, macromolecular complex and synapse part.  
DISCUSSION 
Better management of feeding dairy cows during transition period can ensure the 
maximum milk production with minimum possible incidence of metabolic and infectious 
diseases. Several dietary strategies have been proposed to optimize the productivity of transition 
period in dairy cows (Dann et al., 2006, Douglas et al., 2006, Litherland et al., 2011). Feeding 
long chain fatty acids (LCFA) in the form of saturated or unsaturated fatty acids can benefit cow 
health and reduce possible health related complexities in dairy management (Mashek et al., 
2005). Although physiological and blood data from transition dairy cows have shown the effects 
of lipid supplementation on body weight and overall metabolic status, investigation at the 
molecular level using advanced gene expression techniques can uncover the principal molecular 
factors responsible for metabolic adaptations. Our group has determined the effect of the 
transition period and either restricted or overfeding energy prepartum in bovine liver using a 
microarray platform of quantitative gene expression (Loor et al., 2005, Loor et al., 2006). To our 
knowledge, this is the first study to evaluate the effect of lipid supplementation on hepatic gene 
expression using microarray techniques.   
In this experiment, the category ‘Metabolism’ of KEGG pathways was highly impacted 
in both within diet and within time comparisons. Metabolism is a general category and sub-
categorized into 11 metabolic pathways including 1.1) carbohydrate metabolism, 1.2) energy 
metabolism, 1.3) lipid metabolism, 1.4) nucleotide metabolism, 1.5) amino acid metabolism, 1.6) 
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metabolism of other amino acids, 1.7) glycan biosynthesis and metabolism, 1.8) metabolism of 
cofactors and vitamins, 1.9) metabolism of terpenoids and polyketides, 1.10) biosynthesis of 
other secondary metabolites and 1.11) xenobiotics biodegradation and metabolism (Kanehisa et 
al., 2006). The change in metabolism was obvious because nutrients can act as modulators of 
gene expression and play major role to control gene regulation in different cellular responses and 
biological processes (Bionaz et al., 2012). Long chain fatty acids can act as modulator and bind 
directly to control genes expression in various tissues such as adipose tissue and liver (Grimaldi 
et al., 1999).  
 Carbohydrate metabolism, lipid metabolism and amino acid metabolism was highly 
impacted in the result of feeding saturated and unsaturated fatty acids which explained the role of 
LCFA. In part of adaptation mechanism of liver to nutritional changes, especially high fat diet, 
increases the expression of proteins involved in lipid catabolism, fatty acid uptake and utilization 
of other tissues (Goldberg et al., 2009). Similarly, high fat diet induced changes in carbohydrate 
metabolism because the nutritional requirement and process change according to the availability 
of nutrients. Kennedy et al. (2007) and Schmidt et al. (2012) investigated the effects of high fat 
diet in mice and human respectively and reported an up-regulation of genes in lipid metabolism 
and protein metabolism. Negligible change in overall metabolism was observed 2 wk before 
calving except lipid metabolism, which could be the effect of nutritional shift towards more fatty 
acids as energy fuel. The nutrient demand by the fetal calf and placenta increases during the last 
3 wk of pregnancy and DMI may decrease from 10 to 30% compared with intake during early 
dry period (Bell, 1995).  Moreover, the down-regulation in glycolysis/gluconeogenesis pathway 
2 wk before calving and at the onset of lactation suggests fatty acids were used as a major energy 
fuel in hepatocytes and glucose was used for fetal growth during pregnancy and for milk 
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production during early lactation (Drackley, 2005). However, after two weeks postpartum, 
glycolysis/gluconeogenesis was up-regulated to maintain overall energy status with progressive 
clearance of calving stress.     
Surprisingly, fatty acid metabolism was down-regulated around parturition regardless of 
diet, which could be due to the limitation of interpretation in data because KEGG pathway of 
metabolism includes both catabolism and anabolism, and DIA approach presents the net effect 
only due to both catabolism and anabolism pathways. Feeding dietary fat can increase the β-
oxidation of fatty acids and reduce accumulation of TAG in the liver of transition cows. In the 
same set of cows from which our samples were obtained, Ballou et al. (2009) reported that 
supplemental fish oil altered the FA composition of liver phospholipids and TAG, decreasing 
total saturated fatty acids and increasing total n-3 and long-chain polyunsaturated fatty acids 
(>20 carbon fatty acids). Despite the altered fatty acid composition, hepatic total triacylglycerol 
concentrations were unaffected by supplemental fish oil. Furthermore, the improved metabolic 
profile following lipid supplementation did not decrease hepatic total triacylglycerol 
concentrations. Also, the blood concentration of fatty acids in the form of NEFA increases due to 
adipose tissue mobilization at the time of calving, these NEFA are the major source of energy to 
the cow during transition period (Drackley et al., 2005). The down-regulation of fatty acid 
elongation in mitochondria indicates the halt in de novo lipogenesis in fact the cow liver is not 
lipogenic. A decline in blood concentration of NEFA and BHBA with TAG level in liver agrees 
with  our gene expression data.  
Within time comparisons, the down-regulation of all metabolic pathways except amino 
acid metabolism in control diet suggests that this group experienced more drastic changes as 
shown by blood NEFA and BHBA, and lipid TAG data. The down-regulation of 
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glycolysis/gluconeogenesis and up-regulation of amino acid metabolism is the indication of 
active protein machinery to metabolize fatty acids. Hepatic adaptations in the response of 
parturition are characterized by gene expression changes in several biological pathways such as 
lipid metabolism, metabolic stress, insulin signaling etc. (Loor et al., 2005).   
Contrary to the effect of control diet, most of the metabolic pathways including fatty acid 
metabolism, synthesis and degradation of ketone bodies and steroid biosynthesis were strongly 
up-regulated in the result of feeding dietary lipids around parturition. These effects indicate the 
metabolic processing in liver to use fatty acids as energy fuel and/or source for steroid synthesis. 
The source of saturated fatty acids also induced the immune system that is the result of immune 
response activation by saturated fatty acids in this group of transition dairy cows. Dietary fat 
plays an important role to modulate immune and inflammatory response and high fat diets 
suppress the immune system (Han et al., 2002). Fatty acids can also modulate cascade signaling 
pathways at multiple levels to control immune response.   
CONCLUSION 
Hepatic transcriptome analysis from this experiment indicated that saturated and 
unsaturated lipid supplements induce strong changes on overall function of liver in dairy cows. 
Biological alterations in metabolism include lipid, carbohydrate, protein and energy metabolism. 
The application of DIA approach on microarray data also revealed effects on non-metabolic 
pathways such as immune functions and endocrine system. Further extensive data interpretation 
and presentation with accurate biological reasoning can help us to better understand the gene 
expression data.       
 
 
142 
 
REFERENCES 
Ballou, M. A., R. C. Gomes, S. O. Juchem, and E. J. DePeters. 2009. Effects of dietary 
supplemental fish oil during the peripartum period on blood metabolites and hepatic fatty 
acid compositions and total triacylglycerol concentrations of multiparous Holstein cows. 
J Dairy Sci 92:657-669. 
Bell, A. W. 1995. Regulation of organic nutrient metabolism during transition from late 
pregnancy to early lactation. J Anim Sci 73:2804-2819. 
Bionaz, M., K. Periasamy, S. L. Rodriguez-Zas, W. L. Hurley, and J. J. Loor. 2012. A novel 
dynamic impact approach (DIA) for functional analysis of time-course omics studies: 
validation using the bovine mammary transcriptome. PLoS One 7:e32455. 
Dann, H. M., N. B. Litherland, J. P. Underwood, M. Bionaz, A. D'Angelo, J. W. McFadden, and 
J. K. Drackley. 2006. Diets during far-off and close-up dry periods affect periparturient 
metabolism and lactation in multiparous cows. J Dairy Sci 89:3563-3577. 
Douglas, G. N., T. R. Overton, H. G. Bateman, 2nd, H. M. Dann, and J. K. Drackley. 2006. 
Prepartal plane of nutrition, regardless of dietary energy source, affects periparturient 
metabolism and dry matter intake in Holstein cows. J Dairy Sci 89:2141-2157. 
Drackley, J. K. 1999. ADSA Foundation Scholar Award. Biology of dairy cows during the 
transition period: the final frontier? J Dairy Sci 82:2259-2273. 
Drackley, J. K., H. M. Dan, G. N. Douglas, N. A. J. Guretzky, N. B. Litherland, J. P. 
Underwood, and J. J. Loor. 2005. Physiological and pathological adaptations in dairy 
cows that may increase susceptibility to periparturient diseases and disorders. Italian J 
Ani Sci 4:323-344. 
143 
 
Goldberg, I. J., R. H. Eckel, and N. A. Abumrad. 2009. Regulation of fatty acid uptake into 
tissues: lipoprotein lipase- and CD36-mediated pathways. J Lipid Res 50 Suppl:S86-90. 
Grimaldi, P. A., L. Teboul, D. Gaillard, A. V. Armengod, and E. Z. Amri. 1999. Long chain fatty 
acids as modulators of gene transcription in preadipose cells. Mol Cell Biochem 192:63-
68. 
Grummer, R. R. and D. J. Carroll. 1991. Effects of dietary fat on metabolic disorders and 
reproductive performance of dairy cattle. J Anim Sci 69:3838-3852. 
Han, S. N., L. S. Leka, A. H. Lichtenstein, L. M. Ausman, E. J. Schaefer, and S. N. Meydani. 
2002. Effect of hydrogenated and saturated, relative to polyunsaturated, fat on immune 
and inflammatory responses of adults with moderate hypercholesterolemia. J Lipid Res 
43:445-452. 
Huang, D. W., B. T. Sherman, and R. A. Lempicki. 2009. Systematic and integrative analysis of 
large gene lists using DAVID bioinformatics resources. Nat Protoc 4:44-57. 
Jump, D. B. 2002. Dietary polyunsaturated fatty acids and regulation of gene transcription. Curr 
Opin Lipidol 13:155-164. 
Kanehisa, M., S. Goto, M. Hattori, K. F. Aoki-Kinoshita, M. Itoh, S. Kawashima, T. Katayama, 
M. Araki, and M. Hirakawa. 2006. From genomics to chemical genomics: new 
developments in KEGG. Nucleic Acids Res 34:D354-357. 
Kennedy, A. R., P. Pissios, H. Otu, R. Roberson, B. Xue, K. Asakura, N. Furukawa, F. E. 
Marino, F. F. Liu, B. B. Kahn, T. A. Libermann, and E. Maratos-Flier. 2007. A high-fat, 
ketogenic diet induces a unique metabolic state in mice. Am J Physiol Endocrinol Metab 
292:E1724-1739. 
144 
 
Litherland, N. B., H. M. Dann, and J. K. Drackley. 2011. Prepartum nutrient intake alters 
palmitate metabolism by liver slices from peripartal dairy cows. J Dairy Sci 94:1928-
1940. 
Loor, J. J., H. M. Dann, R. E. Everts, R. Oliveira, C. A. Green, N. A. Guretzky, S. L. Rodriguez-
Zas, H. A. Lewin, and J. K. Drackley. 2005. Temporal gene expression profiling of liver 
from periparturient dairy cows reveals complex adaptive mechanisms in hepatic function. 
Physiol Genomics 23:217-226. 
Loor, J. J., H. M. Dann, N. A. Guretzky, R. E. Everts, R. Oliveira, C. A. Green, N. B. Litherland, 
S. L. Rodriguez-Zas, H. A. Lewin, and J. K. Drackley. 2006. Plane of nutrition prepartum 
alters hepatic gene expression and function in dairy cows as assessed by longitudinal 
transcript and metabolic profiling. Physiol Genomics 27:29-41. 
Loor, J. J., R. E. Everts, M. Bionaz, H. M. Dann, D. E. Morin, R. Oliveira, S. L. Rodriguez-Zas, 
J. K. Drackley, and H. A. Lewin. 2007. Nutrition-induced ketosis alters metabolic and 
signaling gene networks in liver of periparturient dairy cows. Physiol Genomics 32:105-
116. 
Mashek, D. G., S. J. Bertics, and R. R. Grummer. 2005. Effects of intravenous triacylglycerol 
emulsions on hepatic metabolism and blood metabolites in fasted dairy cows. J Dairy Sci 
88:100-109. 
Mashek, D. G. and R. R. Grummer. 2003. Effects of long chain fatty acids on lipid and glucose 
metabolism in monolayer cultures of bovine hepatocytes. J Dairy Sci 86:2390-2396. 
Schmidt, S., F. Stahl, K. O. Mutz, T. Scheper, A. Hahn, and J. P. Schuchardt. 2012. Different 
gene expression profiles in normo- and dyslipidemic men after fish oil supplementation: 
results from a randomized controlled trial. Lipids Health Dis 11:105. 
145 
 
Table 9. Ingredient and nutrient composition of the basal prepartum and postpartum diets fed to 
multiparous Holstein cows during late pregnancy and early lactation (Ballou et al. 2009). 
Item Diet 
 
Prepartum Lactating 
Ingredient   
Low-DCAD alfalfa hay, chopped 31.0 — 
Lactating alfalfa hay, chopped — 49.9 
Oat hay, chopped 20.6 — 
Almond hulls 10.4 9.2 
Beet pulp, shredded 3.4 4.8 
Corn, steam-flaked 11.4 14.8 
Barley, steam rolled 7.0 10.1 
Soybean meal 1.2 4.9 
Dried distillers grains — 3.1 
Fat — 0.8 
Salt — 0.4 
Postpartum vitamin mineral mix1 — 2 
Prepartum vitamin mineral mix2 5.8 — 
Anionic supplement3 9.2 — 
Nutrient content4   
DM 92.1 ± 0.5 91.9 ± 0.2 
CP 13.9 ± 0.3 19.4 ± 0.7 
ADF 30.9 ± 0.3 22.9 ± 0.5 
NDF 43.4 ± 0.6 29.7 ± 0.7 
Ether extract 2.4 ± 0.06 3.4 ± 0.10 
NFC 34.0 39.7 
NEL, Mcal/kg of DM 1.38 ± 0.01 1.55 ± 0.02 
Ca 0.78 ± 0.04 0.89 ± 0.03 
P 0.29 ± 0.01 0.40 ± 0.02 
Mg 0.47 ± 0.02 0.43 ± 0.04 
K 1.38 ± 0.05 2.15 ± 0.13 
Na 0.21 ± 0.003 0.38 ± 0.02 
S 0.21 ± 0.003 — 
Cl 1.13 ± 0.02 — 
DCAD, mEq/kg −0.84 — 
1
 Mix contained a minimum of 8.5% Ca, 4.5% P, 6.5% Mg, 1.0% K, 1.6% S, 500 mg of Cu/kg, 
2,000 mg of Mn/kg, 17 mg of Se/kg, 3,250 mg of Zn/kg, 44 mg of I/kg, 400,000 IU of vitamin 
A/kg, 140,000 IU of vitamin D/kg, and 3,150 IU of vitamin E/kg. 
2
 Mix contained a minimum of 3.0% Ca, 1.0% P, 0.4% Mg, 1.0% K, 145 mg of Cu/kg, 615 mg 
of Mn/kg, 3.7 mg of Se/kg, 4.5 mg of I/kg, 97,000 IU of vitamin A/kg, 22,000 IU of vitamin 
D/kg, and 1,650 IU of vitamin E/kg. 
3
 SoyChlor 16-7 (West Central Soy, Ralston, IA) 
4
 Nutrient content based on monthly composites of TMR samples (n = 7 for each TMR). Values 
for NFC and DCAD were estimated by the NRC (2001) model using mean composition data. 
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Table 10. Differentially expressed genes (DEG) within diet comparisons (P < 0.028, FDR < 
0.04) in hepatic tissue of cows (n = 6/treatment) fed a control (CON), saturated fatty acid 
(EB100) and unsaturated fatty acids (FO) diet from d -21 to d 10 around parturition.  
 
Comparison Day DEG DEG annotated to Bovine 
gene ID 
Up-regulated Down-
regulated 
FISH vs. CON 14 1140 887 515 374 
EB100 vs. CON 14 810 582 207 375 
EB100 vs. FO 14 1280 1034 406 628 
FISH vs. CON 1 362 289 126 163 
EB100 vs. CON 1 1257 1008 508 500 
EB100 vs. FO 1 1082 882 468 414 
FISH vs. CON -14 519 429 155 274 
EB100 vs. CON -14 180 145 59 86 
EB100 vs. FO -14 630 516 194 322 
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Table 11.  Differentially expressed genes (DEG) within day comparisons (P < 0.028, FDR < 
0.04) in hepatic tissue of cows (n = 6/treatment) fed a control (CON), saturated fatty acid 
(EB100) and unsaturated fatty acids (FO) diet from d -21 to d 10 around parturition.  
 
Comparison Treatment DEG DEG annotated to 
Bovine gene ID 
Up-
regulated 
Down-
regulated 
Day 14 vs. -14 CON 1438 1166 551 615 
Day 14 vs. 1 CON 1498 1165 565 600 
Day 1 vs -14 CON 1160 921 491 430 
Day 14 vs. -14 EB100 1608 1328 594 734 
Day 14 vs. 1 EB100 1754 1454 712 742 
Day 1 vs -14 EB100 907 731 315 416 
Day 14 vs. -14 FO 1313 1093 649 444 
Day 14 vs. 1 FO 1648 1338 585 553 
Day 1 vs -14 FO 2386 1925 944 981 
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Figure 13. Impact and flux of major KEGG categories with pathways (by DIA) within diet 
comparisons (P < 0.028, FDR < 0.04) in hepatic tissue of cows (n = 6/treatment) fed a control 
(CON), saturated fatty acid (EB100) and unsaturated fatty acids (FO) diet from d -21 to d 10 
around parturition. Reported are the total impact (blue horizontal bars; larger the bars higher the 
impact) and the direction of the impact (or flux; green shade denotes inhibition and red shade 
denotes activation). Fish oil vs. control is denoted by FvC, EB100 vs. control by EBvC and 
EB100 vs. fish oil by EBvF at respective days -14, 1 and 14 around parturition. 
Category
1. Metabolism
0.1 Metabolic Pathways
1.1 Carbohydrate Metabolism
1.2 Energy Metabolism
1.3 Lipid Metabolism
1.4 Nucleotide Metabolism
1.5 Amino Acid Metabolism
1.6 Metabolism of Other Amino Acids
1.7 Glycan Biosynthesis and Metabolism
1.8 Metabolism of Cofactors and Vitamins
1.9 Metabolism of Terpenoids and Polyketides
1.10 Biosynthesis of Other Secondary Metabolites
1.11 Xenobiotics Biodegradation and Metabolism
2. Genetic Information Processing
2.1 Transcription
2.2 Translation
2.3 Folding, Sorting and Degradation
2.4 Replication and Repair
3. Environmental Information Processing
3.1 Membrane transport
3.2 Signal Transduction
3.3 Signaling Molecules and Interaction
4. Cellular Processes
4.1 Transport and Catabolism
4.2 Cell Motility
4.3 Cell Growth and Death
4.4 Cell Communication
5. Organismal Systems
5.1 Immune System
5.2 Endocrine System
5.3 Circulatory System
5.4 Digestive System
5.5 Excretory System
5.6 Nervous System
5.7 Sensory System
5.8 Development
5.9 Environmental Adaptation
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Figure 15. Impact and flux of major KEGG categories with pathways (by DIA) within time 
comparisons (P < 0.028, FDR < 0.04) in hepatic tissue of cows (n = 6/treatment) fed a control 
(CON), saturated fatty acid (EB100) and unsaturated fatty acids (FO) diet from d -21 to d 10 
around parturition. Reported are the total impact (blue horizontal bars; larger the bars higher the 
impact) and the direction of the impact (or flux; green shade denotes inhibition and red shade 
denotes activation). Control is denoted by C, EB100 by EB and fish oil by F at respective 
comparisons of days -14, 1 and 14 around parturition.
Category
1. Metabolism
0.1 Metabolic Pathways
1.1 Carbohydrate Metabolism
1.2 Energy Metabolism
1.3 Lipid Metabolism
1.4 Nucleotide Metabolism
1.5 Amino Acid Metabolism
1.6 Metabolism of Other Amino Acids
1.7 Glycan Biosynthesis and Metabolism
1.8 Metabolism of Cofactors and Vitamins
1.9 Metabolism of Terpenoids and Polyketides
1.10 Biosynthesis of Other Secondary Metabolites
1.11 Xenobiotics Biodegradation and Metabolism
2. Genetic Information Processing
2.1 Transcription
2.2 Translation
2.3 Folding, Sorting and Degradation
2.4 Replication and Repair
3. Environmental Information Processing
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3.2 Signal Transduction
3.3 Signaling Molecules and Interaction
4. Cellular Processes
4.1 Transport and Catabolism
4.2 Cell Motility
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Figure 17. DAVID Terms analysis uncovered (by DIA) within time comparisons (P < 0.028, 
FDR < 0.04) in hepatic tissue of cows (n = 6/treatment) fed a control (CON), saturated fatty acid 
(EB100) and unsaturated fatty acids (FO) diet from d -21 to d 10 around parturition. Reported 
are the total impact (blue horizontal bars; larger the bars higher the impact) and the direction of 
the impact (or flux; green shade denotes inhibition and red shade denotes activation). 
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GO:0051704~multi-organism process
GO:0016032~viral reproduction
GEOTERM_MF_1 Impact Flux
GO:0022610~biological adhesion
GO:0032501~multicellular organismal process
GO:0016032~viral reproduction
GO:0016043~cellular component organization
GO:0022414~reproductive process
GO:0001906~cell killing
GO:0008152~metabolic process
GO:0009987~cellular process
GO:0000003~reproduction
GO:0002376~immune system process
GO:0016265~death
GO:0032502~developmental process
GEOTERM_CC_1 Impact Flux
GO:0031974~membrane-enclosed lumen
GO:0044422~organelle part
GO:0031975~envelope
GO:0044421~extracellular region part
GO:0032991~macromolecular complex
GO:0043226~organelle
GO:0005576~extracellular region
GO:0005623~cell
GO:0044464~cell part
GO:0045202~synapse
GO:0044456~synapse part
GO:0019012~virion
GO:0044423~virion part
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CHAPTER 5 
SUMMARY AND CONCLUSIONS 
The overall objective of this dissertation was to evaluate hepatic gene expression as 
affected by feeding, and to integrate these data with production data including blood metabolites 
and hepatic lipid contents. Our general hypothesis was that overfeeding dietary energy prepartum 
and supplementation of saturated and unsaturated LCFA would affect hepatic metabolism, and 
that these effects are controlled at the molecular level by cross-talk of gene expression. 
Results from chapter 1 indicated that overfeeding during the entire dry period resulted in 
increased metabolic burden on liver to control energy status of milking cows during early 
lactation. Overfed cows may have had more risk to metabolic disorders as a result of consistent 
change in fatty acid oxidation and accumulation of TAG in liver. The abrupt change in lipid 
metabolism in liver is associated with the release and down-stream function of hepatokines, e.g., 
FGF21, and the classical nuclear receptor PPARα. The gene expression data from this 
experiment revealed a similar effect of gene regulation by FGF21 and PPARα as described in 
non-ruminants.  
The effects of overfeeding dietary energy prepartum on gene expression of the classical 
inflammation pathway, endoplasmic reticulum (ER) stress, oxidative stress and apoptosis were 
evaluated in chapter 2. Results of gene expression data indicate a continuous risk of 
inflammation and negative status of immune response in overfed cows after parturition.  
To better understand the molecular effect of lipid supplementation on hepatic metabolism 
in Holstein dairy cows, microarray platform with advanced computational and bioinformatics 
techniques were used in chapter 3. Cows fed with lipid supplements, either saturated or 
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unsaturated source of fatty acids, resulted in highly impacted metabolism especially in pathways 
of carbohydrate and lipid metabolism.  
 In general, overfeeding dietary energy during dry period and lipid supplements around 
parturition resulted in significant metabolic changes in bovine liver to maintain energy status 
early postpartum. The pattern of hepatic gene expression indicated the molecular control of 
potential physiological changes around the transition period and also the effects of prepartum 
dietary energy and lipid supplementation. Recent advancement in the field of molecular biology 
along with the application of bioinformatics is a new approach to better understand the molecular 
basis of physiological effects. Results from above mentioned experiments suggest establishing a 
new dimension of molecular research to evaluate cow health and productivity during transition 
period. Very few groups have reported hepatic gene expression in transition dairy cows and here 
we have evaluated the changes in mRNA expression of genes related to lipid metabolism, 
heptokines e.g., FGF21, growth hormones, nuclear receptors, inflammation, endoplasmic 
reticulum stress, oxidative stress and whole transcriptome adaptations in liver of transition dairy 
cows. The results of above mentioned gene expression are very important to establish molecular 
tool for cow’s health and more production. In short, emerging new molecular techniques with 
classical methods of physiology are helping to improve dairy management.  
